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Introduction
The extensive networks of blood and lymphatic vessels within the vertebrate body are essential for the transport and delivery of fluids, gases, macromolecules and cells, and play important roles in facilitating immune responses. The development 
of the vascular tree requires a highly coordinated interplay of hierarchical genetic and 
environmental factors, ultimately leading to the formation of a functional network of 
interconnected tubules that efficiently perfuses tissues. Through the use of various in 
vitro and in vivo model systems many major interactors in vascular development have 
been identified in the past decade. The zebrafish (Danio rerio) system in particular offers 
several advantages for in vivo studies, and has played a pivotal role in new discoveries 
within the angiogenesis field (Lawson and Weinstein, 2002). Further understanding of the 
mechanisms whereby blood and lymphatic vessels form is an important question that 
could yield therapeutic options to alleviate vascular disorders, which are leading causes 
of mortality. 
The vasculature is among the first organs to develop in vertebrate embryos. For the 
normal functioning of the complex vertebrate body architecture a continuous and efficient 
transport of liquids, gases, hormones, and circulating cells to tissues and organs is required. 
This requirement is met by two endothelial structures that form highly branched, tubular 
networks; the blood vessels and the lymphatic vessels. Although these two endothelial 
structures are intimately linked and even form functional connections, they fulfill different 
functions; whereas the main function of the blood vessels is to allow the transport of blood 
and to oxygenate distal tissues, the lymphatic vessels are key in draining fluids from the 
interstitium.  Both endothelial networks are indispensable in maintaining homeostasis and 
their malformation or dysfunction is causative to the pathogenesis of many diseases (Cueni 
and Detmar, 2006; Alitalo et al., 2005). Insufficient delivery of oxygen by blood vessels 
causes tissue ischemia and might even lead to myocardial infarction. During cancer growth, 
stimulation of angiogenesis by the tumor tissue leads to improved supply of oxygen and 
nutrients to the tumor, which further stimulates tumor growth (Carmeliet, 2005; Ferrara, 
2005). Cancer metastasis to distal tissues on the other hand, mainly occurs through 
spreading via the lymphatic vasculature (Aachen and Stacker, 2006). As cardiovascular 
diseases and cancer are the major causes of mortality in westernized societies (Lusis, 
2000), the understanding of blood- and lymphatic vessel growth and the ability to control 
pathogenic vessel growth is of utmost importance to public health. 
The assembly of the vasculature
The growth of the vascular system is a highly coordinated process of cell proliferation, 
differentiation and migration during tissue morphogenesis. Blood vessels in the vertebrate 
embryo initially form through a process called vasculogenesis (Risau et al., 1995). During 
vasculogenesis, mesodermally derived precursor cells, termed angioblasts (Choi et al., 
1998; Vogeli et al., 2006), differentiate to endothelial cells and subsequently proliferate in 
situ within a previously avascular tissue and coalesce to form a primitive tubular network 
(Fig. 1). During vasculogenesis, the major vessels in the embryo, including the dorsal aorta 
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and cardinal vein are formed (Drake et al., 2000). The primary network is then remodeled 
through angiogenesis, which includes the pruning, growth and sprouting of pre-existing 
vessels to form the interconnecting branching patterns that characterize the mature 
vasculature (Carmeliet, 2000; Adams and Alitalo, 2007) (Fig. 1). With the growing maturity 
of the vasculature, the endothelial cells also tightly integrate supporting cell types like 
vascular smooth muscle cells (vSMCs) and pericytes into the vessel wall, further enhancing 
the functionality of the vascular bed (Folkman and D’Amore, 1996; Armulik et al., 2005; 
Bergers et al., 2005). Exchange of fluids and gases is chiefly accomplished within the 
capillaries of the vascular system, which are almost completely composed of endothelial 
cells and only rarely covered with vascular smooth muscle cell-like pericytes (Yancopoulos, 
1998). A further differentiation of the embryonic veins enables the sprouting of lymphatic 
Fig. 1. The assembly of the vasculature. Mesodermally derived cells differentiate to angioblasts and coalesce to 
form cord-like structures, in a process called vasculogenesis. A further differentiation of the endothelial cells gives 
rise to arteries (red) and veins (blue), which are progressively remodeled into a hierarchical network of arterioles, 
capillaries, and venules during subsequent steps of angiogenesis. During angiogenesis, endothelial cells sprout 
and branch of from pre-existing vessels in respond to environmental factors that stimulate vessel growth. After 
lumenization of the newly formed vessels, circulation is initiated, allowing for perfusion and oxygenation of distal 
tissues. A further maturation of the vascular tree is characterized by the coverage of arteries and veins with vascular 
smooth muscle cells or pericytes. Similarly, lymphatic endothelial cells differentiate and sprout from the venous 
compartment to give rise to the lymphatic system (green). Adapted from Adams and Alitalo, 2007
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endothelial cells, which then migrate and proliferate to give rise to the lymphatic system 
(Francois et al., 2008) (Fig. 1). 
In the zebrafish embryo, similar heamangiogenic features can be distinguished; first 
the major vessels including the dorsal aorta and the posterior cardinal vein are formed 
through vasculogenesis, followed by remodelling and growth of the vasculature through 
angiogenesis (Roman and Weinstein, 2000; Baldessari and Mione, 2008). As is the case in 
other vertebrates, angioblasts arise during early gastrulation in the mesoderm of zebrafish 
embryos (Jin et al., 2005). After consecutive processes of differentiation, proliferation and 
migration of the angioblasts towards the midline, a distinct cord of endothelial cells is 
formed that will lumenize (Blum et al., 2008; Kamei et al., 2006; Jin et al., 2005) and give 
rise to the axial vessels of the primary vascular network including the dorsal aorta (DA) and 
posterior cardinal vein (PCV) (Fouquet et al., 1997) (Fig. 2). Shortly thereafter, at 24-26 hours 
post fertilization, circulation is initiated through a simple single circulatory loop, making the 
cardiovascular system the first functional organ to arise. During subsequent developmental 
angiogenesis two distinct stages can be distinguished in the zebrafish embryo; primary 
sprouts form from the DA to give rise to intersegmental vessels (arterial angiogenesis) from 
approximately 22 hours post fertilisation (hpf) and then secondary sprouts form from the PCV 
to give rise to intersegmental veins and lymphatic vascular precursors (venous angiogenesis) 
from approximately 32 hpf (Isogai et al., 2003; Yaniv et al, 2006) (Fig. 3). Although primary 
sprouts will contribute to both functional arteries and veins after the later remodelling of 
the trunk vasculature based on flow (Isogai et al., 2003), primary sprouting is considered an 
arterial angiogenic process as sprouts derive exclusively from the dorsal aorta and express 
arterial markers (Siekman and Lawson, 2007), whilst secondary sprouting from the PCV is 
considered a venous angiogenic process.
The intersegmental arteries that sprout bilaterally from the DA (also referred to as 
primary sprouts) extend between the somites and the notochord and elongate dorsally. 
Pathfinding and patterning of these developing blood vessels is regulated by repulsive and 
attractive plexin queues, similarly to axonal pathfinding and neuronal patterning (Torrez-
Vasques et al., 2004). During this elongation process numerous active filopodia can be 
seen extending and retracting near the leading tip of the extending sprout. At the time 
the extending sprouts reach the dorsal side of the embryo trunk, a “T” shaped branching 
of the intersegmental arteries is observed. These “T” shaped endothelial cells extend 
longitudinally and ultimately anastamose with neighbouring intersegmental arteries at 
approximately 28 hpf to form a right and left pair of dorsal longitudinal anastamotic vessels 
(DLAVs). Not long after the formation of the DLAVs, vessel lumenization takes places and 
active circulation in the intersegmental arteries and the DLAVs can be observed. At this 
timepoint, an intersegmental artery is composed of three linked endothelial cells (Childs et 
al., 2002); (1) one cell resides close to the dorsal side of the roof of the DA and forms the 
base of the intersegmental artery, (2) another cell sits at the junction of the intersegmental 
artery with the DLAV, while (3) a third cell is found at the midline connecting the other 
two cells. After the formation of the primary, aorta-derived ad-axial vascular network a 
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secondary wave of angiogenic sprouting from the PCV (referred to as secondary sprouting) 
is initiated at approximately 32 hpf. 
Similar to primary sprouts the secondary sprouts emerge bilaterally near the somite 
boundaries and display active filopodic behaviour in the leading tip of the emerging sprout. 
The secondary sprouts extend dorsally towards the nearest primary vessel (Isogai et al., 
2003). Approximately half of the secondary sprouts connect with the existing primary 
sprouts, remodelling the arterial connections to venous ones and linking the PCV to the 
primary vascular network. After circulation is established in the connecting secondary 
sprouts, the primary sprouts will regress and finally disappear. The remainder of the 
secondary sprouts that do not reconnect to the primary sprouts will further migrate up 
to the horizontal myoseptum from approximately 36 hpf onwards (Fig. 3). Between 48 
and 72 hpf these cells remain in this region before migrating either dorsally or ventrally to 
contribute to the formation of the dorsal longitudinal lymphatic vessel (DLLV) or the thoracic 
duct respectively (Hogan et al., 2009).  
Besides the formation of the axial vasculature, intensive vascularization of other tissues 
including the embryonic brain, gills and the intestine is accomplished through angiogenesis 
(Isogai et al., 2001). Zebrafish vascular development takes place in a temporally and 
spatially highly coordinated fashion. Alterations of flow characteristics, for instance by 
complete blockage of cardiac contraction, leads to little or no changes in the patterning 
and development of the vasculature (Isogai et al., 2003; Sehnert et al., 2002). The highly 
patterned and robust nature of the vasculature suggests a strong genetic control that drives 
the formation and growth of the vascular system. 
Genetic control of vascular development
With the discovery of the vascular endothelial growth factors (VEGFs) and their receptors as 
essential regulators of endothelial cell differentiation and blood vessel formation (Ferrara et 
al., 1997; Ferrara et al., 1999; Olsson et al., 2006) an initial step towards the identification 
of the genetic pathways controlling vascular development had been made. Since then, 
increasing knowledge of the mechanisms through which downstream target genes of the 
VEGF receptors and other factors involved in vascular development are regulated has been 
gained. As is the case for the basic development and architecture of the vascular system, 
the genetic programs that underlie both vasculogenesis and angiogenesis are evolutionary 
largely conserved across vertebrates (Thisse and Zon, 2002).
Vascular endothelial growth factor A (VEGF-A), also known as vascular permeability 
factor (VPF), is a major player in blood vessel development, controlling chemotaxis, EC 
differentiation and proliferation. Five different VEGF-A isoforms are generated as a result of 
the alternative splicing of a single VEGF-A gene (Ladomery et al., 2006), which is part of a large 
family of angiogenic regulators including placental growth factor PlGF, VEGF-B, VEGF-C and 
VEGF-D (Shibuya, 2006; Ferrara et al., 2003). The responses of endothelial cells to VEGF are 
strictly regulated by temporal and spatial differences in the expression of the different VEGF 
family members, but also by their different binding affinities to their respective receptors. In 
mammals, three signaling tyrosine-kinase receptors belonging to the VEGF-receptor family 
Introduction
Ch
ap
te
r 
1
|13
Fig. 2. Zebrafish vascular development. 
A schematic overview of the early stages 
of the developing zebrafish embryo is 
displayed in (A). Following fertilization, 
the cytoplasm accumulates in a single cell 
at the animal pole of the embryo, on top 
of the yolk. After multiple rounds of cell 
division, morphogenic cell movements will 
commence in a process called gastrulation 
(>5hpf). Using in situ hybridization for 
sox18, the dynamic movements of the 
angioblasts during gastrulation can be 
visualized; during gastrulation (>10hpf), 
angioblasts arise in the lateral plate 
mesoderm (B, 14hpf), which will migrate 
towards the midline (B, 16hpf) to coalesce 
and form cord-like structures (B, 18hpf) 
that give rise to the dorsal aorta and 
posterior cardinal vein (B, 26hpf).  In (C), 
a schematic overview of a cross-section of an embryo at the level of the red bar in (B) is displayed; angioblasts 
that originally arise in the lateral plate mesoderm migrate towards the midline, where they will form a cord-like 
structure. The first cells to reach the midline will form the future dorsal aorta, dorsal to the notochord (No) and 
in between the somites (So), followed by the formation of the posterior cardinal vein (PCV). At 26hpf, a simple 
circulatory loop is established that allows the transport of blood from the anterior side of the embryo toward the 
posterior side via the dorsal aorta (red) and back to the heart through the PCV (blue). Anterior is to the left, NT is 
neural tube. 
Fig. 3. Assembly of the zebrafish vascular 
tree. The assembly of the vascular 
network in the zebrafish trunk proceeds 
in a highly coordinated fashion. Primary 
sprouts emerge bilaterally from the dorsal 
aorta (in red) at approximately 22hpf, 
which will migrate toward the dorsal side 
of the embryo (A,B). For clarity, sprouts 
from only one side of the embryo are 
displayed. At the dorsal side, the primary 
sprouts branch off in a “T-shaped” 
fashion, where they will meet neighboring 
endothelial cells (C). After connection of 
neighboring endothelial cells at the dorsal 
side of the embryo, the dorsal longitudinal 
anastomitic vessel is formed (28hpf) (D). 
Not long thereafter, secondary sprouts 
will arise from the posterior cardinal vein 
(blue) (D). Approximately 50% of the 
secondary sprouts will connect to the 
base of a primary sprout; ultimately these 
intersegmental vessels (ISVs) become part of the venous ISVs, while the ones that are not remodeled serve as 
arterial ISVs (E). Precursors to the lymphatic vasculature (termed parachordal lymphangiogenic cells (PLs)) arise 
from secondary sprouts that do not connect with a primary sprout, but in stead migrate to the parachordal region 
(green). At the parachordal region, these PLs show tangential migration, followed by ventral and dorsal migration 
along arterial ISVs along with the formation of intersegmental lymphatic vessels (ISLVs) (F,G). At the dorsal and 
ventral side of the developing zebrafish trunk, the dorsal longitudinal lymphatic vessel (DLLV) and the thoracic duct 
(TD) are both formed by longitudinal extension and fusion of lymphatic endothelial cells (LECs) (H).
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(VEGFR-1/Flt1, VEGFR-2/Kdr/Flk1 and VEGFR-3/Flt4) (Shalaby et al., 1997; Yamashita et 
al., 2000) can be discriminated, all having different binding affinities for the different VEGF 
ligands. This allows tight regulation of the cellular responses to VEGF. VEGF-A for instance 
binds to VEGFR-2 and stimulates endothelial cell proliferation and differentiation. VEGFR-1, 
which has a higher binding affinity to VEGF-A, but a weaker tyrosine-kinase function, in 
turn antagonizes VEGFR-2 function. VEGF-C and VEGF-D, on the other hand, mainly bind to 
VEGFR-3 and play important roles during lymphatic development. In addition to the receptor 
tyrosine kinases (RTKs), VEGF interacts with a family of coreceptors, the neuropilins (Neufeld 
et al., 1999). The neuropilins have short intercellular domains and are therefore unlikely to 
fulfill a signaling role independent of the RTKs. Targeted disruption of neuropilin-1 however, 
leads to cardiovascular defects during early development, whereas VEGF stimulation of cells 
transfected with neuropilin-1 has no effect (Soker et al., 1998; Kitsukawa et al., 1997). It 
has been proposed that the neuropilins function as coreceptors for VEGF (Lee et al., 2002; 
Martyn and Schulte-Merker, 2004), enhancing the binding properties of VEGF to Flk-1. The 
interaction of the various VEGF forms and their receptors are summarized in Fig. 4. 
Besides the VEGF-receptors, other RTKs are found on endothelial cells that play 
important roles in endothelial cell survival and vascular maturation, as illustrated by the 
Tie2-Angipoeitin signaling system. The Angipoeitin (Ang) ligand family consists of 4 different 
members, Ang-1 through Ang-4, while only two members of the Tie-receptor family are 
known, Tie1 and Tie2. Ang-1 is a specific ligand for Tie2, which upon activation stimulates 
Fig. 4. Interaction of the various VEGF 
forms with their receptors. The VEGF-
receptors contain seven immunoglobulin 
(Ig)-like loops in their extracellular part 
and a split tyrosine-kinase domain in their 
intracellular part. Two VEGF-receptor 
molecules form homodimers, facilitated 
through binding of the fourth Ig-like 
loop. The second and third Ig-like loops 
allow for binding of VEGF to its receptors, 
while the intracellular part is required 
for downstream signaling. VEGF-A binds 
to both VEGFR-1 and VEGFR-2, whereas 
VEGF-B and PlGF only bind to VEGFR-1. 
VEGF-C and VEGF-D can bind to VEGFR-2, 
but mainly function through VEGFR-3, 
which is present on lymphatic endothelial 
cells. The accessory proteins neuropilin-1 
and neuropilin-2 also bind VEGF, but do not 
fulfill any signaling function; in turn they 
act as coreceptors for VEGF, enhancing the 
signaling properties of VEGFR-2. Although 
VEGFR-2 is the main regulator of angiogenic 
growth, the binding affinity of VEGF-A to 
VEGFR-1 is much higher. The presence of 
soluble VEGFR-1 together with the lower 
tyrosine kinase function of VEGFR-1 and the absence of a phenotype in kinase-deficient knock out mice (Hiratsuka 
et al., 1998) has led to the conclusion that VEGFR-1 acts as a decoy receptor to control the availability of VEGF to 
other receptors. 
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vessel assembly and maturation. In contrast, binding of Ang-2 to Tie2 has an antagonistic 
effect on Ang-1 mediated Tie2 activation (Thomas and Augustin, 2009). 
Functional studies in mice and fish have also shown the involvement of Notch signaling in 
the angiogenic growth of blood vessels and the arteriovenous differentiation of endothelial 
cells. The Notch signaling pathway is an evolutionarily highly conserved mechanism that 
plays an essential role in cell fate specification, tissue patterning, and morphogenesis. 
Notch receptors are transmembrane proteins with large extracellular domains that contain 
multiple epidermal growth factor (EGF)-like repeats. The Notch receptors interact with the 
Delta, Serrate and LAG-2 (DSL) cell-surface ligands Delta-like 1, Delta-like 3, Delta-like 4 (Dll4), 
Jagged1 and Jagged2.  Upon binding of the DSL cell-surface ligands to the transmembrane 
Notch receptors, the Notch intracellular domain (NICD) is ultimately released (Weinmaster 
et al., 2000; Selkoe and Kopan 2003; Schweisguth et al., 2004). The NICD is then translocated 
to the nucleus where it causes the release of the RBP-J corepressor proteins to allow for 
downstream transcriptional activation of Notch target genes such as Hes and Hey (Fig. 5).
Given the common origin of blood and endothelial cells, it is not surprising that several 
of the factors required for the early development of endothelial cells are also important for 
hematopoietic development. For example the basic helix-loop-helix transcription factor Tal1 
(Scl) is indispensable for both blood and endothelial cell development. Tal1 is expressed 
in both endothelial and hematopoietic precursor cells during early embryogenesis and 
its disruption leads to severe defects in the development of both the hematopoietic and 
vascular lineages in both mice and zebrafish (Visvader et al., 1998; Gering et al., 1998; 
Patterson et al., 2005; Bussmann et al., 2007).  
The large ETS family of transcription factors plays a central role in controlling 
the transcriptional programs in hematopoietic and endothelial cell development. 
Characterization of endothelial enhancers and promoters revealed the presence of multiple 
ETS binding sites, while many Ets factors are expressed in endothelial cells (Hollenhorst et al., 
2004; Liu and Patient, 2008). The large number of Ets factors present in the endothelial cells 
exhibit a substantial functional redundancy; knockout of the majority of single Ets genes in 
either mouse or zebrafish results in little to no vascular phenotype (Pham et al., 2007). The 
recently discovered Etv2 (Etsrp) represents a single exception to this functional redundancy. 
Removal of Etv2 protein function in mice or knockdown of the zebrafish orthologue Etsrp 
results in a severe impairment of vasculogenesis and it has been suggested that Etv2/
Etsrp plays a central role in angioblast differentiation (Ferdous et al., 2009; Lee et al., 2008; 
Sumanas et al., 2008). 
Many other genes have been found to fulfill important roles during vascular development, 
including members of the GATA family of transcription factors (Lee et al., 1991), members 
of the Forkhead (Fox) transcription factors (Pananicalaou et al., 2008) and members of 
the Krüppel-like factor (Klf) transcription factor family (Atkins and Jain, 2007), all fulfilling 
different functions to control the transcriptional pattern of vascular development.  
Arteriovenous differentiation
Shortly after the differentiation of the angioblast, arteries and veins are formed in a process 
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known as arteriovenous differentiation (Jain, 2003; Swift and Weinstein, 2009). Before the 
initiation of circulation, but after the aggregation of the angioblasts into a cord-like structure, 
arteriovenous identity is determined by a variety of genetic factors. The two components 
of the vascular system have distinct functional and structural differences (Lawson and 
Weinstein, 2002). To meet the haemodynamic requirements of the vascular network, 
arteries are covered with vascular smooth-muscle cells (vSMCs), extracellular matrix, and 
elastic fibers that allow them to resist pressure and shear stress. The venous portion of the 
network facilitates low-pressure flow, and is thus covered with fewer vSMCs and contains 
valves that prevent backflow. Deregulation of arteriovenous differentiation or failure to 
segregate arterial and venous endothelial cells causes potentially lethal clinical conditions 
including hereditary hemorrhagic telangiectasia and cerebral cavernous malformations 
(Carmeliet, 2005; Irrthum et al., 2003; Sorensen et al., 2003; Urness et al., 2000). 
Several signaling molecules are known to be involved in the specification of arteriovenous 
cell fate, including Hedgehog (Hh), VEGF, Notch, and chicken ovalbumin upstream-
transcription factor II (COUP-TFII) (Lawson et al., 2003;  Liang et al., 2001; Lawson et al., 2001; 
Lin et al., 2007). Other transcription factors that function downstream of these signaling 
cascades involve hey2/Gridlock (Kokubo et al., 2005; Zhong et al., 2000), a member of the 
hairy and enhancer of split related family bHLH transcription factor, the Foxc1 and Foxc2 
transcription factors (Seo et al., 2006; Kume et al., 2006), and two members of the Sox-F 
family, Sox7 and Sox18 (Herpers et al., 2008; Cermenati et al., 2008; Pendeville et al., 2008) 
(Fig. 6). The complex hierarchal arrangement of interacting signaling pathways can either 
promote arterial cell fate at the expense of venous cell fate, or vice versa. The requirement 
of VEGF–Notch signaling for arterial cell specification in the zebrafish originally resulted in 
the belief that the venous state is derived from a default pathway, whereas arterial identity 
is conferred by the presence of additional signaling (Thurston and Yancopoulos, 2001). 
Recently however, COUP-TFII was identified to be an upstream genetic factor that acts as a 
positive mediator of venous specification. Disruption of COUP-TFII leads to the acquisition of 
arterial characteristics in veins, whereas ectopic expression results in the fusion of arteries 
and veins (You et al., 2005). It has been suggested that COUP-TFII establishes the venous 
identity by downregulation of Notch signaling via the release of factors such as EphB4 and 
Flt4 from Notch-mediated repression (You et al., 2005). 
Angiogenic sprout formation
During angiogenic growth, growth factors and chemokines stimulate the endothelial cells to 
sprout and form new vessels from the walls of pre-existing ones to meet the oxygen demands 
of local tissues (Fraisl et al., 2009).  After stimulation of endothelial cells towards angiogenic 
sprouting by environmental growth factor signals, formation of leading endothelial tip cells 
occurs. Stimulation of endothelial cells with VEGFA leads to the formation of long, dynamic 
filopodia that probe the environment for directional cues. The endothelial cells that 
directly follow the tip cells, termed the stalk cells, produce significantly fewer filopodia and 
proliferate upon stimulation with VEGFA (Gerhardt et al., 2003). The ability of endothelial 
cells within the vascular bed to respond differently to similar environmental factors is largely 
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Fig. 5. Notch signaling. Simplified model of the Notch 
signaling pathway based on (Roca et al., 2007). The 
Delta-Notch pathway uses a distinct molecular 
mechanism to transduce a signal from the cell surface 
to the nucleus; after Delta, Serrate and LAG-2 (DSL) 
ligand binding, Notch is cleaved by γ-secretase and 
the Notch intercellular domain (NICD) is released. 
The Notch extracellular domain (NECD) is extracted 
from the plasma membrane by trans-endocytosis 
into the DSL cell-surface ligand-presenting cell. 
Release and nuclear translocation of the NICD and its 
interaction with the CBF1, Su(H) and LAG1 (CSL) family 
of transcription factors results in the release of the 
transcriptional co-repressor (Co-R) complex, which 
in turn triggers the expression of target genes such 
Hey and Hes. The domains schematically highlighted 
in Notch are EGF-like repeats (light blue), some of 
which are involved in DSL binding (yellow), Notch/
LIN-12 repeats (red), a single transmembrane (TM) 
region, intracellular ankyrin repeats (green), and the 
C-terminal PEST sequence (dark blue). Ligands contain 
an N-terminal DSL domain (orange), EGF repeats (light 
blue), a transmembrane region, and a cytoplasmic 
area with a C-terminal PDZ-binding motif. 
Fig. 6. Genetic model of arteriovenous 
specification in the developing 
embryo. Sonic hedgehog (Shh) 
secreted by the notochord and floor 
plate induces vascular endothelial 
growth factor (Vegf) levels in the 
somites, which in turn activate 
angioblasts arising from the lateral 
plate mesoderm. Within an arterial-
fated angioblast, Vegf interacts 
with the Vegf receptor 2 (Vegfr2)–
neuropilin 1 (NP-1) complex to activate 
downstream phospholipase Cγ-1 
(Plc-γ), extracellular signal-regulated 
kinase (Erk) and Notch signalling 
pathways, thereby inducing arterial 
marker expression, such as ephrin B2 
(efnb2). Forkhead box c 1 (Foxc1)/Foxc2 proteins activate the Notch pathway by inducing the expression of Delta-
like 4 (Dll4), thereby leading to an arterial fate. Conversely, chicken ovalbumin upstream promoter transcription 
factor II (COUP-TFII) and phosphatidylinositol-3 kinase (PI3K)–Akt signalling promote venous fate by suppression of 
the Notch pathway and Erk signalling, respectively, thereby repressing arterial fate. COUP-TFII not only suppresses 
the Notch pathway, but also inhibits NP-1 expression, therefore attenuating Vegf and downstream Notch activation. 
Unconfirmed interactions are indicated by question marks. Ephb4, B4 ephrin receptor; grl, gridlock; Hey, hairy-
and-enhancer-of-split related; Mek, mitogen-activated protein kinase kinase; Pkc, protein kinase c. Adapted from 
Lamont and Childs, 2006; Lin et al., 2007.
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accomplished by Delta-like-4 (Dll4)-Notch signaling. Expression of Dll4 is induced in the tip 
cell upon stimulation with VEGFA, and subsequent Notch signaling through lateral inhibition 
in adjacent endothelial cells is believed to impair sprouting of these cells (Suchting et al., 
2007; Hellstrom et al., 2007). Reduced levels of Dll4 or abolishment of Notch signaling 
enhances the formation of tip cells, leading to increased sprouting (Hellstrom et al., 2007; 
Leslie et al., 2007; Siekmann and Lawson, 2007). These results show that, rather than 
following a static patterning of tip and stalk cells, cells continuously compete with each 
other for the tip cell position; the cell that produces more Dll4 than its neighboring cells will 
acquire and maintain the tip position of the extending sprout by suppressing its neighbors’ 
response through activation of Notch signaling.
The exact mechanism whereby Notch signaling regulates endothelial cell motility during 
angiogenic sprouting is unclear. Downregulation of VEGFR2 and VEGFR3 upon Notch signaling 
(Sainson et al., 2005) could potentially reduce the migratory properties of endothelial cells 
by making them less responsive to VEGFA. Phosphorylation of distinct VEGFR2 tyrosine 
residues (Olsson et al., 2006) also leads to the activation of several signaling pathways, 
including PI3K, which are known to stimulate endothelial cell migration, which might explain 
how Notch signaling contributes to endothelial cell migration.  
Lymphatic development
The lymphatic vasculature consists of blunt-ended vessels that form a unidirectional network 
of collecting vessels, capillaries and lymph nodes, the function of which is to retrieve protein-
rich fluids from the interstitium and lipids from the intestine. The lymphatic network is also 
involved in immune responses; lymphocytes migrate towards the lymphoid organs, in which 
the immune responses are initiated, via the lymphatic vessels. 
Lymphatic endothelial cells (LECs) are derived from blood vessel endothelial cells (BECs), 
and share many of their characteristics. However, in contrast to BECs, the LECs are not 
covered by a layer of vSMCs and exhibit weaker intercellular contacts. Anchoring filaments 
that bind the LECs to the extracellular matrix (ECM) allow the opening of intercellular gaps 
in the lymphatic vessels upon fluid accumulation in the interstitium, which facilitates the 
uptake of fluids by the lymphatics. The functional and architectural differences between 
LECs and BECs are genetically controlled. In mouse embryos, patched expression of the 
transcription factor prospero-related homeobox-1 (Prox1) can be detected in endothelial 
cells of the dorsal aspect of the jugular vein. Prox1 expressing cells upregulate several 
lymph-specific genes and eventually adopt the lymphatic fate (Wigle et al., 2002). Recently, 
another transcription factor, Sox18, was shown to directly induce the local expression of 
Prox1 (Francois et al., 2008). 
In zebrafish, the thoracic duct (TD), which is located between the DA and PCV, is the first 
lumenized lymphatic vessel to arise (Küchler et al., 2006; Yaniv et al., 2006). During secondary 
angiogenic sprouting from the vein (Fig. 3), approximately half of the endothelial sprouts 
that emerge transdifferentiate to lymphatic endothelial cells (LECs) and bud off from the 
vein towards the parachordal region. These LECs first undergo tangential, then either ventral 
or dorsal migration along arterial ISVs, along with the formation of intersegmental lymphatic 
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vessels (ISLVs). At the dorsal and ventral side of the developing zebrafish trunk respectively 
the dorsal longitudinal lymphatic vessel (DLLV) and TD are formed by longitudinal extension 
and fusion of LECs (Fig. 3) (Hogan et al., 2009). 
Vascular development and pathology
The adult vasculature acquires a quiescent, non-angiogenic state, while retaining its 
growth potential upon stimulation by certain environmental factors. Unfortunately, in 
several human diseases, angiogenesis is related to a pathological setting, during which 
blood vessels are stimulated by VEGF to grow and facilitate tumor growth and metastasis 
(Holash et al., 1999). Controlling the angiogenic growth potential of the vascular tree 
would constitute an attractive strategy of preventing tumor growth and tumor metastasis 
(Folkman, 1992; Ferrara, 2004). Additionally, controlled stimulation of angiogenic growth 
could be of great value in alleviating ischemic conditions by improving local tissue perfusion. 
As VEGF-mediated angiogenesis is relatively rare in adults, except during wound healing and 
female reproductive cycling, targeting of VEFG should have only little effect on physiological 
processes. In recent years, the possibility to reduce tumor growth by blocking angiogenesis 
has been intensively studied, resulting in several therapeutic benefits. As VEGF acts directly 
on endothelial cells and circulates via the blood it has proven a suitable target to limit 
angiogenic growth potential (Ferrara, 2005). Monoclononal antibodies targeted against 
VEGF have already successfully been used to that end (Ferrara, 2004); the newly formed 
vessels that invade tumor tissue upon VEGF secretion by the tumor cells are disorganized 
and blind-ended. These highly permeable vessels poorly perfuse the tumor and cause high 
tumor interstitial pressure. Therefore, the effectiveness of chemotherapy might be elevated 
by vessel normalization and reduction of interstitial tumor pressure by inhibition of VEGF. In 
recent years, targeting of the Notch ligand Dll4 has arisen as an important treatment option 
in anti-angiogenic therapies. Unlike VEGF, compromised Dll4 function leads to excessive, but 
paradoxically unproductive angiogenesis, which in turn leads to decreased tumor growth 
(Thurston et al., 2007). The vessels that form in the absence of Dll4 are highly branched and 
often lack a vessel lumen or are too disorganized to support perfusion. With the combined 
targeting of both VEGF and Dll4, even more potent effects on tumor growth have been 
achieved, stressing the effectiveness of combinatorial anti-angiogenesis strategies to 
improve anti-tumor therapies.    
The major causes of lethality in westernized societies next to cancer are heart disease 
and stroke, which mainly arise as a result of atherosclerosis. Atherosclerosis is characterized 
by a progressive accumulation of lipids and fibrous elements in large arteries. The lesions 
that arise during atherosclerosis can cause an acute occlusion of the large arteries by 
the formation of a thrombus or blood clot after rupture of the lesion, ultimately leading 
to myocardial infarction and stroke. Studies that investigated the mechanisms underlying 
atherosclerosis have revealed several environmental and genetic factors to be causative of 
the progression of this pathological setting (Ross, 1993). Besides the lowering of cholesterol 
levels and high blood pressure as effective strategies of decreasing the mortality from 
atherosclerosis, a number of new, genetic targets are successfully being explored to improve 
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the stability of existing plaques (Schonbeck et al., 2000).
Other, potentially lethal vascular diseases are attributable to mutations in single genes. 
For example, cerebral cavernous malformations (CCMs) are vascular malformations 
characterized by enlarged thin-walled capillary clusters in the brain. CCM is inherited as an 
autosomal dominant trait and loss of function mutations in three genes, CCM1, CCM2 or 
CCM3, have been demonstrated to cause CCM (Labauge et al., 2007; Hogan et al., 2008). The 
arteriovenous malformations in hereditary hemorrhagic telangiectasia and hypotrichosis–
lymphedema–telangiectasia have also been associated with mutations in single genes, 
namely endoglin/activin-like receptor kinase-1 and SOX18 respectively (Irrthum et al., 2003; 
Sorenson et al., 2003; Urness et al., 2000). A greater understanding of vascular pathogenesis 
as well as an understanding of how vascular biology is intertwined with tumor development 
and metastasis will be of great help to improve current treatment strategies for a wide range 
of diseases.  
Concluding remarks
Recent studies have greatly improved our understanding of the various aspects of endothelial 
cell biology and our knowledge of heamangiogenic and lymphangiogenic development. 
Great progress in our ability to study vascular development has also been made by the 
use of increasingly sophisticated model systems, such as tissue specific knock-out mice, a 
wide variety of cell-culture systems, and in vivo imaging in transgenic reporter-fish. A well-
based understanding of the fundamental mechanisms that underlie de novo formation and 
growth of the vascular system has proven invaluable in targeting pathological conditions 
that arise as a result of vascular dysfunction. Our knowledge of angiogenic growth of blood 
and lymphatic vessels is already being used in cancer therapies, where inhibition of vessel 
growth may prevent tumor growth and metastasis. With the clinical development of a 
variety of angiogenesis inhibitors, pathological angiogenesis in numerous tumor models can 
be inhibited. Likewise, pro-angiogenic treatments of ischemic conditions may benefit from 
improved growth of blood and lymphatic vessels.
The central question of this thesis is to gain insight into the molecular players during the 
initial stages of vascular assembly and growth. Although this chapter provides a summary 
of our current knowledge of the major aspects of vascular development and introduces 
zebrafish as a model organism for vascular studies, it is certainly not a complete overview of 
the many facets that drive the growth of the vascular tree. Rather, it is intended to support 
the following chapters described within this thesis. 
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Abstract
Knowledge of the genetic pathways controlling the emergence of the angioblast is essential to our understanding of both vascular and stem cell biology. To define the genetic pathways involved in angiogenesis we utilize fluorescent activated 
cell sorting of Flk1-positive cells at early stages during mouse embryonic development 
(E10.5, E11.5 and E16.0) and perform microarray analysis. Distinct differences were 
found in the comparison of the expression profiles of Flk1-positive and Flk1-negative 
cell populations at the timepoints analyzed. Subsequent in situ expression analysis using 
zebrafish embryos identified 61 genes with blood- or (cardio)vascular specific expression, 
of which 11 were novel. We next performed an in vivo functional screen in zebrafish using 
morpholino antisense oligomers to assess gene function. Our results represent a robust, 
high-throughput screen for the identification and characterization of novel genes involved 
in the molecular mechanisms of vascular development.
Introduction
Vascular development is a complex and tightly regulated process that involves the de novo 
assembly of blood vessels from mesodermally derived precursor cells, also referred to as 
vasculogenesis (Risau et al., 1997; Flamme et al., 1997). Vascular endothelial cells are derived 
from a common precursor, called the hemangioblast, which has been shown to contribute 
to both endothelial cells (angioblasts) and blood cells (hematopoietic stem cells) (Choi et al., 
1998; Vogeli et al., 2006). After differentiation from the hemangioblast, the establishment 
of the vascular endothelial lineage involves several key processes including the migration 
and assembly of the angioblasts to form cord-like structures, which will lumenize and form 
the major vascular network. As early as embryonic day E6.5 extraembryonic angioblasts, 
marked by expression of Flk1 (Fetal liver kinase 1), can be detected in regions where blood 
vessels form (Drake et al., 2000). Intraembryonic vasculogenesis of bilateral primordia, also 
referred to as the dorsal aortae, which later fuse to give rise to the dorsal aorta, can already 
be detected at E7.6.  Only after the de novo formation of major vessels during vasculogenesis, 
will growth and remodeling of the vascular network occur through sprouting angiogenesis. 
At E9.0 an increase of markers associated with more mature vessels like PECAM and Tie2 
(Suri et al., 1996; Drake et al., 2000) can be observed in the vasculature and rapid remodeling 
and expansion of the vascular system takes place, while dispersed angioblasts contributing 
to the developing aortae can still be detected.  In addition to vessel maturation the vascular 
system progressively becomes more specialized as different structures like arteries, veins 
and lymphatics develop (Carmeliet, 2000; Adams and Alitalo, 2007).  
Vascular endothelial growth factor (VEGF) is a highly specific mitogen for vascular 
endothelial cells (Ferrara, 2003) and has been shown to induce angiogenesis and plays a 
central role during vasculogenesis. Five different VEGF-A isoforms are generated as a result 
of alternative splicing of a single VEGF-A gene, which is part of a large family of angiogenic 
regulators like PLGF, VEGF-B, VEGF-C and VEGF-D. Three signaling tyrosine kinase receptors 
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belonging to the VEGF-receptor family (VEGFR-1/Flt1, VEGFR-2/Kdr /Flk1 and VEGFR-3/Flt4) 
can be distinguished, all exhibiting different binding affinities for the different VEGF ligands, 
allowing tight regulation of the cellular responses to VEGF. VEGF-A for instance binds to 
VEGFR-2 and stimulates endothelial cell proliferation and differentiation. In contrast, 
VEGFR-1, which has a higher binding affinity for VEGF-A, but a weaker tyrosine kinase 
function, antagonizes VEGFR-2 function (Fong et al., 1999). VEGF-C and VEGF-D mainly 
bind to VEGFR-3 and play important roles during lymphatic development (Karkkainen et 
al., 2004).  Several studies have shown the association of Flk1 with vascular progenitors 
and vasculogenesis (Shalaby et al., 1997; Yamashita et al., 2000) and its importance during 
later stages of angiogenesis (Jain, 2003). Although significant progress has been made in the 
identification of the molecular mechanisms that control vasculogenesis and angiogenesis, 
there are still many unknowns.
In this study, we have combined zebrafish genetics with mouse genomics in an effort 
to identify genes governing vascular development. Zebrafish have recently become an 
attractive model organism for the study of vertebrate organogenesis (Roman and Weinstein, 
2000; Baldessari and Mione, 2008). The transparency of the zebrafish embryo combined 
with the availability of various reporter lines allows for real-time non-invasive in vivo 
analysis of organogenesis. Its small size and fecundity greatly facilitate large scale forward 
genetic screens in which numerous mutants have been described. With the availability of 
morpholino antisense oligomers that either block translation or splicing of a gene transcript 
(Nasevicius et al., 2000), reverse genetic approaches for the characterization of candidate 
genes have also become possible. Several studies have used microarray analysis combined 
with whole mount in situ hybridisation analysis in order to analyze gene expression profiles 
during hematopoietic and vascular development (Weber et al., 2005; Sumanas et al., 2005; 
Eckfeldt et al., 2005; Covassin et al., 2006; Wong et al., 2009). Although these screens have 
been successful in the identification of novel genes involved in hematopoietic and vascular 
development, they generally relied on whole embryos as a source for RNA for microarray 
profiling. However, the cell types involved in the development of the hematopoietic and 
vascular cell lineages might only represent a small fraction of the total number of cells 
within the embryo. In an effort to tackle this problem one study made use of FACS enriched 
cell populations from transgenic zebrafish embryos expressing eGFP under the control of 
a fli1 promotor (Covassin et al., 2006). However, expression of fli1 is not restricted to the 
endothelial lineage, but is also found in cartilagenous tissues. In addition, eGFP expression 
in a transgenic background might not completely recapitulate endogenous fli1 expression. 
Lastly, folding times for eGFP induce a time lag between transcriptional activation and 
actual protein detection, which could potentially obscure the dynamic temporal expression 
profiles in developing embryos. An even more sophisticated means of screening for novel 
molecular regulators of blood vessel development is thus desirable.
In this study, we describe the global analysis of gene expression in the developing mouse 
vasculature. We utilize fluorescent activated cell sorting to acquire a population of cells 
enriched for Flk1 expression at early stages of mouse development (E10.5, E11.5 and 
E16.0). Expression of Flk1 is already found within the early hemangioblast and continues 
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to be expressed on mature endothelial cells, making it a suitable marker for the sorting 
of both angioblasts and differentiated endothelial cells. Subsequently, we used microarray 
analysis at various timepoints for both the Flk1-positive and Flk1-negative cell populations 
and described the dynamic changes of expression profiles found. Gene transcripts showing 
elevated differential expression profiles in Flk1+ cells at the early timepoints (E10.5 and E11.5) 
were translated to their zebrafish orthologues. Next, whole mount in situ hybridization 
was used to assess the temporal and spatial expression pattern of the upregulated gene 
transcripts in zebrafish embryos. Finally, the gene function of transcripts that showed an 
expression pattern closely associated with vascular development was assessed by an in vivo 
functional screen using morpholino antisense oligomers in transgenic zebrafish embryos 
(summarized in Fig. 1). Using this strategy, not only have we identified a number of genes 
that potentially represent novel regulators of vascular development, but we also present 
functional data that links these genes to developmentally relevant processes.
Fig. 1. Genome wide 
screen for molecular 
regulators of vascular 
development. General 
overview of the setup 
of the genome wide 
screen for molecular 
regulators of vascular 
development. Firstly, 
an enriched population 
of Flk1+ cells was 
harvested from mouse 
embryos at E10.5, E11.5 
and E16.0 by using 
fluorescent activated 
cell sorting (FACS). 
Total RNA from both 
Flk1+ and Flk1- cells was 
isolated for the various 
timepoints and used for 
subsequent microarray 
analysis (1). Secondly 
we translated all 
transcripts differentially 
upregulated in the Flk1+ 
population at early 
timepoints to their 
zebrafish orthologues 
and used these for 
wholemount in situ 
hybridisation to look 
for specific expression 
in the vascular bed (2). 
Next we performed a functional analysis of the genes with an expression pattern closely linked to the vascular 
system by morpholino knockdown to assess gene function (3).  Lastly, future research using in vitro assays and
murine analysis will be performed to assess conserved gene function (4).
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Materials and Methods
Animal husbandry
Zebrafish were kept under standard husbandry conditions at the Hubrecht Institute. Transgenic lines used were 
Tg(kdrl:eGFP)s843 (Jin et al., 2005) and Tg(fli1:eGFP)y7 (Lawson and Weinstein, 2002). Plugged FVB/N mice were 
ordered at Harlan, and embryos collected at the embryonic days indicated. Animal experiments were in accordance 
with the Animal Experimentation Committee of the Royal Netherlands Academy of Arts and Sciences (DEC) and 
performed according to their guidelines. 
Isolation of Flk1+ and Flk1- cells from mouse embryos
At the selected timepoints, embryos were collected from plugged FVB/N female mice and homogenized by 
incubation for 45 minutes at 37°C in DM (PBS (no Ca, no Mg) and 10% FCS) with 0.12 % Collagenase type I (Sigma 
C-0130). Single cells were stained at a concentration of 6x107 cells/ml in a 1/50 PE anti mouse Flk1 antibody dilution 
(BD, 555308). Hoechst was used as a marker to select for dead cells. Two populations (Flk1+/Hoechst- cells and 
Flk1-/Hoechst- cells) were sorted on a FACS Diva using two consecutive rounds of sorting to improve purity. High 
quality mRNA was isolated using the Qiagen, RNeasy mini kit. 
Processing of RNA samples and Microarray analysis
Microarray analysis was performed at the Rotterdam Erasmus University Medical Center. 5µg of mRNA was used 
to make double stranded cDNA using the Invitrogen choice system. Using the ENZO BioArray High Yield RNA 
Transcript, biotin labeled RNA was generated. After clean-up and fragmentation approximately 20 µg of labeled 
cRNA was hybridized to the GeneChip® Mouse Genome 430A & 430B 2.0 Arrays. Rosetta resolver was used 
to import calls and intensities, followed by quantile normilization. Raw data were merged into OmniViz and a 
threshold minimum for intensities was set at 30. Fold differences were calculated from log averages determined 
for the different experimental conditions. Correlating mouse gene transcripts with zebrafish orthologues was done 
by using BioMart and the Ensembl database http://www.ensembl.org, release 38, April 2006.
In situ probes generation and whole mount in situ hybridisation
Template DNA for in situ probe generation was obtained by direct amplification of target genes from genomic 
DNA. Primers for probe generation were designed to span exons of at least 250 basepairs in size to ensure probe 
specificity. Reverse primers were tagged with a T3 RNA polymerase promotor tail to allow direct in vitro transcription 
and generation of antisense probes after PCR purification. Primer sequences are listed in supplemental table 1. In 
situ probes were DIG labeled using the Roche DIG labeling mix. Bacterial clones for the generation of in situ probes 
of selected genes were obtained from Open Biosystems http://www.openbiosystems.com. Whole-mount in situ 
hybridization was performed as previously described (Thisse and Thisse, 2008). Coarse in situ transcript detection 
was automated using the Intavis AG in situ robot http://www.intavis.com followed by manual in situ transcript 
detection to increase the signal to noise ratio. 
Morpholino antisense oligomer injections
Morpholinos (MOs) were obtained from Gene Tools http://www.gene-tools.com and diluted in water containing 
0.2% phenol red. One cell stage embryos were injected with 1 to 9ng of MO with a maximum volume of 3nl as 
described previously (Nasevicius, 2000). Morpholino sequences are displayed in supplemental table 2. Morpholino 
knockdown efficiency was tested for splice-site targeting morpholinos by RNA isolation from morpholino-injected 
fish. Subsequently cDNA was synthesized using the SuperScript II RT Kit (Invitrogen). Primers used for reverse 
transcriptase PCR are listed in supplemental table 3. 
Imaging procedures
Zebrafish embryos were mounted in 1% low melting point agarose in a culture dish with a cover slip replacing the 
bottom. Imaging was performed with a Leica Microsystems SP2, SPE or SP5 confocal microscope using a 10x, 20x 
or 40x objective with digital zoom. Angiography was performed as previously described (Weinstein et al., 1995). 
Images were processed by using Photoshop CS2 and Illustrator CS2 (Adobe).
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Results
Isolation of enriched Flk1+ cell populations from mice
Vascular development involves the proliferation, migration and differentiation of endothelial 
cells. However, these cells only represent a small fraction of the total number of cells within 
the developing embryo. As a result, genes expressed in endothelial cells might be poorly 
represented in cDNA libraries derived from whole embryo material. Moreover, subtle but 
important changes in temporal expression profiles within the endothelial cells might not 
be apparent as a result. Therefore, we took advantage of the possibility to sort enriched 
populations of endothelial cell types by fluorescent activated cell sorting (FACS) for 
subsequent expression analysis. 
Developing mouse embryos were collected at E10.5, E11.5 and E16.0, timepoints at which 
intensive vascular development is seen (Drake et al., 2000). After proteolytic dissociation 
of the embryos, the Flk1+ cells were labeled with PE-labeled antibodies, to allow for FACS 
(Figure 2). Flk1 is an early marker for the hemangioblast, but is also expressed in endothelial 
cells during vasculogenesis and angiogenesis, making it an excellent marker for both early 
and late stage vascular development. Hoechst was used as a marker to sort for living versus 
dead cells. Diagnostic fluorescent activated cell sorting showed that approximately 1.5% of 
the cells were found to be Flk1-positive and we were able to sort Flk1-positive cells by FACS 
to a purity greater than 97%. 
Microarray analysis of Flk1+ cells
We hypothesized that genes differentially expressed between Flk1+ and Flk1- cell populations 
across E10.5 and E11.5 would represent genes that are involved in the molecular regulation 
of early vascular development. Exclusion of genes that were also differentially upregulated in 
Flk1+ cells at E16.0 was used to selectively filter for early regulators of vascular development. 
Total RNA from both Flk1+ and Flk1- cell populations, collected by FACS, was isolated for all 
three timepoints (summarized in Fig. 2). We next acquired and compared the expression 
profiles for both Flk1+ and Flk1- cell populations at the three different timepoints (E10.5, 
E11.5 and E16.0). Gene expression analysis for both Flk1+ and Flk1- cells from E10.5, E11.5 
and E16.0 mouse embryos showed a clear separation of the Flk1+ and Flk1- cell populations 
as shown by the correlation plot (Fig. 2b), indicating that the sorted Flk1+ and Flk1- cell 
populations show clear differences in their respective expression patterns. We also found a 
marked clustering within the duplicate experiments of the different timepoints analyzed, as 
well as a distinctive correlation for the expression profiles of Flk1+ cells at E10.5 and E11.5. 
The high values seen for the correlation of the earlier timepoints (e.g. compare E10.5 and 
E11.5) would gradually diminish by temporal changes in expression levels (e.g. compare 
E10.5 and E16.0), showing the dynamics of the expression profiles over time.
Differential gene expression among Flk1+ and Flk1- cells was determined by the commonly 
used fold change cut-off calculated by using log transformed expression values. We found 
2,161 transcripts  that were differentially upregulated (fold-change >2.0) in Flk1+ at both E10.5 
and E11.5, and only 784 after exclusion of genes that were also differentially upregulated in 
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Flk1+ cells at E16.0 (see supplemental table 4 and 5). The differential gene expression profiles 
for the early timepoints (E10.5 and E11.5) showed a high level of similarity, but appeared 
markedly different from the expression profile for E16.0 as illustrated by the heatmap (Fig. 
2c). We anticipated finding such temporal differences in gene expression levels within Flk1+ 
cells as most intensive levels of vascular growth are found from E7.5 to E12.5 (Drake, 2000).
Among the genes that are differentially upregulated in Flk1+ cells during early development, 
many are associated with vascular development, including Flt1, a member of the VEGF-
receptor family (Ferrara et al., 2003). Several transcription factors implicated in either 
hematopoeisis (Lmo2) (Landry et al., 2003) or angiogenesis (Ets-family members) (De Val 
and Black, 2009) were also identified. Cell fate specification is mainly regulated through the 
action of transcription factors; therefore it is not surprising to find a number of transcription 
factors in the enriched gene list. Tie1, a member of the tyrosine kinase receptor family and 
Fig. 2. Fluorescent activated cell 
sorting and gene expression 
analysis. (A) Mouse embryos 
were collected at E10.5, E11.5 
and E16.0, followed by labeling of 
Flk1-positive cells by PE-labeled 
antibodies after proteolytic 
dissociation of the embryos. 
Both Flk1+/Hoechst- and Flk1-/
Hoechst- cells were sorted for all 
of the selected timepoints (n=2 
for E10.5 and E11.5) by means 
of fluorescent activated cell 
sorting, followed by total RNA 
isolation for all samples collected. 
Next, the isolated total RNA was 
directly labeled without any 
additional linear amplification 
steps and used for hybridization 
to the Affymetrix GeneChip® 
Mouse Genome 430A & 430B 
2.0 Array for expression analysis. 
Gene expression analysis for both 
Flk1+ and Flk1- cells from E10.5, 
E11.5 and E16.0 mouse embryos 
showed a clear separation of the 
Flk1+ and Flk1- cell populations 
and clustering within the 
different timepoints analyzed as 
shown by the correlation plot 
(B).  Whereas the differential 
gene expression profiles for 
the early timepoints (E10.5 and 
E11.5) showed a high level of 
similarity, the differential gene expression profile for E16.0 appeared to be clearly distinctive from E10.5 and E11.5 
as illustrated by the heatmap (C). Transcripts that showed a clear differential up-regulation at E10.5 and E11.5, but 
not E16.0 were translated into their corresponding zebrafish orthologues. Exons exceeding 250 basepairs in size of 
the corresponding genes were subsequently amplified from genomic DNA and used as a template for in situ probe 
generation (D). 
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its ligand Angiopoeitin2 (Thurstson, 2003) were also found to be differentially upregulated in 
Flk1+ cells during early vascular development. Furthermore, we identified both Neuropilin1 
and Neuropilin2 (Gerhardt et al., 2004) as well as several members of the Notch signaling 
pathway (Phng and Gerhardt, 2009) in the Flk1+ enriched gene list.  
Remarkably, a number of genes that have been implied in vascular development 
are absent from the enriched gene list, including Flt4 and Flk1. These genes do show a 
significant differential expression in Flk1+ cells at E10.5 and E11.5, but are also differentially 
upregulated in Flk1+ cells at E16.0. As these genes continue to be expressed at high levels 
at later stages of development, they failed to meet our criteria of early expression and are 
excluded from further analysis. 
Expression analysis screen in zebrafish
To further evaluate our gene expression data from microarray profiling, we set out to 
correlate the in silico data with in situ expression analysis. Our initial goal was to perform an 
unbiased, genome wide, screen to look for novel molecular regulators of vascular biology. 
However, the expression analysis of 784 individual murine genes would be a cumbersome 
and time-consuming task. We therefore reverted to the zebrafish model organism, which 
allows for high-throughput whole mount in situ hybridization analysis because of its small 
size, transparency and fecundity. Organogenesis has largely been evolutionarily conserved 
from zebrafish to mice and a lot of common genetic pathways are shared (Thisse and Zon, 
2003). We used Biomart http://www.ensembl.org to look for evolutionarily conserved 
genes and found 419 corresponding zebrafish orthologues for the 784 transcripts present 
in the Flk1+ enriched mouse gene list. Comparison of our enriched gene list with expression 
data publicly available through ZFIN http://www.zfin.org shows that multiple genes are 
indeed expressed in vascular tissues. For a large number of genes however there was no 
corresponding expression pattern available. Therefore, we performed an expression analysis 
screen: we designed primers to specifically amplify exons from the translated orthologues, 
which then served as a template for probe generation. Using this strategy we successfully 
generated 363 unique zebrafish in situ probes (Fig. 2d and Supplemental table 6). 
At approximately 10hpf mesoderm-derived angioblasts first arise in the zebrafish embryo, 
which will migrate towards the midline to coalesce and form a cord-like structure (Vogeli et 
al., 2006). This structure is then remodeled through tubulogenesis and as a result the dorsal 
aorta (DA) and posterior cardinal vein (PCV) are formed at 20hpf (Fouquet et al., 1997). At 
about 22hpf sprouting angiogenesis from the DA is initiated and the intersegmental vessels 
(ISVs) are formed (Isogai et al., 2003). Three different timepoints (12hpf, 18hpf and 24hpf) 
that span the early stages of vascular development within the zebrafish embryo were used, 
with a minimal number of 10 embryos per selected gene for each timepoint. Coarse whole 
mount in situ hybridisation expression analysis of the enriched gene list was achieved by using 
the Intavis AG in situ robot. In situs that showed a gene expression pattern closely linked to 
the vascular system were manually repeated to minimize the risk of probe carryover and to 
improve the signal to noise ratio. Expression patterns for genes that had not been described 
at the time this expression screen was performed are shown in Fig. 3. Angiotensin receptor-
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like 1, a gene duplicated in the zebrafish genome, shows strong expression in vascular 
tissues for both gene duplicates. Whereas agtrl1a is mainly expressed in the PCV, agtrl1b is 
expressed in the DA, PCV, midhindbrain channel (MHBC) and intersegmental vessels (ISVs) at 
24hpf. Two members of the Ets-family of genes, elk3 and ets2, were also identified as having 
marked vascular expression. Ets2 is expressed in the angioblasts at 12hpf and in the DA, 
PCV and caudal vein (CV) at 24hpf. elk3 is highly expressed in the angioblasts at both 12 and 
16hpf and maintains a high level of expression at 24hpf within the DA, PCV, MHBC and ISVs. 
FYVE, RhoGEF and PH domain-containing protein 5 (fgd5), shows a very similar expression 
profile; early expression in the angioblast is marked, as well as continued expression within 
the DA, PCV, MHBC and ISVs at 24hpf. The recently characterized member of the family 
of cadherins, cdh5, as well as the uncharacterized protocadherin 12 (pcdh12), part of a 
subfamily of the superfamily of cadherins, were also identified as having vascular restricted 
expression at the timepoints analyzed. Other genes with expression patterns closely linked 
to vascular development were the laminin B1 subunit 1 (lamb1-1), the myc target 1 (myct1), 
Fig. 3. Whole mount in situ hybridization analysis of vascular markers. Global whole mount expression profiles for 
agtrl1a, agtrl1b, cgnl1, crip2, dll4, elk3, ets2, fgd5, igfbp7, lamb1-1, mmp14, msn, myct1, pcdh12, rock2, sh3tc1, 
sox7, sox18, tagln2 and tbx1 showed apparent  vascular expression patterns at 24-28 hours post fertilization. 
Embryos are imaged from a lateral view (inset for crip2 in dorsal view), anterior is to the left. 
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the matrix metalloproteinase 14 (mmp14), a family member of the metalloproteinases that 
are involved in the breakdown of extracellular matrix, moesin (msn), T-box transcription 
factor Tbx1 (tbx1) and transgelin2 (tagln2). Two members of the Sox-F family of transcription 
factors, sox7 and sox18 were found to be highly expressed during early stages of vascular 
development and with continued high levels of expression in the vascular bed at later stages. 
Several genes (flt1, flt4, notch1 and ephnb2a) show an expression pattern which is restricted 
to either the arterial or venous compartment of the vascular system. We found that the 
Notch-ligand dll4 is exclusively expressed in arterial tissues, whereas the SH3 domain and 
tetratricopeptide repeats-containing protein 1 (sh3tc1) is restricted to venous structures.
The expression of another group of genes was not only restricted to the vascular system, 
but was also found in the developing zebrafish heart. For example, the cysteine-rich protein 
2 (crip2), rho-associated, coiled-coil containing protein kinase 2 (rock2) and cingulin-
like 1 (cgnl1) show strong expression in the myocardium as well as in vascular tissues 
(Supplemental Figure 2). Other genes, including nfatc1, podxl, anxa6, rhoc and slco3a1 
were also found to be expressed in the heart. Expression patterns closely associated with 
hematopoietic development were found for several genes, including adora2a, lrrc13, spnb2 
and stk10 (Supplemental Figure 2). In total we found 61 genes with an expression pattern 
closely linked to cardiovascular or hematopoietic development, of which 11 had previously 
not been characterized (Supplemental table 6).
In vivo functional screen in zebrafish
As expression data alone does not answer questions of functional relevance, we followed 
our initial findings up with an in vivo screen for vascular development in zebrafish. The 
common precursor for hematopoietic and angiogenic development, also referred to as 
the hemangioblast, was recently shown to be evolutionarily conserved in both zebrafish 
and mice (Vogeli et al, 2006).  The signals (gata1, tal1, lmo2, flk1) required for the 
specification events in the establishment of both lineages to arise from the angioblast are 
also evolutionary conserved (Thisse and Zon, 2002). The evolutionarily conserved nature of 
these processes makes them an ideal subject for cross-species analysis and thus for rapid 
functional screening in zebrafish. We used morpholino knockdown (Nascevicius et al., 2002) 
as a reverse genetic approach to assess gene function in the developing zebrafish embryo. 
We designed 2 independent morpholinos for each of the 19 different genes targeted, 
including three gene duplicates. We further confirmed the specificity of the morpholino 
targeting of the genes of interest by using RT-PCR, the results of which are summarized in 
supplementary table 3 and supplemental figure 1. We injected the morpholinos into one- to 
two-cell stage embryos in a kdrl:eGFP transgenic background (the zebrafish orthologue of 
Flk1 (Bussmann et al., 2008)) and screened for effects in vascular development (table 1). Our 
initial findings classified 8/19 morpholinos as inducing an effect on vascular development, 
ranging from defective cardiac development and functionality to failure of vascular growth. 
Some of the injected morpholinos affected cardiovascular development, but the effects seen 
could partially be ascribed to secondary effects as a result of the abnormal development 
of the zebrafish embryo. For example, injection of morpholinos targeting both duplicates 
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Fig. 4. Morpholino knockdown analysis of vascular genes. Global results of the in vivo functional screen revealed 
a specific requirement for normal vascular development for some of the genes found to be expressed in the 
vascular bed. Simultaneous injection of morpholinos targeting sox7 and sox18 led to a vast reduction of kdrl:eGFP 
expression in the endothelial cells at 24 hours post fertilization (hpf) (A and B, arrow). Loss of Agtrl1b function is 
characterized by defective outgrowth of the intersegmental vessels (ISVs) toward the dorsal side of the embryos 
and a concurrent loss of the dorsal longitudinal anastomotic vessel at 28 hpf (C and D). Morpholino targeting of dll4 
results in excessive angiogenic sprouting of the ISVs at the dorsal side of the embryo at 54hpf (E and F). Morpholino 
targeting of cgnl1 results in a progressive loss of cardiac function at >5dpf, together with a failure of the formation 
of the gill vasculature (G and H, see also Fig. 5). Injection of morpholinos targeting tagln2 resulted in the ectopic 
sprouting of ISVs at 6 dpf (I and J). Embryos are imaged in a lateral view, anterior is to the left. All embryos are in a 
kdrl:eGFP transgenic background, except for G and H, which are in a Fli1:eGFP transgenic background. High power 
images of the morpholino phenotypes are displayed in Fig. 5. 
Table 1. Genes differentially expressed between mice Flk1+ and Flk1- cell populations subjected to the in vivo 
functional assay in zebrafish and the gross phenotypes observed upon knockdown.
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of adora2a affected the development of the intersegmental vessels, but also led to more 
general developmental defects including reduced eye size, necrosis, reduced pigmentation, 
defective yolk extension and abnormal somite formation. As the intersegmental vessels 
develop in close proximity to the somites, which are a local source of vegfa, it is most likely 
that the defects seen on the development of the intersegmental vessel are secondary 
in nature. To limit the possibility of taking along cardiovascular defects that are merely 
a secondary effect of general developmental abnormalities we excluded embryos that 
displayed an overall defective morphology from our screen. Examples of the effects seen on 
(cardio)vascular development are summarized in Fig. 4 and 5.
Two of our identified candidates, sox7 and sox18, and the endodermally expressed sox17 
together form the Sox-F (Sry-related HMG box) family of DNA-binding proteins (Bowles et 
al., 2000). Members of the Sox-F family play crucial roles during the formation of definitive 
endoderm, and during hematopoietic stem cell, cardiovascular and lymphatic development 
(Kanai-Azuma, 2002; Kim et al., 2007; Pennisi et al., 2000; Francois et al., 2008).  Morpholino 
targeting of either sox7 or sox18 showed no clear defect on vascular development. However, 
simultaneous targeting of both genes led to loss of kdrl:eGFP expression in almost all 
vascular tissues (Fig. 4 A,B). We found sox7 and sox18 to be essential for the arteriovenous 
differentiation of the angioblasts during the establishment of the vascular lineages as shown 
by molecular characterization of these morphant fish. Combinatorial knockdown of Sox7 and 
Sox18 function caused a loss of circulation in the posterior part of the developing embryo 
as a result of a failure of segregation of arteries and veins and the concurrent formation of 
shunts. A detailed characterization of the effects of the loss of combined Sox7 and Sox18 
function is given in chapter 3 of this thesis.
Recent studies in zebrafish showed an indispensable role for agtrl1b in the specification 
of myocardial cells during gastrulation (Scott et al., 2006; Zeng et al., 2006), while reporting 
no vascular abnormalities. Confirming this finding, morpholino knockdown of both agtrl1a 
Fig. 5. Morpholino knockdown analysis of vascular genes. High power images of the results of the in vivo 
functional screen for agtrl1b clearly show a failure of the ISVs to extend towards the dorsal side of the embryo (A 
and F). Morpholino targeting of dll4 leads to excessive angiogenic sprouting of the ISVs at the dorsal side of the 
embryo at 54hpf (B and G). Morpholino targeting of cgnl1 results in a progressive loss of cardiac function at >5dpf, 
concurrent with a failure of the formation of the gill vasculature (aortic arches, arrows) and the hypobranchial 
artery (arrowheads) (C,D and H,I). Injection of morpholinos targeting tagln2 resulted in the ectopic sprouting of 
ISVs at 6 dpf (E and J). All embryos are in a kdrl:eGFP transgenic background, imaged in a lateral view, anterior is to 
the left. Embryos in D and I are imaged from in a ventral view, anterior to the top. 
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and agtrl1b gave rise to a reduced heart size, and even a near complete loss of the heart 
in some embryos. However, by generation of a stable mutant knockout line for agtrl1b we 
found a specific requirement for agtrl1b in the extension of the ISVs towards the dorsal side 
of the embryo (Fig. 4 C,D) and the cellular architecture of the tip-cell during angiogenesis, 
independently of the reduced heart and the loss of circulation. The role of agtrl1b during 
angiogenic migration of ISVs and tip-cell behavior is described in further detail in chapter 4 
of this thesis. 
Cgnl1 encodes a plaque protein localized in the apical junctional complex and has been 
reported to be specifically expressed in the endocardium of the embryonic heart (Narumiya 
et al., 2007). Cellular adhesion molecules are known to play important roles during the 
patterning of the embryonic heart (Simard et al., 2006). Knockdown of cgnl1 showed no 
obvious early defects of vascular development. However, at 5dpf, slight edema near the 
eyes was observed, as well as complete loss of circulation and death after 6dpf. Closer 
analysis of the embryos at earlier timepoints showed normal development of the heart and 
valves as well as normal expression of marker genes of cardiac specification (supplemental 
Figure 3). Analysis of the gill vasculature in contrast, showed a vast reduction in the number 
of vessels that contribute to the respiratory system, coincident with a substantial reduction 
of the cartilagenous tissues that support the craniofacial structures (supplemental Figure 3). 
Whether the loss of the gill vasculature is a direct result of the loss of cgnl1 protein function, 
or a secondary effect to the craniofacial defects remains to be seen. 
In vertebrates, the maturation of the cardiovascular system is accompanied by the 
recruitment of smooth muscle cells, referred to as vascular myogenesis (Carmeliet et al., 
2000; Jain et al., 2003). These smooth muscle cells are marked by tagln2 (sma22a) expression 
and can be found perivascularly (Santoro et al., 2009; Yang et al., 2003). Knockdown of 
tagln2 did not result in obvious defects in vascular development during the first 4 days after 
fertilization. In contrast, at 6dpf reduced vascularization of the gills and clear hyperplasticity 
of the ISVs (Fig. 4 G,H) was observed in a small proportion of the embryos, reminiscent of 
the effects caused by knockdown of dll4. 
Dll4/Notch signaling has long been associated with cell fate specification and 
differentiation and plays a pivotal role in cardiovascular development (Phng and Gerhardt, 
2009). Recent studies have shown an essential role for dll4 in limiting the angiogenic 
properties of the ISVs (Siekmann et al., 2007; Leslie et al., 2007). Embryos injected with 
morpholinos targeting dll4 initially develop a normal DA, PCV, ISVs and dorsal longitudinal 
anastomotic vessels (DLAVs). After 2dpf however, marked ectopic sprouting of the ISVs at 
the dorsal side of the embryo is observed (Fig. 4 E,F). We found that one of the functions 
of Dll4 is to repress the angiogenic response of developing intersegmental vessels to Vegfc/
Flt4 signaling, as discussed in chapter 5 of this thesis. We also found a specific requirement 
for Dll4/Notch signaling in normal lymphatic development. The loss of lymphatic structures 
upon dll4 knockdown and the molecular mechanism responsible are further described in 
chapter 6 of this thesis. 
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Discussion
In this study we describe an improved method for the identification of molecular regulators 
involved in early vascular development. By FACS sorting Flk1-positive cells from early mouse 
embryos that contribute to the vascular lineage we were able to compile a global expression 
profile of endothelial cells. Comparison and analysis of the temporal expression changes in 
both Flk1+ and Flk1- cells yielded an enriched expression list of genes which was verified by 
whole mount in situ hybridization in zebrafish embryos. Novel genes found to be restrictively 
expressed in the vascular lineage were subjected to an in vivo functional screen in zebrafish 
to assess their function, which led to the identification of several factors essential for the 
assembly of the vascular bed.
Multiple genes with an essential role in vascular development were found to be 
significantly upregulated in our enriched gene list, validating our method. In addition, 
several genes with a previously uncharacterized role in vascular development were also 
found to have an expression pattern linked to vascular development in the whole mount 
in situ hybridization screen, proving the reliability of the approach taken in finding cell type 
specific genes. However, several genes known to be expressed in Flk1+ tissues are absent 
from the enriched gene list. One explanation for this could be that these genes are also 
abundantly expressed in other, non Flk1+ tissues, rendering the detection of a significant 
differential up-regulation virtually impossible. For example, in zebrafish, notch3 is strongly 
expressed in the DA, but is also found at high levels in the neural tube (Lawson et al., 2001). 
Some genes known to be exclusively expressed in the vascular bed are not present in the 
enriched gene list either. This is a result of the strict selective criteria we set to look for 
early regulators of vascular development. Flt4 for example, is expressed at high levels in 
Flk1+ tissues at early stages of development. Unsurprisingly, loss of Flt4 function leads 
to several angiogenic and vasculogenic defects (Ober et al., 2004; Dumont et al., 1998; 
Hogan et al., 2009). At later timepoints, we find continued high levels of expression for 
flt4 in Flk1+ tissues. Similarly, other studies have reported increasingly restricted expression 
of flt4 to the lymphatic vasculature perinataly and shown a selective contribution of flt4 
to lymphangiogenesis (Karpanen et al., 2006; Hogan et al., 2009). As a result of its role in 
both early and late stages of vascular development, flt4 fails to meet our criteria of early 
modulators of blood vessel formation and is excluded from the enriched gene list. A final 
explanation for the absence of some genes from our candidate gene list can be found in 
small but significant phenotypic changes of the cells that occur after proteolytic dissociation 
and during cell sorting. As a result changes in gene expression profiles might occur with a 
concurrent loss of expression of specific genes. Although we cannot rule out any of these 
scenarios, the expression profile of the endothelial cell type appears well represented in our 
enriched gene list. 
As a general rule, most genes expressed during vascular development were highly 
upregulated in Flk1+ cells, meaning that they clustered at the top of the enriched gene list. 
We also found that a number of the genes present in the enriched gene list were expressed in 
multiple cell types whereas others were expressed ubiquitously in the embryo. Yet according 
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to our microarray analysis these genes were upregulated in Flk1+ cells. These results suggest 
that combined sorting of specific cell types and microarray profiling may in some cases be 
more sensitive than in situ hybridisation profiling of cell type specific expression patterns. 
Novel genes with an expression pattern closely linked to vascular development, or with 
an uncharacterized role in vascular development at the time this screen was performed, 
served as candidate genes in our in vivo functional assay. By using morpholino oligomers 
we transiently knocked down the function of 19 different genes (including three gene 
duplicates) in zebrafish embryos, of some of which displayed some remarkable phenotypes. 
A detailed description of the phenotypes observed in this screen is provided in chapter 3 - 
chapter 6 of this thesis.
In summary, we identified a set of genes that is specifically expressed in Flk1+ cells, which 
will generate the endothelial lineages, during early mouse development. This led to the 
identification of multiple genes that show an expression pattern restricted to the vascular 
lineage during early zebrafish development. Not only do we provide a robust and rapid 
means of screening for novel genes involved in cell type specific development, we also 
provide functional data linking these genes to essential processes during normal vascular 
development. The signaling pathways that act during early vascular development are 
evolutionarily highly conserved across species. In an ongoing effort to study the conserved 
nature of the molecular background of vascular development, the genes identified in this 
study have been subjected to analyses in other model organisms (Fig. 1). Linking functional 
data from several model organisms, supplemented with in vitro assays provides a solid 
basis for our understanding of the conserved nature of vascular development. The data 
presented here will help to provide insight in the molecular hierarchy of genetic control of 
angioblast specification events. A better understanding of the transcriptional networks and 
signaling pathways involved in the emergence of the angioblast lineage and subsequent 
vessel formation can ultimately contribute to therapeutic benefits such as new molecular 
targets for augmenting or inhibiting vessel growth.
Supplemental Material
Supplemental material, including 6 data tables and 3 supplemental figures can be found in 
the data supplement.
Supplemental figure 1
Representative example of the RT-PCR controls 
of morpholino knockdown efficiency; RNA from 
morpholino injected embryos was isolated and cDNA 
was generated. Following PCR reactions showed a 
shift in size for the morphant samples compared to 
the wild type controls, indicating improper splicing of 
the transcripts upon injection of splice-site targeting 
morpholinos.  
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Supplemental figure 2
Global whole mount expression profiles of adora2a, 
lrrc13, spnb2 and stk10 at 24-28 hours post fertilization 
(hpf) are highly reminiscent of the expression of markers 
of the development of the blood lineage. Global whole 
mount expression profiles of spnb2, anxa6, nfatc1, 
rhoc and slco3a1 at 24-28hpf are highly reminiscent of 
markers of cardiac development. Embryos are imaged 
from a lateral view (insets for spnb2, anxa6, nfatc1 rhoc 
and slc03a1 in dorsal view), anterior is to the left.
Supplemental figure 3
Cardiac development in cgnl1 morphants was assessed 
by expression analysis of several cardiac markers at 
stages (56hpf) prior to the onset of the cardiac failure 
(5dpf) observed in cgnl1 morphants. No changes were 
found in the expression of myocardial markers cmlc2 
(which labels all myocardial cells), amhc (which labels the 
myocardial cells of the atrium) and vmhc (which labels the 
myocardial cells of the ventricle) (compare A-C with G-I). 
Expression analysis of the markers anf, bmp4 and nfatc1 
showed no apparent changes (compare D-F with J-L), 
indicating wildtype development of the cardiac valves. 
Confocal imaging of cgnl1 morphants in a kdrl:eGFP 
background (which labels all endocardial cells) at 78hpf showed no morphologic defects when compared to 
wildtype siblings (M and N). Cartilage staining (alcian blue staining) of 5dpf old cgnl1 morphants however, revealed 
gross abnormalities in cranio-facial development of these embryos compared to wildtype siblings (O and P). The 
gill-arches are completely lacking (yellow arrowhead in P), with a concurrent mis-patterning of the anterior part of 
the head. Similarly, confocal imaging of cgnl1 morphants in a kdrl:eGFP background at 5dpf showed a loss the gill 
vasculature (aortic arches, yellow arrow) and absence of the hypobranchial artery (yellow arrowhead) (compare Q 
and R). All embryos are imaged from a ventral view, at the position of the head/heart region, anterior is to the top. 
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Abstract
The specification of arteries and veins is an essential process in establishing and maintaining a functional blood vessel system. Incorrect arteriovenous specification disrupts embryonic development but has also been diagnosed in human syndromes 
such as hypotrichosis-lymphedema-telangiectasia, characterized by defects in blood and 
lymphatic vessels and associated with mutations in SOX18. Here we characterize the 
role of sox7 and sox18 during zebrafish vasculogenesis. Sox7 and sox18 are specifically 
expressed in the developing vasculature, and simultaneous loss of their function results 
in a severe loss of the arterial identity of the presumptive aorta which instead expresses 
venous markers, followed by dramatic arteriovenous shunt formations. Our study 
identifies members of the Sox family as key factors in specifying arteriovenous identity 
and will help to better understand hypotrichosis-lymphedema-telangiectasia and other 
diseases.
Introduction
Arteriovenous (AV) specification and differentiation are two critical events required for 
the progression of vascular development and function, as evidenced by diseases such as 
hypotrichosis-lymphedema-telangiectasia and hereditary hemorrhagic telangiectasia, which 
have been associated with mutations in SOX18 and endoglin/activin-like receptor kinase-1, 
respectively (Irrthum et al., 2003; Sorensen et al., 2003; Urness et al., 2000). To study the 
process of AV specification, zebrafish embryos have proven particularly useful. Following 
the specification of arterial and venous cell types (Lawson et al., 2002), endothelial cells 
coalesce into cord-like midline structures and subsequently reshape into tubes (Jin et al., 
2005). However, although several signaling molecules and transcription factors (Lawson et 
al., 2002; Liang et al., 2001; Fouquet et al., 1997; Sumanas et al., 2006) have been implicated 
in these processes, we are still only beginning to understand their regulation. In an attempt 
to identify new factors involved in the regulation of AV specification and vasculogenesis, we 
analyzed the function of sox7 and sox18, which, together with the endodermally expressed 
sox17, form the Sox-F (Sry-related HMG box) family of DNA-binding proteins (Bowles et al., 
2000). Members of the Sox-F family play crucial roles during the formation of definitive 
endoderm (Kanai-Azuma et al., 2002), hematopoietic stem cell regulation (Kim et al., 2007), 
and cardiovascular development (Pennisi et al., 2000). Here we show temporal and spatial 
overlap of sox7 and sox18 expression and identify functionally redundant roles for these 
genes during vascular development in zebrafish embryos. Our results demonstrate a novel 
role for sox7 and sox18 in specifying the molecular identity of endothelial cells in their 
commitment to arterial tissues during vasculogenesis. 
Materials and Methods
Zebrafish Husbandry
Zebrafish (Danio rerio) were raised as described (Bussmann et al., 2007). Transgenic lines used were Tg(vegfr4:gfp)
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s843 (Bussmann et al., 2007), originally referred to as Tg(flk1:EGFP)s843 (Jin et al., 2005), and  Tg(fli1a:gfp)y1 
(Lawson and Weinstein, 2002).
Histological Procedures
In situ hybridization and immuno-histochemistry were performed as described (Jin et al., 2005; Bussmann et al., 
2007). The riboprobes used are specified in the online data supplement, available at http://circres.ahajournals.org.
Morpholino Injections and Microangiographs
Procedures are specified in the online data supplement.
Results and Discussion
Expression Analysis for sox7 and sox18
We first examined embryonic expression of sox7 and sox18. RT-PCR expression analysis 
(Figure I in the online data supplement) revealed that sox7 and sox18 are provided 
maternally. In situ hybridization showed that sox7 and sox18 transcripts localized to the 
lateral mesoderm at 12 hours post fertilization (supplemental Figure I). Reminiscent of 
migrating angioblasts, these presumptive precursor cells localized to the midline during 
somitogenesis (supplemental Figure I) and finally homed to the endothelium of the axial, 
head, and intersegmental vessels at 26 hpf (Figure 1A and 1B). Cells expressing sox7 and 
sox18 are likely endothelial based on the expression pattern of these genes at later stages 
and the absence of mesodermal sox7 and sox18 expression in cloche mutants and etsrp 
morphants (Sumanas et al., 2006), both of which lack the endothelial lineage (supplemental 
Figure II). In addition, sox7-expressing cells were found in rhombomeres at 26 hpf (Figure 
1A, arrowhead), whereas sox18 expression was observed in the eye and retina (Figure 1B, 
arrowhead). The expression patterns of zebrafish sox7 and sox18 closely resemble the 
expression pattern of Sox18 in mice (Pennisi et al., 2000).
Morpholino Knockdown Analysis of sox7 and sox18
Embryos injected with morpholinos (MOs) targeting sox7 or sox18 individually (two 
independent MOs for each gene; see supplemental Figure III for specificity tests) did not 
show any apparent morphological defects, or loss of endothelial cells (supplemental Figure 
I), or loss of circulation (supplementary Movies 2 to 3). Strikingly, on simultaneous injection of 
low amounts of both sox7- and sox18-MO, virtually all double knockdowns (dKDs) exhibited 
a loss of circulation in the posterior part of the embryo, whereas cardiac contractile function 
was normal (Figure 1E; supplementary Movie 1). Later, blood accumulated in a short 
circulatory loop near the heart leading to pericardial edema (>2 days post fertilization; not 
shown). Endothelial cells were specified in sox7/sox18-dKDs as demonstrated by fli1a:gfp 
expression, but we noticed poor segregation of artery and vein (compare supplemental 
Figure Ij and Im, insets). In addition, in microangiographs, the major axial vessels in the 
posterior part of sox7/sox18-dKDs were not filled with dye at 2 days postfertilization (Figure 
1C and 1D). Dye injected into the sinus venosus drained from the heart into the posterior 
cardinal vein (PCV) rather than the dorsal aorta (DA) (Figure 1D, arrow). We conclude that 
combined loss of sox7 and sox18 function results in a severe disturbance of circulation.
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Arteriovenous Specification and Vascular Tube Formation in sox7/sox18-dKDs
To further investigate this phenotype, we analyzed the expression of several molecular 
markers in sox7/sox18-dKDs compared with uninjected control embryos or silent heart 
morphants (Sehnert et al., 2002). No alteration was detectable in the primitive erythroid 
lineage marker gata1 (supplemental Figure IV), vegf receptors 2 and 4, or pan-endothelial 
markers like tie2, cdh5, and fli1a (not shown). However, we observed a dramatic decrease 
in the expression of arterial markers notch3, ephrinB2a (Figure 2A through 2D), and dll4 
(supplemental Figure IV) and a concurrent increase in the expression of venous markers 
dab2 and flt4 in arterial tissues, such as the DA and intersegmental vessels (supplemental 
Figure IV and Figure 2C and 2F, respectively). These results suggest a key role for sox7 
and sox18 in specifying the arterial fate of endothelial cells. A possible shift in AV identity 
attributable to the lack of circulation was excluded by analyzing silent heart morphants, 
Figure 1. Sox7 and sox18 
expression profiles and lack of 
trunk circulation in sox7/sox18-
KDs. A and B, Twenty-six hours 
post fertilization, lateral view; 
anterior is to the left. A, Sox7 
expression is restricted to the 
endothelial cells of the main 
axial (white arrow), head (black 
arrow), and intersegmental 
(white arrowhead) vessels, as 
well as to 2 rhombomeres (black 
arrowhead). B, Sox18 expression 
is restricted to endothelial 
cells of the main axial (white 
arrow), head (black arrow), and 
intersegmental (white arrowhead) 
vessels, as well as to the eye (black 
arrowhead). C and D, Confocal 
images of microangiographs at 
2.5 days postfertilization of an 
uninjected vegfr4:gfp embryo (C) 
and a vegfr4:gfp sox7/sox18-dKD 
embryo (D). Dye injected into the 
sinus venosus drained from the 
heart into the posterior cardinal 
vein rather than the dorsal aorta 
(arrow) in sox7/sox18-dKDs. E, 
Near-complete loss of circulation 
in the posterior part of the embryo 
is consistently observed in sox7/
sox18-dKDs, as evidenced by 
different injection regimes using 
varying concentrations of the 
respective morpholinos. dKD, 
double knockdown.
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Figure 2. 
A r t e r i a l 
specification 
is perturbed 
in sox7/
sox18-dKDs. 
A and B, 
U n i n j e c te d 
c o n t r o l 
embryos. C, 
Silent heart 
m o r p h a n t . 
D through 
F, sox7/
sox18- dKDs. 
All embryos 
were at 26 
hpf; notch3 
(A and D), 
ephrinB2a (B 
and E), flt4 (C 
and F). A, B, 
D, and E, Note the dramatic reduction in expression levels of arterial markers notch3 and ephrinB2a in the dorsal 
aorta (brackets) in sox7/sox18-dKDs. C and F, Ectopic expression of the venous marker flt4 in the dorsal aorta 
(brackets) and intersegmental vessels (white arrow) in sox7/sox18-dKDs.
Figure 3. 
Vascular tube 
formation is 
p e r t u r b e d 
in sox7/
sox18-dKDs. 
Tr a n s v e r s e 
sections of 
the trunk 
region of 30 
hpf fli1a:gfp 
e m b r y o s , 
stained with 
p h a l l o i d i n 
(red) and 
DAPI (blue). 
Two distinct, 
l u m e n i z e d 
vessels (the 
DA and the 
PCV) can be 
observed in 
uninjected control embryos (A and D) and silent heart morphants (B and E). C and F, Sox7/sox18-dKDs show a 
fusion of the DA and PCV (white arrow). ISV indicates intersegmental vessel; No, notochord; NT, neural tube; PD, 
pronephric duct; So, somites. Scale bar in A through C, 25 μm.
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which showed no alteration in marker gene expression (Figure 2C and supplemental Figure 
VI). This demonstrates that sox7 and sox18 are essential regulators of AV identity. To better 
understand the lack of lumen formation observed in sox7/sox18-dKDs in microangiographs, 
we next examined transverse sections of sox7/sox18-dKDs, uninjected control embryos, and 
silent heart morphants. The nonvascular morphology in sox7/sox18-dKDs (Figure 3C) was 
completely normal, suggesting a vessel-specific phenotype. Uninjected controls and silent 
heart morphants exhibited normal segregation and lumenization of axial vessels (Figure 
3A, 3B, 3D, and 3E). In all sox7/sox18-dKDs (n=16), we observed stretches of normal and 
physically separated axial vessels, alternating with regions where only a single PCV was 
present. At particular locations in sox7/sox18-dKDs, the DA apparently fused with the PCV 
(Figure 3C and 3F; see also supplemental Figure V). We conclude that the combined loss of 
Sox7 and Sox18 function disrupts AV specification and leads to severe shunt formation. Our 
study provides novel insights into the molecular roles of sox7 and sox18, which are essential 
to the specification of the molecular identity of the dorsal aorta during embryogenesis and 
possibly during later stages of life. These findings, for the first time, offer direct insights 
into the molecular consequences of Sox function in endothelial cells at the in vivo level. 
Understanding the requirement for Sox7 and Sox18 in the process of arteriovenous 
specification might help to better understand syndromes such as hypotrichosis-lymphedema-
telangiectasia and hereditary hemorrhagic telangiectasia.
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Supplemental Material
Supplementary information, including 6 figures and 3 movies can be found in the data 
supplement or online, at http://circres.ahajournals.org.
Zebrafish husbandry
Zebrafish (Danio rerio) embryos were obtained from wild-type strains and raised at 28ºC as previously described. 
The transgenic line Tg(vegfr4: gfp)s843, originally referred to as Tg(flk1:EGFP)s843 was obtained from Didier 
Stainier (San Francisco, CA, USA). The transgenic line Tg(fli1a:gfp)y1 was obtained from Brant Weinstein (Bethesda, 
ML, USA). Homozygous mutant cloche or scl (tal1t21384) embryos were obtained by incrossing these fish.
RT-PCR analysis
cDNA was synthesized from RNA isolated from 0, 1, 2.5, 6, 8, 10 and 24 hours post fertilization old embryos using 
the SuperScript II RT Kit (Invitrogen). Primers used for reverse transcriptase PCR were:
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sox7-Fwd: 5’-ACCAGCTGCTCACTCAAAC-3’
sox7-Rev: 5’-GATCTCTGAAGACCCTGACG-3’
sox18-Fwd: 5’-ACACTTCCGAGACCTCCAC-3’
sox18-Rev: 5’-GGTCAAACTCAATCCTGTCC-3’
Whole-mount in situ hybridization and immuno-histochemistry
Whole-mount in situ hybridization was performed as previously described. Previously described riboprobes used 
in this manuscript were: notch3, ephrinB2a, dll4, dab, flt4, vegf-receptors 2 and 4, gata1, tie2, cdh5, fli1a. Bacterial 
clones for sox7 and sox18 were obtained from Open Biosystems (http://www.openbiosystems.com). Embryos were 
mounted in glycerol and documented with a Zeiss axioplan mounted with a Leica DFC 480 camera.
Immuno-histochemistry was performed as previously described. Briefly, embryos were fixed overnight with 2% 
paraformaldehyde and embedded in 4% low melting point agarose (Invitrogen). Embedded embryos were cut using 
a HM650V vibratome (Microm) into 250μm sections. Filamentous actin was visualized with rhodamine phalloidin 
(Fluka). Nuclei were visualized with 4,6-diamino-2-phenylindole (DAPI) (Sigma).Processed samples were mounted 
in Aquamount improved (BDH laboratory supplies) and imaged using a Leica TCS SPE confocal microscope.
Morpholino injections and microangiograms
Morpholinos (MOs) were obtained from Gene Tools (http://www.gene-tools.com) and diluted in water containing 
0.2% phenol red. One cell stage embryos were injected (maximum volume of 2nl) as described. Live embryos were 
anaesthetized using MS222 and mounted in a glass-bottom dish containing 0.4% agarose. Images were taken with 
a LEICA CLSM SP2 AOBS confocal microscope. Confocal microangiography was performed as described. Embryos 
were injected with silent heart, etsrp, or sox7 and sox18 specific morpholinos. Morholino (MO) sequences were:
MOsox7-ATG: 5’-CGCACTTATCAGAGCCGCCATGTGC-3’
MOsox18-ATG: 5’-ATATTCATTCCAGCAAGACCAACAC-3’
MOsox7-UTR: 5’- CTGTCAAAACTTAGGCTTCCTTTTG-3’
MOsox18-UTR: 5’- AGCAAGCTGTTGTCTTTGAGTAAAG-3’
MOsilent heart: 5’-CATGTTTGCTCTGATCTGACACGCA-3’
MOetsrp: 5’-CACTGAGTCCTTATTTCACTATATC-3’
Movie Legends
Supplementary movie 1.
Phase-contrast movie showing circulation in trunk and tail of an uninjected control embryo at 2.5dpf (top, dorsal 
is up) and loss of circulation in trunk and tail of a sox7/sox18-dKD embryo at 3dpf (bottom, ventral is up). Anterior 
is to the right.
Supplementary movie 2.
Phase-contrast movie showing circulation in trunk and tail of an uninjected control embryo at 2.5dpf (top, dorsal is 
up) and a sox7-morphant embryo at 2.5dpf (bottom, dorsal is up). Anterior is to the left.
Supplementary movie 3.
Phase-contrast movie showing circulation in trunk and tail of an uninjected control embryo at 2.5dpf (top, dorsal is 
up) and a sox18-morphant embryo at 2.5dpf (bottom, dorsal is up). Anterior is to the left.
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Supplementary figure 1: Sox7 and sox18 expression and lack of trunk circulation in sox7/sox18-dKDs
a-c. Expression profile of sox7 (a) At 12hpf, sox7 is expressed in the lateral mesoderm of the embryo. (b) At 18hpf, 
sox7 expression is found in a cord-like structure (future DA and PCV) and in presumptive migrating angioblasts 
(arrowheads). (c) At 26 hpf (lateral view), sox7 expression is restricted to the endothelial cells of the main axial 
(white arrow), head (black arrow) and intersegmental (white arrowhead) vessels, as well as to two rhombomeres 
(black arrowhead). d-f. Expression profile of sox18 (d) At 12hpf, sox18 is expressed within the lateral mesoderm 
of the embryo. (e) At 18hpf, sox18 expression is found in a cord-like structure and in presumptive migrating 
angioblasts (arrowheads). (f) At 26 hpf (lateral view), sox18 expression is restricted to endothelial cells of the 
main axial (white arrow), head (black arrow), and intersegmental (white arrowhead) vessels, as well as to the eye 
(black arrowhead). (g) RT-PCR expression analysis showed maternal expression of both sox7 and sox18, expression 
levels for sox18 however are lower at 0, 1 and 2.5 hours post fertilization compared to expression levels for sox7. 
Sox7 and sox18 mRNA expression shown for 0, 1, 2.5, 6, 8, 10 and 24 hours post fertilization old embryos. h-i. 
Microangiographies at 2.5 dpf. Major axial vessels in the posterior part of sox7/sox18-dKDs were not filled with 
dye. j-m. Confocal images (30hpf) of (j) an uninjected fli1a:gfp embryo, (k) a vegfr4:gfp embryo injected with 10ng 
of sox7-MO, (l) a vegfr4:gfp embryo injected with 10ng of sox18-MO and (m) a fli1a:gfp embryo injected with 5ng 
of both sox7-MO and sox18-MO. Insets show magnifications at the posterior level of the trunk. (m, inset) Note the 
partial fusion of the DA and PCV in sox7/sox18-dKDs. DA, dorsal aorta; dKD, double knock-down; MO, morpholino; 
PCV, posterior cardinal vein.
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Supplementary figure 2: 
Sox7 and sox18 expression in 
cloche mutants, scl mutants 
and etsrp morphants
Whole mount in situ 
hybridization expression analysis 
for sox7 and sox18 in embryos 
defective in the blood lineage, 
the endothelial lineage or both. 
Mesodermal sox7 and sox18 
expression was lost in cloche 
mutants, which lack nearly all 
blood and endothelial cells. 
Early sox7 and sox18 expression 
in scl mutants, defective in 
dorsal aorta as well as blood 
formation, appeared normal. 
Mesodermal sox7 and sox18 
expression was vastly reduced 
in etsrp morphants, which lack 
the endothelial lineage only. 
Based on these results and the 
expression pattern of these genes at later stages we conclude that sox7 and sox18 expression is restricted to the 
endothelial lineage and does not contribute to other cell lineages derived from the mesoderm.
Supplementary figure 3: Morpholino specificity controls
MOsox7-ATG-, MOsox18-ATG-, MOsox7-UTR- and MOsox18-UTR-
binding sites were cloned into pCS2+, which contained a transcript 
encoding for GFP, upstream of the translation initiation site. Translation 
of capped mRNA was efficiently blocked by the respective MOs, 
demonstrating efficacy and specificity (sox7-MO does not block sox18 
translation) of the reagents used. Results shown for MOsox7-UTR- 
and MOsox18-UTR; similar results were obtained with MOsox7-ATG-, 
MOsox18-ATG. Given the efficacy and specificity of the MOs used, we 
did not perform rescue experiments by co-injection of sox7- or sox18-
mRNA.`
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Supplementary figure 4: Arterial specification is perturbed in sox7/sox18-dKDs
a-d. Uninjected control embryos; e-h. sox7/sox18-dKDs. All embryos at 26hpf. (a,e) gata1, (b,f) dll4, (c,g) dab2, 
(d,h) flt4. (a,e) Levels of gata1 appear normal in sox7/sox18-dKDs. (b,f) Note the dramatic reduction in expression 
levels of the arterial marker dll4 in the dorsal aorta (brackets) in sox7/sox18-dKDs. (c,d; g,h) Ectopic expression of 
the venous markers dab2 and flt4 in the dorsal aorta (brackets) and intersegmental vessels (white arrow) in sox7/
sox18-dKDs. dKD, double knock-down.
Supplementary figure 5: 
Vascular tube formation 
is perturbed in sox7/
sox18-dKDs
The lack of lumen formation 
observed in sox7/sox18-
double knock downs 
(dKDs) was examined in 
both sagital and transverse 
7μm thick sections of sox7/
sox18-dKDs and uninjected 
control (UIC) embryos. a. 
Sagital section of the tail 
section of a 30hpf sox7/
sox18-dKD (n=10) showing 
shunt formation between 
DA and PCV, indicated by 
the arrow. No shunts were 
observed in a comparable 
number of UIC embryos 
(data not shown). b-f. 
Consecutive transverse 
sections of the midtrunk 
region of a 30hpf sox7/
sox18-dKD, showing the 
loss and reappearance 
of the physical boundary 
between the DA and PCV, 
indicated by the arrows. This is a representative case from 10 examined sox7/sox18-dKDs. No shunts were observed 
in UIC embryos (n=10) (data not shown). Sections were stained with hematoxylin and eosin. Scale bar in b-f 25 μm. 
NT, neural tube; No, notochord; So, somites; DA, Dorsal Aorta; PCV, Posterior Cardinal Vein; PD, pronephric duct.
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Supplementary figure 6: Arteriovenous 
specification is unaltered in sox7-, sox18- and 
silent heart morphants
a,b. Uninjected control (UIC) embryos; c-d. sox7-
morphants; e-f. sox18-morphants; g-h. silent heart-
morphants. Expression analysis of 26 hpf old embryos 
using the markers (a,c,e,g) ephrinB2a or (b,d,f,h) flt4 
as a probe. Sox7- and sox18-morphants show normal 
levels of expression for ephrinB2a and flt4 compared 
to sox7/sox18-double knock downs (Figure 2 and 
Supplementary Figure 4), confirming the observed 
redundancy amongst sox7 and sox18. Expression 
levels of the markers tested appeared normal in silent 
heartmorphants, excluding the possibility of a shift in 
arteriovenous identity caused by a lack of circulation.
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Abstract
The G protein-coupled receptor Angiotensin receptor like 1b (Agtrl1b, APJ, Msr) is expressed in the developing vasculature where it serves as a receptor for the small peptide Apelin. Recent studies showed an indispensable role for Agtrl1b-
Apelin signaling in controlling heart field formation. Here we report a novel role for 
Agtrl1b in facilitating angiogenic sprout migration from the dorsal aorta in early zebrafish 
development independent of cardiac specification. We show that agtrl1b mutant fish 
exhibit normal cell numbers in sprouting intersegmental vessels, but that the tip-cells of 
the intersegmental vessels display abnormal filopodic behavior and that the migration of 
the intersegmental vessels is defective. 
Introduction
The vertebrate vascular system is critical for the uptake and exchange of gases, nutrients, 
delivery of hormones, and for facilitating immune responses. The development of a 
functional vasculature involves the specification of arteries, veins and lymphatic vessels in 
a timely and spatially highly coordinated fashion. A strong hierarchical control of genetic 
factors enables the coordinated sprouting, proliferation and migration of endothelial 
cells in a process called angiogenesis.  Factors including the vegf-receptors (Ferrara et al., 
1997), scl (Patterson et al., 2005) and plcγ (Lawson et al., 2003) have been shown to be 
indispensable for early angiogenic sprouting from the dorsal aorta (DA) of the developing 
zebrafish embryo. Other factors like semaphorins and plexins (Torrez-Vasques et al., 2004) in 
turn guide the patterning of the developing vasculature. Although several factors have been 
described in early angiogenesis, this process is yet not fully understood. 
Recently, two independent studies in zebrafish showed a critical role for Agtrl1b in 
myocardial specification, but reported no Agtrl1b function in vascular development 
despite its restricted expression in the vasculature (Scott et al, 2007; Zeng et al, 2007). 
Two similar studies in Xenopus reported differing findings; whereas one study showed 
perturbed intersegmental vessel branching (Cox et al, 2006), another study showed a more 
pronounced effect on cardiovascular development (Inui et al, 2006). The nature of these 
discrepancies is largely unclear, but is in part ascribed to differences in the experimental 
setup (Kälin et al., 2007). Knockout studies in mice showed a hypotensive effect for APJ 
but reported no vascular abnormalities (Ishida et al., 2004), whereas Apelin deficient mice 
showed a retardation of retinal vascular development (Kasai et al., 2008).  Apelin signaling 
has also been associated with regenerative and tumour (neo)angiogenesis (Eyries et al., 
2008; Sorli et al., 2007; Kälin et al., 2007) and has recently become a promising target for 
drug development (Masri et al., 2005; Sorli et al., 2006).
In this study we used reverse genetics to generate an Agtrl1b knockout zebrafish. As 
reported previously the embryos display a loss of cardiomyocytes in only a limited subset 
of the mutant embryos (Scott et al, 2007). Strikingly, all mutant embryos failed to form 
fully grown ISVs and had no dorsal longitudinal anastomotic vessel (DLAV). We show that 
58|
defective ISV outgrowth in agtrl1b mutant embryos is independent of blood flow and is not 
caused by a lower number of cells per ISV, but rather by defective migration of the ISVs and 
concurrent abnormal filopodic behavior of the tip-cells of the ISVs.
Materials and Methods
Zebrafish
Zebrafish were kept under standard husbandry conditions at the Hubrecht Institute. Transgenic lines used were 
Tg(kdr-l:GFP)s843 (Jin et al., 2005) and Tg(fli1:neGFP)y7 (Roman et al., 2002). 
TILLING of Agtrl1b
A library of randomly ENU mutagenized F
1
-zebrafish was screened for mutations in the agtrl1b gene by DNA 
resequencing (Wienholds, 2002).  After filtering for SNPs, 26 ENU-induced mutations were detected of which 
one led to a premature stop just after the first transmembrane domain (W54Stop). The identified F
1
 carrier fish 
(agtrl1bhu4145) was crossed into the desired transgenic backgrounds and bred for several generations (up to F
5
) to 
remove the majority of background mutations. Primers used for TILLING were: 
Ag1-1A-1-5’-GACCTGAGCACATGACAAAC-3’, 
Ag1-1A-2-5’-TGTAAAACGACGGCCAGTTGGACAACATGACTGCTGAC-3’, 
Ag1-1A-3-5’-AGGAAACAGCTATGACCATCAGATGGCTGTCAGAGAGG-3’ and 
Ag1-1A-4-5’- ATACACTGTGGTGCGGAAG-3’. 
Morpholino injections
Morpholinos (MOs) against silent heart (SIH) (5’-CATGTTTGCTCTGATCTGACACGCA-3’) (Sehnert et al., 2002) were 
obtained from Gene Tools http://www.gene-tools.com and diluted in water containing 0.2% phenol red. One cell 
stage embryos were injected with 1ng of MO with a maximum volume of 1nl. 
Histological and Imaging Procedures
Whole-mount in situ hybridization was performed as previously described (Zeng et al., 2007). Bacterial clones for 
apln and agtrl1b were obtained from Open Biosystems http://www.openbiosystems.com. Immunohistochemistry 
(rabbit αGFP 1:200) was performed as described previously (Jin et al., 2005) following in situ hybridization 
immediately after the staining was completed.
Embryos were mounted in 1% low melting point agarose in a culture dish with a cover slip replacing the bottom. 
Imaging was performed with a Leica Microsystems SP2, SPE or SP5 confocal microscope using a 10x, 20x or 40x 
objective with digital zoom. Timelapse movies were assembled using ImageJ. Cellcounts were performed using 
Volocity software (PerkinElmer). Angiography was performed as previously described (Weinstein et al., 1995). 
Images were processed by using Photoshop CS2 and Illustrator CS2 (Adobe).
Statistical analyses
Calculations for mean, standard deviation, the probability associated with the Student’s t-test were carried out in 
Microsoft Excel. 
Results
Expression analysis for apln and agtrl1b
We examined the expression of agtrl1b and its ligand apln at 24 hours post fertilization 
(hpf) and found agtrl1b to be expressed in the vascular system (Fig. 1A), whereas apln was 
found at the dorsal side of the trunk where the future DLAV will form (Fig. B) as reported 
previously (Zeng et al., 2007).  Immunohistochemistry using αGFP in Tg(kdr-l:GFP)s843 fish 
immediately following in situ hybridisation showed a colocalization of  agtrl1b in all cells of 
the ISV (Fig. 1C).
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Generation of an agtrl1b mutant
After screening of a library of randomly ENU mutagenized F
1
-zebrafish a premature stop 
(Fig. 1D) just after the first transmembrane domain (W54Stop) (Fig. 1E) was identified for 
agtrl1b. The identified mutant carrier was crossed into the desired transgenic backgrounds.
Analysis of agtrl1b-/- mutant fish reveals an angiogenesis defect
Agtrl1b mutant analysis showed a loss or reduction of the heart field in only a limited 
number of embryos (13.8%, n=58) similar to what was reported previously (Scott et al., 
2007), whereas defective ISV sprouting surprisingly was found at a Mendelian ratio (24.1%, 
n=58). Major vessels like the DA and the Posterior Cardinal Vein (PCV) formed normally, and 
showed normal expression of markers like ephB2a, flt4, kdr-l and cdh5 (data not shown). 
Circulation was initiated normally in a subset of mutant embryos (10.3%, n=58), but to our 
surprise the ISVs that sprout from the DA failed to complete migration to the dorsal side of 
the trunk and no DLAV was ever formed (Fig. 1F,G). 
Fig. 1. Zebrafish agtrl1b mutants display defects of the intersegmental vessels. (A-C) Expression patterns for 
agtrl1b and apln at 24 hours post fertilization (hpf). Agtrl1b is expressed in the dorsal aorta (DA), posterior cardinal 
vein (PCV) and intersegmental vessel (ISV) (A, red arrowhead) and colocalizes with the pan-endothelial marker kdr-l 
(C). Apln is expressed at the dorsal side of the trunk at the location of the future dorsal longitudinal anastomotic 
vessel (DLAV) (B, yellow arrowhead). (D and E) Screening of a library of ENU mutagenized F
1
-zebrafish for 
mutations in the agtrl1b gene by DNA resequencing identified a G>A mutating (see chromatogram in D), changing 
a Tryptophan residue to a premature stop (W54Stop) just after the first transmembrane domain (E). (F-H) Confocal 
analysis of agtrl1b mutants in a Tg(kdrl:GFP)s843 background at 28hpf showed normal development of the DA (red 
bar), PCV (blue bar), ISVs (red arrowhead) and DLAV (yellow arrowhead) in wildtype siblings (F, inset). Agtrl1b-/- 
mutant embryos displayed normal development of the DA (red bar) and PCV (blue bar), but had abnormal ISVs (red 
arrowhead) and completely lacked a DLAV (yellow asterisk) (G, inset). Angiographies at 50 hpf in agtrl1b-/- embryos 
demonstrated flow in major vessels like the DA and PCV (H). 
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Closer analysis of the observed phenotype by confocal timelapse analysis revealed 
normal timing of the initial sprouting of ISVs from the DA in agtrl1b mutants. After initial 
sprouting the ISVs migrated towards the dorsal side of the embryo at a lower pace relative 
to wildtype siblings, only to stall halfway the dorso-ventral axis of the trunk (Supplementary 
movies 1 and 2; supplementary figure 1). 
Defective arterial sprouting in agtrl1b-/- mutant fish is independent of flow
To rule out the possibility that perturbed angiogenic sprouting in agtrl1b mutants is 
caused by a reduction or lack of blood flow (Lawson and Weinstein, 2002), we performed 
angiographies at 50 hpf which demonstrated flow in major vessels like the DA and PCV (Fig. 
1H). At this stage, after which secondary sprouting from the PCV has taken place (Isogai et 
al., 2003), some ISV had lumenized and migrated to the dorsal side of the trunk and these 
blunt-ended vessels would readily take up dye. Formation of a DLAV however was never 
observed. To further investigate the importance of flow on angiogenic sprouting from the 
DA we injected silent heart (SIH) morpholinos, which have been shown to effectively block 
cardiac contractility and thus blood flow (Sehnert et al., 2002) and assessed ISV sprouting 
in these morphants by confocal timelapse analysis. Normal sprouting of ISVs and formation 
of a DLAV in these morphants was observed (supplementary figure 1), indicating that ISV 
sprouting, DLAV formation and migration from the DA towards the dorsal side of the trunk 
is independent of flow. 
Agtrl1b-/- ISVs have normal numbers of cells but altered filopodic behavior
As Apln has been suggested as a mitogenic factor (Cox et al., 2006), we investigated the 
number of cells in ISVs in agtrl1b mutants at 28 hpf, when most wildtype siblings had 
started to form a DLAV, using fli:neGFP embryos, which express nuclear localized eGFP in all 
endothelial cells (ECs). Surprisingly, we found the number of nuclei per ISV in agtrl1b mutants 
(2.76 ± 0.93, n=330 in 55 embryos) to be almost identical to that of wildtype counterparts 
(2.73 ± 0.97, n=348 in 58 embryos) (Fig. 2A-C). Although they proliferated normally, the ECs 
of agtrl1b mutant ISVs failed to both elongate and to migrate towards the dorsal side of the 
trunk, but rather stayed compacted in close proximity to their origin of sprouting from the 
DA (compare Fig. 2A and Fig. 2B).
Typically, two different cell populations are distinguished within a sprouting vessel; the 
leading tip-cell and the stalk-cells, which are both specialized in a distinct manner (Gerhardt 
et al., 2003; Phng and Gerhardt, 2009). The tip-cell is characterized by guided migration, 
has numerous actin rich filopodic protrusions and hardly ever proliferates. The stalk-cells 
on the other hand are capable of proliferation and form the vascular lumen. As we found 
no alteration in typical stalk-cell behavior, we determined whether more features of the 
tip-cell besides migration were affected in agtrl1b mutants. We analyzed individual ISVs in 
both wildtype and mutant embryos and categorized them for having normal (I), moderate 
(II) or weak (III) filopodic behavior (Fig. 2D-F). Whereas most wildtype ISV could be placed 
in categories (I) & (II), the mutant genotype was almost completely absent from category 
(I), but was enriched in the category of weak sprouting (III) (Fig. 2G). These data show that 
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defective ISV outgrowth in agtrl1b mutant embryos is not caused by a lower number of 
cells per ISV, but rather by abnormal filopodic behavior of the tip-cells of the ISVs which 
potentially causes the migratory defects observed.
Fig. 2. agtrl1b-/- 
ISVs have wildtype 
numbers of cells 
but display altered 
filopodic behavior. 
(A-C) The number 
of cells constituting 
an intersegmental 
vessel (ISV) at 
28 hours post 
fertilization (hpf) 
was assessed in 
both wildtype 
(A) and agtrl1b-/- 
mutant (B) embryos 
in a Tg(fli1:neGFP)
y7 background. 
No significant 
difference (p=0.67) 
in the number of 
nuclei per ISV in 
wildtype (2.73 ± 0.97, n=348 in 58 embryos) compared to agtrl1b-/- mutant embryos (2.76 ± 0.93, n=330 in 55 
embryos) was found (C). (D-G) ISVs at 26 hpf were categorized into three different groups for having either (I) 
normal sprouting behavior (showing distinct protrusions (red arrows) and extending filopodia (yellow arrow)) (D), 
(II) moderate sprouting behavior (showing no protrusions but normal extending filopodia (yellow arrow)) (E) or 
(III) weak sprouting behavior (no protrusions and few to no filopodia) (F). Subsequent genotyping showed a vast 
reduction of the mutant genotype in category (I) compared to wildtype genotype (8.7% vs 50%) and a concurrent 
enrichment of the mutant genotype in category (III) compared to wildtype genotype (52.9% vs 20%) (G).     
Fig. 3. Agtrl1b is 
required for the 
filopodic behavior 
of the angiogenic 
sprout. (I and II) 
Schematic overview 
of the developing 
vasculature of 
the zebrafish 
trunk. Agtrl1b is 
expressed in the 
dorsal aorta (DA), 
posterior cardinal 
vein (PCV) and the 
i n t e r s e g m e n t a l 
vessels (ISVs). Apln 
is expressed at the dorsal side of the zebrafish trunk and induces an Apln gradient along the dorso-ventral axis. ISVs 
sprout from the DA in response to Vegfa, locally produced in the neighboring somites (I). In wildtype embryos, the 
endothelial cells (ECs) in the sprouting ISV proliferate and migrate towards the Apln source, guided by intensive 
filopodic behavior of the tip-cell. In agtrl1b mutants however, proliferation of the ECs is unaltered, but fewer and 
shorter filopodia are present and migration stalls at the midline (II). 
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Discussion
Here we describe a novel zebrafish mutant for the G-protein coupled receptor agtrl1b which 
encodes a premature stop just after the first transmembrane domain. Using this in vivo model 
we uncovered a specific requirement for agtrl1b in the early development of the zebrafish 
arterial vasculature formed by angiogenesis. The major blood vessels like the dorsal aorta 
(DA) and posterior cardinal vein (PCV), develop normally in zebrafish agtrl1b mutants, but 
the intersegmental vessels (ISVs) fail to extend to the dorsal side of the trunk. Consequently 
no dorsal longitudinal anastomotic vessels (DLAVs) are formed. This phenotype is not due to 
a proliferative defect as the ISVs in agtrl1b mutants had normal numbers of cells. In contrast, 
the filopodic behavior of the ISVs in agtrl1b mutants is severely affected. 
Previous studies have shown a temporal delay in the early stages of vascular development 
of retinal vascularization in apelin null mice (Kasai, 2008). In addition, a chemotactic role 
for Apln, the ligand for Agtrl1b, has been reported (Cox et al., 2006; Kälin et al, 2007). In 
mice and tadpoles, apln is expressed in the tip-cells of the angiogenic sprout preceding ISV 
angiogenesis and Agtrl1b/APJ expression (Sorli et al., 2006; Kälin et al, 2007). Mammalian 
signaling of Agtrl1 via binding of Apelin, results in the activation of the PI3K/Akt pathway 
(Masri et al., 2005; Kojima and Quertermous, 2008). PI3K and Akt have previously been 
implicated in the control of directional cell migration and the sensing of chemoattractant 
gradients by the cell (reviewed by Shiojima and Walsh, 2002; Sasaki and Firtel, 2006); Akt 
transiently localizes to the leading edge membrane of migratory cells in a PI3K dependent 
manner (Meili et al., 1999; Servant et al., 2000). In order for a cell to generate contractile 
forces to migrate towards a chemotactic source, the establishment of a leading edge and 
the reorganization of the actin cytoskeleton are essential. The Rho family of small G proteins 
have been identified as major regulators of actin reorganisation, and its member Cdc42 
induces the formation of filopodia and is involved in chemotactic sensing (van Nieuw 
Amerongen and Hinsbergh, 2001). Constitutively active Akt in turn has been shown to be 
able to activate Cdc42 (Higuchi et al., 2001). 
In zebrafish, we find expression of the receptor agtrl1b in the DA, PCV and all cells 
of the ISVs, while apln is expressed at the dorsal side of the trunk at the location of the 
future DLAV. Our data suggests a requirement for agtrl1b during angiogenesis in which 
the sprouting ISVs are guided along a gradient of Apln across the dorso-ventral axis of the 
embryo trunk by signaling through Agtrl1b. During this migration process, tip-cells send out 
numerous filopodia, enabling guided migration towards a chemotactic source, while at the 
same time stalk-cells proliferate and form the vascular lumen. In agtrl1b mutant fish we find 
normal characteristics of stalk-cells as endothelial cell proliferation within the ISVs is normal 
and lumenization of the ISVs is observed (summarized in Fig. 3). Initially, we hypothesized 
that the ISVs would have increased numbers of filopodia and/or show multi-directionality 
when chemotaxis through Apln-Agtrl1b signaling could not be established. However, the 
impaired migration of ISVs in agtrl1b zebrafish mutants was coincident with reduced 
filopodic behavior. This finding is in concert with the notion that Agtrl1b not only mediates 
chemotaxis, but also influences architectural aspects of tip-cells through downstream 
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signaling via the PI3K/Akt pathway. In summary, this study shows that Agtrl1b is essential 
for the wildtype behavior of tip-cells and subsequent migration of endothelial cells during 
the development of angiogenic intersegmental sprouts.     
Supplemental Material
Two supplemental movies can be found in the data supplement.
Supplementary figure 1.
Still pictures from confocal timelapse movies showing the migration of the intersegmental vessels (ISVs) (red 
arrowhead) from the dorsal aorta (DA) (red bar) towards the dorsal side of the embryo to form the dorsal 
longitudinal anastomotic vessel (DLAV) (yellow arrowhead) in a wildtype Tg(kdr-l:GFP)s843 embryo (a-a’’’). Agtrl1b-/- 
fish develop a lumenized DA (red bar) and posterior cardinal vein (PCV) (blue bar) and have sprouting ISVs (red 
arrowhead) from the DA that fail to extend to the dorsal side of the embryo (b-b’’’). Whereas wildtype ISVs would 
have reached the dorsal side of the embryo and started to extend laterally at ~26hpf (a’), agtrl1b-/- mutant ISVs 
would stall at the midline and never form a DLAV (yellow asterisk) even at later stages (b’-b’’’). Silent heart (SIH) 
injected Tg(kdr-l:GFP)s843 embryos show normal migration of intersegmental vessels (ISVs) (red arrowhead) from 
the dorsal aorta (DA) towards the dorsal side of the embryo and formation of the dorsal longitudinal anastomotic 
vessel (DLAV) (yellow arrowhead) compared to wildtype embryos (compare a-a’’’ and c-c’’’).
Supplementary movie 1.
Representative example of a confocal timelapse movie of the development of the intersegmental vessels (ISV) and 
the dorsal longitudinal anastomotic vessel (DLAV) just after sprouting from the dorsal aorta (DA) (24 - 34 hours post 
fertilization) in a wildtype Tg(kdr-l:GFP)s843 embryo. Note the typical filopodic behavior of the ISVs while migrating 
towards the dorsal side of the trunk (~24-26 hpf) after which they extend laterally (~26-28 hpf) and connect with 
neighboring ISVs to form the DLAV (>28hpf). 
Supplementary movie 2.
Representative example of a confocal timelapse movie of the development of the intersegmental vessels (ISVs) just 
after sprouting from the dorsal aorta (DA) (24 - 34 hours post fertilization) in an agtrl1b-/- Tg(kdr-l:GFP)s843 mutant 
embryo. Initial sprouting of ISVs from the DA is timed normally, however the ISVs fail to extend to the dorsal side of 
the trunk and no dorsal longitudinal anastomotic vessel is formed, but instead remain stalled halfway the dorsal-
ventral axis of the trunk. 
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Role of Dll4 / Notch in the formation and wiring 
of the lymphatic network in zebrafish
 
Robert Herpers1,2*, Ilse Geudens3,4*, Karlien Hermans3,4*, Inmaculada 
Segura,4, Carmen Ruiz de Almodovar3,4, Jeroen Bussmann1, Frederik 
De Smet1,2, Wouter Vandevelde3,4, Ben Hogan1, Arndt Siekmann5, Filip 
Claes3,4, John Moore5, Anna Silvia Pistocchi6, Sonja Loges3,4, Massimiliano 
Mazzone3,4, Giovanni Mariggi8, Françoise Bruyère9, Franco Cotelli6, Dontscho 
Kerjaschki7, Agnes Noël9 , Jean-Michel Foidart9, Holger Gerhardt8, Annelii 
Ny3,4, Tobias Langenberg3,4, Nathan Lawson5, Henricus J Duckers2, Stefan 
Schulte-Merker1*, Peter Carmeliet3,4* and Mieke Dewerchin3,4*
 
1Hubrecht Institute, Utrecht, the Netherlands; 2Experimental Cardiology, Thoraxcenter,Erasmus 
University Medical Center, Rotterdam, the Netherlands; 3Vesalius Research Center, VIB, 
Leuven, Belgium; 4Vesalius Research Center, K.U.Leuven, Leuven, Belgium; 5Program in Gene 
Function & Expression, University of Massachusetts Medical School, Worcester MA, USA; 
6Department of Biology, University of Milan, Milan, Italy; 7Clinical Institute of Pathology, 
Medical University Vienna, Vienna, Austria; 8Vascular Biology Laboratory, London Research 
Institute - Cancer Research, London, UK; 9Laboratory of Tumor and Developmental Biology, 
University of Liège, Sart Tilman, B-4000 Liège, Belgium
* These authors contributed equally to this work 
66|
Dll4-Notch in lymphangiogenesis
Ch
ap
te
r 
5
|67
Summary
In zebrafish embryos, sprouts from the axial vein have lymphangiogenic potential, as they give rise to the first lymphatics. Here, we studied whether Notch signaling, which regulates cell fate decisions and blood vessel morphogenesis, controls lymphatic 
development. Knockdown of Dll4 or its receptors Notch-1b or Notch-6 in zebrafish 
embryos impaired lymphangiogenesis at two levels. First, Dll4/Notch silencing reduced 
the number of lymphangiogenic sprouts from their venous precursor; instead, angiogenic 
sprouts were formed. Also, activation of Notch in venous endothelial cells upregulated 
lymphatic markers in vitro. Second, silencing of Notch signaling impaired navigation of 
lymphatic intersomitic vessels along their arterial templates. These studies imply critical 
roles for Notch signaling in the formation and wiring of the early lymphatic network.
Introduction 
The lymphatic vasculature regulates interstitial fluid homeostasis, fat resorption, immune 
defense, inflammation and metastasis (Alitalo et al., 2005). In mammalian embryos, venous 
blood vascular endothelial cells (BECs) differentiate to lymphatic endothelial cells (LECs) (Ny 
et al., 2005; Oliver and Srinivasan, 2008). Previous studies documented that, in response 
to Sox18, Prox-1 induces lymphatic transdifferentiation of venous BECs (Francois et al., 
2008; Johnson et al., 2008; Oliver and Srinivasan, 2008). Additional cues regulate lymphatic 
development, but their molecular nature remains unknown. Another outstanding question 
is how lymph vessels, particularly the larger ones, become wired into a stereotyped network. 
Circumstantial evidence indicates that deep lymphatics regularly fasciculate with other 
vessels and, in particular, track along arteries (Alitalo et al., 2005; Gale et al., 2002; Jensen 
et al., 2009). Similar to blood vessels (De Smet et al., 2009; Larrivee et al., 2009), lymphatic 
sprouts have tip cells at their front, with filopodia to probe guidance cues (Tammela et al., 
2005). Though molecules, such as VEGFR-3, VEGF-C, Neuropilin-2, Ccbe1 and others regulate 
lymphatic migration (Alitalo et al., 2005; Hogan et al., 2009a), navigation of lymph vessels 
remains poorly understood. Which mechanisms and molecules underlie the development 
and wiring of the lymphatic network therefore remains largely unknown. 
Intriguingly, despite the venous origin of lymph vessels, several molecular players that are 
involved in arterial BEC regulation, also regulate lymphangiogenesis. For instance, EphrinB2, 
an initial marker of arterial BECs (Herbert et al., 2009; Lawson et al., 2001), regulates 
lymphatics later in development (Makinen et al., 2005). Also, forkhead transcription factors 
are required for arterial specification, but later regulate sprouting of LECs from veins (Seo 
et al., 2006). This relationship between “arterial” factors and lymphangiogenesis, as well 
as the anatomical congruence between arteries and lymphatics prompted us to investigate 
whether Notch, known to induce arterial endothelial fate (Emuss et al., 2009; Herbert et al., 
2009; Hofmann and Iruela-Arispe, 2007; Shawber and Kitajewski, 2008; Swift and Weinstein, 
2009), also regulates lymphatic development. Notch and its ligand Dll4 seemed intriguing 
candidates, given their role in vessel branching (Phng and Gerhardt, 2009; Roca and Adams, 
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2007; Sainson and Harris, 2007). 
In zebrafish embryos, the thoracic duct (TD) develops between the dorsal aorta (DA) 
and posterior cardinal vein (PCV); it is considered to be the first perfused lymphatic, as 
it expresses Prox-1, contains anchoring filaments and drains interstitial dyes (Jensen et 
al., 2009; Kuchler et al., 2006; Yaniv et al., 2006). For reasons of clarity, formation of this 
early lymphatic network is schematically illustrated in Figure S1. Around 30 hpf, half of 
the secondary sprouts from the PCV, on average one per two unilateral somite segments, 
migrate radially in the ventral-dorsal direction to the horizontal myoseptum; these sprouts 
exist transiently (Hogan et al., 2009a; Isogai et al., 2003). At the horizontal myoseptum, cells 
of these sprouts then migrate tangentially in the anterior-posterior direction to form a string 
of parachordal lymphangioblasts (PL), which act as progenitors of the future LECs in the TD 
(36 to 60 hpf); the PL string also exists only transiently. Since the secondary sprouts, which 
give rise to the PL, participate in the process that leads to the formation of the TD, they 
have been termed “lymphangiogenic secondary sprouts” (Hogan et al., 2009a). The other 
secondary sprouts connect to the primary intersomitic vessels (ISVs), which thereby become 
intersomitic veins (vISV), and have therefore been termed “angiogenic secondary sprouts” 
(Hogan et al., 2009a; Isogai et al., 2003). 
From 60 hpf onwards, the PL cells switch to radial migration again, and navigate both 
ventrally and dorsally alongside arterial intersomitic vessels (aISVs), whereby they form 
structures, that later persist as lymphatic intersomitic vessels (lISVs) (Hogan et al., 2009a). 
These radially migrating cells are termed lISV-PLs to distinguish them from the cells in the 
PL string. Once ventrally migrating lISV-PLs reach their final location in between the DA 
and PCV, they switch again to tangential migration, grow towards each other and fuse to 
establish the TD (3 to 6 dpf) (Hogan et al., 2009a; Isogai et al., 2003). While lymphangiogenic 
secondary sprouts migrate at a distance from and independently of aISVs (Hogan et al., 
2009a), lISVs always navigate alongside aISVs, almost “creeping” over them in their initial 
dorsal and ventral trajectory, but never track alongside vISVs. This close association of lISVs 
with aISVs raised the question whether aISVs act as guidance templates for navigating lISVs-
PLs. 
Using this lymphatic model, we thus explored a possible role of Notch signaling in 
lymphatic development by gene silencing methods in zebrafish. Our findings reveal novel 
roles for Dll4/Notch signaling at multiple steps during early lymphangiogenesis. 
Experimental procedures
 
Zebrafish husbandry
Transgenic zebrafish lines used were Fli1:eGFPy1 (Lawson and Weinstein, 2002), Flt1:YFP, kdr-l:mCherry, Stab1:YFP 
(Hogan et al., 2009a), Fli1:DsRed, Tp1bglob:eGFP (Parsons et al., 2009) and intercrosses. Embryos and fish were 
grown and maintained as described (Lu et al., 2004). All animal experimentation was approved by the local 
institutional ethical committee.
Morpholino injection of zebrafish embryos
Gene-specific antisense morpolino oligos were purchased from Gene Tools (LLC, Corvallis). Sequences are listed in 
Supplementary Table S1. For reasons of consistency, we used the zebrafish nomenclature: zebrafish Notch-5 and 
-6 are mammalian homologues of Notch-3 and -2, respectively, while zebrafish Notch-1a and -1b are duplicated 
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mammalian orthologues of Notch-1 (Theodosiou et al., 2009). As a negative control we made use of a standard 
control morpholino (Gene tools, LLC) (Table S1). For the previously unpublished morpholinos, silencing efficiencies 
of morpholinos directed against the ATG region were determined as previously described (Ny et al., 2005) using 
a luciferase reporter assay (Figure S8). Morpholino injection at the indicated doses was performed as described 
(Hogan et al., 2009a; Lu et al., 2004) Phenotyping data are pooled data from at least 3 independent experiments, 
with analyis of between 33 and 185 injected embryos per injected dose. 
Whole-mount in situ hybridization staining of zebrafish embryos
For whole-mount in situ hybridization, dechorionated embryos were fixed overnight in 4% paraformaldehyde at 
4°C. In situ hybridization using antisense probes for EphrinB2a (Chan et al., 2001), Vegfr3 (Thompson et al., 1998), 
Notch-1b, Notch-6, Dll4, Tie2, Dab2 (Herpers et al., 2008; Hogan et al., 2009a), Tbx20 (Szeto et al., 2002), Cmlc2 or 
MyoD was performed as described (Chittenden et al., 2006). Stained embryos were paraffin- or plastic-embedded, 
sectioned and counterstained with nuclear fast red.
Zebrafish compound inhibitor treatment
A 10 mM stock solution of DAPT (g-secretase inhibitor IX; Calbiochem) in DMSO was diluted in embryo water to 
the indicated treatment concentrations. Embryos were dechorionated by trypsinization (Sigma, 1.5 mg/ml in PBS) 
at 24 hpf and incubated in 6.25 to 25 mM DAPT in embryo water. DMSO was added to the lower concentrations to 
equalize total DMSO to 0.25% in all conditions. Control embryos were incubated in 0.25% DMSO in embryo water. 
Scoring of TD and PL string formation in zebrafish
Live screening and quantification of thoracic duct formation was performed on anaesthetized Fli1:eGFPy1 embryos 
(a few drops of 4 mg/ml Tricaine (Sigma) stock solution in 5 ml embryo water) at 4 or 6 dpf. For DAPT treated fish, 
screening at 6 dpf became impossible because fish became opaque due to loss of trunk circulation and edema 
and many fish died between 4 and 6 dpf. For screening, images were acquired using Zeiss AxioVision 4.6 software 
on a Leica DM RBE fluorescence stereomicroscope equipped with a Zeiss AxioCam MrC5 digital camera (Carl 
Zeiss, Munich, Germany; Leica Microsystems, Wetzlar, Germany). The percentage of thoracic duct formation was 
quantified by scoring its percentile presence in 10 consecutive somite segments in the trunk after the junction of 
DA and PCV (i.e. somites 5-15, see Figure S3E). For screening of thoracic duct formation only embryos with normal 
overall morphology and normal trunk circulation were included. All data are based on scorings of 33-185 embryos 
per condition, generated in at least 3 independent experiments. All analyses were performed by investigators 
blinded for the experimental treatment. Screening of PL string formation in the 10-somite segment of the trunk 
was performed in a similar manner at 52 hpf. Confocal imaging of Fli1:eGFPy1 embryos was performed using a Zeiss 
laser scanning microscope LSM510 or Leica SP2, SPE and SP5 confocal microscopes. Embryos were anaesthetized 
and positioned on a coverslip in a drop of 0.5% low melting point agarose. Fluorescence signal of Stab1:YFP images 
was transformed to a gray-scale image for better contrast. 
Time lapse imaging 
Embryos were mounted in 0.5% low melting point agarose in a culture dish with a cover slip replacing the bottom. 
Imaging was performed with a Leica SP2 or SP5 confocal microscope using a 10x, 20x or 40x objective with digital 
zoom. Timelapse analysis was compiled using ImageJ software (http://rsb.info.nih.gov/ij/). Time points were 
recorded every 10 minutes for the stated time period. A heated stage maintained the embryos at approximately 
28.3 °C. 
Functional assessment of the thoracic duct
For functional studies, anesthetized larvae were subcutaneously injected with 1 nl fluorescent dextran (2.5 mg/
ml) into the muscle mass of the posterior trunk by using glass capillaries and a conventional microinjection setup 
(Kuchler et al., 2006). 
Cell culture experiments
Proliferation, migration and expression analyses of LEC or HUVEC cells in conditions of activation or inhibition of 
Notch signaling are detailed in Supplemental Information. 
Statistical analyses
Each gene-specific morpholino (or compound dose) was always compared to the control morpholino or vehicle 
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in every single experiment. To determine the penetrance of the phenotype, we counted the number of zebrafish 
embryos, exhibiting the different severities of morphant phenotype. Chi-square analysis was used to determine 
whether the severity distribution differed between treatment groups. Absolute values were used to calculate 
means and SEMs. Pairwise comparisons between different conditions were performed by two-sided t-test unless 
otherwise specified. The asterisks on the figures represent the treatment difference at a significance level of P<0.05.
Results
Silencing strategies to study the role of Notch in lymph vessel formation
To explore a role for Notch signaling in lymphatic development, we silenced every known 
zebrafish orthologue of the Notch ligands (DeltaA-D, Dll4, Jagged-1a/b, Jagged-2) and 
receptors (Notch-1a/b, -5, -6) as well as of Notch activators and effectors (presenilins, Su(H)) 
in Fli1:eGFPy1 zebrafish embryos, in which lymphatic, arterial and venous ECs are labeled 
(Kuchler et al., 2006; Lawson and Weinstein, 2002; Yaniv et al., 2006). As Notch-family 
members have been implicated in angiogenesis (Hofmann and Iruela-Arispe, 2007; Roca and 
Adams, 2007; Sainson and Harris, 2007), we used submaximal doses of all morpholinos to 
minimize secondary effects of vascular malformations on lymphatic development (referred 
to as “incomplete silencing” and “Notch hypomorphants”; Figure S2A-H). Only morphant 
embryos with a normal size, trunk circulation and blood flow, and without developmental 
delay, tissue malformations, general edema or toxic defects were included (Figure S3A-D). As 
a read-out of lymphatic development, we quantified the formation of the TD by measuring 
the length over which it formed by 6 dpf, when this vessel was completely developed in 
control embryos. For reasons of standardization and to correct for slight differences in 
embryo size, the length of the TD was expressed as % of the 10-somite fragment analyzed 
(Figure S3E). Because the penetrance of the lymphatic phenotype was variable (Note S1), 
we also determined the fraction of embryos with severe, intermediate or subtle lymphatic 
defects for each morpholino dose. Phenotypic defects were dose-dependent, but for 
reasons of brevity, only the highest dose is shown. A standard control and two independent 
target-specific morpholinos were used routinely. 
Knockdown of Dll4 impairs development of the thoracic duct 
Dll4 knockdown (Dll4KD) inhibited the formation of the TD. Upon injection of a morpholino 
affecting Dll4 mRNA splicing (Dll4SPL; 10 ng), the TD failed to form at all by 6 dpf in up to 52% 
of the morphant embryos, indicating that lymphatic development was completely aborted 
(“severe defects”; Figure 1A-C). In another 27% of Dll4SPL embryos, the TD formed over only 
10 to 30% of its normal length (“intermediate defects”), while in another 15% of morphant 
embryos, the TD formed over 30 to 90% (“subtle defects”) (Figure 1C). As explained above, 
initiation of TD formation occurs via sprouting of lymphangiogenic secondary sprouts at 
discrete locations alongside the PCV, i.e. on average one per two unilateral somite segments. 
Thus, if the TD formed over only 20% of its entire length, then TD development was in fact 
completely aborted in eight out of ten somites analyzed. Follow-up studies at later stages 
(up to 12 dpf) revealed that, in embryos with intermediate defects, the few LECs that did 
arise and formed parts of the TD, were unable to reconstitute the entire TD and could 
Dll4-Notch in lymphangiogenesis
Ch
ap
te
r 
5
|71
not compensate for the lymphatic failure in nearby somites (not shown). Dll4KD embryos 
without TD at 6 dpf also failed to form a TD, even not partially, at later stages (Figure S2G,H), 
indicating that lymphatic development was not simply delayed, but aborted.  
Lymphangiography in 7-dpf kdr-l:mCherryRed Dll4KD embryos (in which blood vessels 
express mCherryRed while lymph vessels are not labeled) revealed no drainage of green 
fluorescent dye in the region where the TD normally forms, confirming that the lack of a 
GFP+ TD in Fli1:eGFPy1 Dll4KD embryos was not due to reduced expression of this marker, but 
to actual absence of the vessel itself (Figure 1D,E). The lymphatic defects in Dll4KD embryos 
were specific, as no overt changes in the formation and differentiation of the DA and PCV 
were noticeable (Figure S4A-H). Consistent with previous reports (Hogan et al., 2009b; Leslie 
et al., 2007), some hyperbranching of the primary ISVs was detected in Dll4KD hypomorphant 
embryos, but to a variable degree and in only 20% of Dll4KD embryos (red arrowheads in 
Figure 1B; Movie S2); hence, TD defects were detected in the majority of Dll4KD embryos that 
did not exhibit any signs of ISV hyperbranching. Also, no abnormalities in heart or somite 
development were observed (Figure S2I-L). Similar TD defects were obtained with another 
morpholino, targeting the ATG of Dll4 (Dll4ATG) (Figure S5A), but silencing of the Notch ligands 
DeltaA-D, Jagged-1a/b or Jagged-2 did not induce lymphatic defects (not shown).
Notch-1b (and Notch-6) regulate formation of the thoracic duct
Incomplete silencing of Notch-1b and, to a lesser extent, of Notch-6, similarly impaired TD 
formation (Figure 1F,G). Of note, the mammalian orthologues of these genes, Notch-1 and 
Notch-2, respectively, are expressed in LECs (Ota et al., 2007; Petrova et al., 2002; Wick et 
al., 2007). Complete loss of TD formation was observed in 30% of the embryos at the highest 
dose of the Notch-1bSPL morpholino (15 ng; Figure 1G). In another 31% of Notch-1bSPL 
embryos, the TD formed in only one to three of the ten somites analyzed. Similar lymphatic 
defects were obtained with a morpholino directed against the start site (Notch-1bATG) (Figure 
S5B). The TD also failed to form in 14% of Notch-6SPL embryos (15 ng; Figure 1G). Combined 
silencing of Notch-1b and Notch-6 yielded more severe lymphatic defects, suggesting 
cooperation of both receptors (not shown). Since Notch-1b down-regulation results in more 
penetrant defects in lymphatic development, only data for Notch-1bKD will be shown from 
hereon. Silencing of Notch-1a or Notch-5, the zebrafish orthologues of mammalian Notch-1 
and Notch-3, failed to cause any lymphatic defects (not shown). Incomplete knockdown 
of the Notch receptors also did not affect, or only minimally influenced the formation, 
differentiation and morphogenesis of blood vessels (Figure S4I-N; not shown)
Silencing of g-secretase impedes lymph vessel formation
Presenilin-1 (PS-1) is the catalytic subunit of the g-secretase complex that activates Notch 
through proteolytic cleavage (Wolfe et al., 1999). Consistent with the results above, 
silencing of PS-1 by morpholino knockdown also impaired TD formation (Figure 1H; Figure 
S5C), without deregulation of blood vessel differentiation (Figure S4O,P). The role of PS-1 
was specific, as silencing of PS-2 did not cause lymphatic defects, neither did combined 
double knockdown of PS-1 and PS-2 exacerbate the PS-1KD phenotype (not shown). These 
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Fig. 1. Role of Notch in TD 
formation. In panels A,B,D-F, 
the head of the embryo 
faces left. DA, dorsal aorta; 
PCV, posterior cardinal 
vein; TD, thoracic duct. A,B, 
Confocal images of GFP+ 
vessels in the trunk of 6 dpf 
Fli1:eGFPy1 zebrafish embryos. 
The control embryo has a 
normal lymphatic TD (yellow 
arrowheads in A), while the 
TD is entirely absent in the 
Dll4KD embryo (B). The yellow 
asterisks in panel B denote the 
location where the TD should 
have developed, while the red 
arrowheads indicate minimal 
hyperbranching of the upper 
part of the ISVs. C, Bar graphs, 
representing the percentage 
of embryos at 6 dpf, which 
develop a normal TD (grey), a 
TD over 30-90% (lilac) or over 10-30% (blue) of its normal length, or completely lack any TD (dark blue) in the 
indicated fraction of control embryos (N=122) or Dll4KD embryos (N=80; 10 ng Dll4SPL; P<0.001 versus controls by 
Chi-Square test). D,E, Lymphangiography, performed by injecting a green fluorescent dye in the trunk of 7-dpf 
kdr-l:mCherryRed embryos, in which blood vessels are red, revealed normal uptake and drainage of the green dye 
by the TD in the control embryo (yellow arrowheads in D), but not in the Dll4KD embryo (yellow asterisks in E). At 
7 dpf, side-branches of the TD are formed, which also drain lymph. F, Abnormal TD formation in 6 dpf Notch-1bKD 
embryos. Absence of the TD is marked with yellow asterisks; minor signs of ISV hyperbranching are indicated by 
red arrowheads. G,H, Bar graphs, representing the percentage of embryos at 6 dpf, which develop a normal TD 
(grey), a TD over 30-90% (lilac) or over 10-30% (blue) of its normal length, or completely lack any TD (dark blue) 
in the indicated fraction of control embryos (N=185 in G; 87 in panel H), Notch-1bKD (N1bKD) embryos (N=84; 15 ng 
Notch-1bSPL; P<0.001 versus controls; panel G), Notch-6KD (N6KD) embryos (N=63; 15 ng Notch-6SPL; P<0.001 versus 
controls; panel G), PS-1KD embryos (N=65; 2.5 ng PS-1ATG1; P<0.001 versus controls; panel H), or of embryos treated 
with control vehicle (N=171.; DMSO; panel H) or DAPT (N=34; 25 µM; P<0.001 versus controls; panel H). Scale bars 
represent 50 µm.
Fig. 2. Incomplete silencing 
of Notch blocks PL string 
formation. In panels B-E, the 
head of the embryo faces left; 
the red vertical bar denotes 
the dorsal aorta (DA); the 
blue vertical bar the posterior 
cardinal vein (PCV). PL: 
parachordal lymphangioblast 
string. A, Bar graphs, 
representing the percentage 
of embryos at 52 hpf, which 
develop a normal PL (grey), a PL over 30-90% (pink) or over 10-30% (red) of its normal length, or completely lack 
any PL (dark red) in the indicated fraction of control embryos (N=73), Dll4KD embryos (N=55; 10 ng Dll4SPL; P<0.001 
versus controls) or Notch-1bKD (N1bKD) embryos (N=49; 20 ng Notch-1bATG; P<0.001 versus controls). B,C, Confocal 
images of embryos of the venous / lymphatic reporter line Stab1:YFP at 52 hpf, showing normal PL formation in the 
control embryo (arrowheads in B), but complete absence in the Dll4KD embryo (asterisks in C). D,E, Whole-mount 
in situ staining for Tie2 at 50 hpf, revealing a normal number of secondary sprouts (arrowheads) in the control (D) 
and Dll4KD (E) embryo. Scale bars are 50 mm in panels B,C; 100 mm in panels D,E.
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genetic findings were confirmed by pharmacological inhibition of the g-secretase activity 
by exposing zebrafish embryos to N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine 
t-butyl ester (DAPT), a well known g-secretase inhibitor, that has been previously used to 
block Notch signaling in zebrafish embryos (Geling et al., 2002) (Figure 1H; Figure S4Q,R). 
Silencing of Su(H), a transcription factor involved in Notch signaling, yielded too severe 
embryonic malformations, precluding trustworthy analysis of the lymphatic vasculature 
(not shown). 
Notch signaling is required for PL string formation
To characterize the role of Notch signaling in lymphatic development in more detail, we 
analyzed whether silencing of Notch would impair development of PL cells, as they directly 
contribute to TD formation. Since PL cells develop initially from lymphangiogenic secondary 
sprouts in a segmented pattern, we used a similar quantification method as employed for 
analysis of the TD. At 52 hpf, formation of the string of PL cells was still proceeding in control 
embryos (already completely formed in 53% and largely completed in another 40% of the 
embryos; Figure 2A). By contrast, in Dll4SPL embryos, the PL string was completely absent in 
38% and formed only in a few segments in another 27% of embryos (Figure 2A). Notably, 
largely comparable fractions of Dll4SPL embryos exhibited similar types of severe, intermediate 
or subtle PL string and TD lymphatic defects (compare Figure 1C with Figure 2A), suggesting 
that the TD defects were, at least in part, attributable to defects in the initial formation 
of the PL string. Imaging of lymphangiogenic structures in Dll4SPL embryos using a novel 
transgenic reporter line, the Stab1:YFP line (Hogan et al., 2009a), which primarily visualizes 
venous and lymphatic ECs, confirmed these findings (Figure 2B,C). A similar absence of the 
PL string was observed when using the Dll4ATG morpholino (not shown), or upon knockdown 
of Notch-1b (Figure 2A) or Notch-6 (not shown). Since the string of PL cells forms as a result 
of lymphangiogenic secondary sprouting from the PCV, these findings suggest that Notch 
signaling acts in part at very early steps prior to formation of the perfused lymphatics.  
Dll4 silencing reduces the fraction of lymphangiogenic secondary sprouts 
Since the lymphangiogenic secondary sprouts are anatomically transiently connected with 
the PL cells, we also studied whether inhibition of Notch signaling might even act at an 
earlier stage, i.e., during branching of these lymphangiogenic secondary sprouts. Whole-
mount staining for Tie2, which marks all secondary sprouts (Hogan et al., 2009b), showed 
a normal number of secondary sprouts in all Dll4KD embryos analyzed (N=20; 50 hpf; Figure 
2D,E). However, high resolution imaging of the trunk vasculature in 4 dpf Fli1:eGFPy1 embryos 
revealed alterations in the proportion of primary ISVs that adopted a venous phenotype 
(vISVs), based on the criterion that they were connected to the PCV. As expected, in control 
embryos, approximately half of the ISVs were connected to the PCV (vISVs, % of total ISVs: 
54 ± 1.3%; N=33). In contrast, in Dll4SPL embryos, a larger fraction of ISVs was connected to 
the PCV and therefore venous (vISVs, % of total ISVs in all Dll4SPL embryos analyzed: 82 ± 
1.8%; N=55, P<0.05 versus control). Similar findings were obtained in Notch-1bSPL embryos 
(vISVs, % of total: 69 ± 2.7%; N=27, P<0.05 versus control). Even though this arterial-venous 
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ISV shift was most prominent in hypomorphant embryos with the most severe lymphatic 
defects, not all aISVs underwent a venous shift (maximally ~90%), possibly reflecting an 
incomplete knockdown or, perhaps, a fundamental physiological need to establish at least 
some residual trunk circulation from aISVs to vISVs. These findings, and the observation that 
silencing of Dll4, Notch-1b or Notch-6 aborted PL string formation in a substantial fraction 
of morphant embryos, indicate that a fraction of secondary sprouts, that would normally 
have been lymphangiogenic, were angiogenic, thereby impairing TD formation (see scheme 
in Figure 6A,B).
To provide additional experimental support for the aforementioned model, we also used 
high resolution video-imaging of a double transgenic reporter line, the kdr-l:mCherryRed 
line which labels arterial and venous ECs, combined with the Flt1:YFP line which exclusively 
labels arterial ECs (Hogan et al., 2009a). Hence, in the Flt1:YFPxkdr-l:mCherryRed line, venous 
cells are red (CherryRed+) and arterial cells are yellow (YFP+CherryRed+) in merged images. 
We expected that, once a primary aISV adopts a venous identity when being “co-opted” 
by a secondary venous angiogenic sprout, this vessel would gradually change its pattern 
of marker expression from yellow (arteries) to red (veins) only. In control embryos, those 
primary aISVs that became connected with a venous secondary sprout and thus adopted 
a venous identity, indeed progressively lost their “arterial” yellow color and acquired a 
“venous” red color (blue arrows in Figure 3A”), while the other half of the aISVs remained 
connected with the DA and retained their yellow color (white arrows in Figure 3A”). Closer 
inspection revealed that, upon establishing a connection with a venous secondary sprout, 
the arterial ECs of the aISV became gradually replaced by venous ECs from the secondary 
sprout in a ventral-to-dorsal direction. In contrast, in Dll4KD embryos with severe lymphatic 
defects, nearly all yellow aISV connections with the DA disappeared (see the single white 
arrow in Figure 3B”), and were gradually replaced by red vISV connections with the PCV 
(blue arrows in Figure 3B”). The kinetics of these changes are shown in Movies S1,2. Thus, 
a supernumerary fraction of angiogenic secondary sprouts is formed in Dll4KD embryos at 
the expense of lymphangiogenic sprouts, that would otherwise go on to form the PL string, 
suggesting that Notch participates in the acquisition of lymphatic potential.
Activation of Notch by Dll4 promotes lymphatic characteristics in vitro
To evaluate whether activation of Notch in venous ECs would induce lymphatic properties, 
we cultured human umbilical venous ECs (HUVECs, which express Notch receptors including 
Notch-1, but negligible levels of Prox-1; not shown) on a feeder layer of COS cells, expressing 
Dll4 (COSDll4) or a control vector (COSCTR), and analyzed by RT-PCR with human gene-specific 
primers the expression of lymphatic markers. As shown in Figure 4, several downstream 
Notch target genes (Hey1, Hey2, Hes1, Nrarp) were upregulated in HUVECs, when cultured 
on COSDll4 feeder cells as compared to control COSCTR feeder cells, indicating that Notch 
signaling was activated. Furthermore, COSDll4-activated HUVECs expressed elevated levels 
of the lymphatic markers Prox-1, VegfR3, Lyve-1 and Sox18 (Figure 4; Note S2). Notably, 
expression of ephrinB2 which has been implicated in both arterial and lymphatic processes 
(Lawson et al., 2001; Makinen et al., 2005), and Coup-TFII which is expressed in both venous 
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Fig. 3. Notch silencing  reduces the fraction of lymphangiogenic sprouts. In all panels, the head of the embryo faces 
left. DA, dorsal aorta; PCV, posterior cardinal vein. A,B Confocal images of the trunk vasculature in Flt1:YFPxkdr-
l:mCherryRed embryos, where kdr-l:mCherryRed marks both venous and arterial vessels in red (A,B), Flt1:YFP labels 
arterial vessels in green (A’,B’), and the merged images show arterial vessels in yellow (green-red) and venous 
vessels in red (A”,B”). Lateral view images of the entire embryo were taken, such that the ISVs at both the left and 
right side of the embryo are shown, partially superimposed onto each other. Embryos were imaged at 54 hpf, when 
secondary sprouts had already connected to the primary ISVs, and the latter were in the process of changing their 
arterial to venous identity in a ventral-to-dorsal pattern. In control embryos (A-A”), on average half of the aISVs 
became connected to the PCV and thus acquired a venous identity, thereby progressively losing their green arterial 
signal (blue arrows in A’) and thus becoming marked in red only (blue arrows in A,A”), while the other half of the 
aISVs remained connected to the DA and labeled in green (white arrows in A’) and thus in yellow on the merged 
images (white arrows in A”). By contrast, in the Dll4KD embryo shown (B-B”), most ISVs lost their green arterial 
marker in a ventral-to-dorsal direction (blue arrows in B’,B”; note the single white arrow), and became marked in 
red only, while loosing their yellow label (blue arrows in B”). White arrow in B-B” denotes a residual aISV retaining 
its green (B’) or yellow (B”) label. Scale bar in B, representative for all panels, is 50 mm.
Fig. 4.  Activation of Notch by Dll4 
promotes lymphatic characteristics in 
vitro. RT-PCR analysis of HUVECs, co-
cultured with COS cells stably expressing 
hDll4 (COSDll4) or a control vector (GFP; 
COSCTR), revealing upregulation of Notch 
target genes (Hes1, Hey1, Hey2, Nrarp; 
blue bars) and lymphatic marker genes 
(VegfR3, Prox-1, Lyve-1, ephrinB2, Sox18; 
green bars), while vascular genes such 
as Neuropilin-1, CD31, VE-Cadherin or 
Endoglin (red bars) were only minimally 
affected. Coup-TFII, which is expressed 
in venous and lymphatic ECs, was also 
upregulated. Results are represented as fold change in HUVEC/COSDll4 co-culture versus HUVEC/COSCTR. Mean±SEM; 
N= 3-11; *, p < 0.05.
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and lymphatic ECs (Yamazaki et al., 2009), were also upregulated, but levels of other blood 
vessel markers (Neuropilin-1, Endoglin, VE-Cadherin, CD31) were not or only minimally 
affected (Figure 4). This upregulation of lymphatic markers was abolished by treatment of 
the cells with DAPT (30 µM; not shown). These in vitro experiments are consistent with 
a model, whereby venous endothelial activation of Notch by Dll4 promotes lymphatic 
reprogramming.
Silencing of Dll4 impairs PL cell migration along aISVs
We also explored whether Notch signaling might regulate the development of the TD by 
controlling lISV formation, as the TD failed to form in a substantial fraction of Dll4SPL embryos 
(25%), even despite the fact that its precursor, the PL string, developed partially in these 
embryos. Several types of lISV abnormalities were observed in Dll4KD embryos, the most 
frequent being absence of lISVs. In control embryos, lISV-PLs only migrated along aISVs 
but never along vISVs, suggesting that vISVs are not permissive (Figure 5A,B). Since there 
were more vISVs and fewer aISVs in Dll4KD embryos, migrating lISV-PLs were deprived from 
their usual arterial template and could therefore not contribute to the formation of the TD 
(Figure 5C; Figure 7C). Intriguingly, however, we also noticed that, even when residual aISVs 
formed in Dll4SPL embryos, lISV-PLs bypassed the aISV post, and failed to turn and migrate 
along aISVs (Figure 5D). Indeed, when analyzing the fraction of aISVs that was accompanied 
by lISV-PLs in Dll4SPL embryos with a nearly complete PL string (over >90% of its length), as 
much as 49 ± 6% of these aISVs were not accompanied by lISV-PLs in Dll4SPL embryos (N=61), 
while only a few aISVs lacked accompanying lISV-PLs in control embryos (15 ± 4%; N=29; 
P<0.05).  
Other, much less frequent, lISV defects were observed in this subgroup of Dll4SPL 
embryos. For instance, some lISV-PLs that accomplished to turn ventrally alongside the 
aISV, stalled (Figure 5E; Figure 7C”). Occasionally, lISV-PLs erroneously navigated away from 
their aISV template, with their tip at the forefront of the sprout projecting erroneously in 
the surroundings (Figure 5E). In a few cases, lISV-PLs became even misrouted and migrated 
along vISVs (Figure 5F; Figure 7C’’’). Additional in vitro studies revealed that inhibition of 
Notch signaling did not affect the cellular migratory/motility capacity nor proliferation of 
primary LECs in various assays (Figure S6A-D), nor did it inhibit lymphatic capillary tube 
formation or sprouting in vitro (not shown). 
Expression of Dll4 and Notch
To examine the expression of Dll4 and Notch, we used whole-mount in situ hybridization 
in control embryos during the developmental processes that were affected in Notch 
hypomorphants. At 30 hpf, when secondary sprout formation starts, Dll4 was strongly 
expressed in the DA but undetectable in the PCV (Figure 6A,B), consistent with previous 
findings (Hogan et al., 2009b; Leslie et al., 2007; Siekmann and Lawson, 2007). Robust 
expression of Notch-1b was detected in the DA (Figure 6C,D), while a weaker signal 
was detectable in the PCV, that appeared to localize more to the dorsal part of the PCV 
(Figure S7). Expression of Notch-6 was at or below the threshold of detection of the in situ 
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hybridization technique; when expression was detectable, a weak signal was observed in 
the axial vasculature consistent with its previously reported expression pattern (Thisse 
et al., 2001). Thus, ligand and receptor appear to be expressed in the near vicinity of the 
emerging lymphangiogenic secondary sprouts. The limited resolution of in situ hybridization 
(whole-mount or sections) did not allow us to evaluate possible expression in the thin 
lymphangiogenic secondary sprouts or the PL string.
Fig. 5. Incomplete 
silencing of Notch 
perturbs lymphatic 
navigation. In all panels, 
the head of the embryo 
faces left. DA, dorsal 
aorta; ISV, intersomitic 
vessel; aISV, arterial 
ISV; lISV, lymphatic 
ISV; vISV, venous ISV; 
PCV, posterior cardinal 
vein; PL, parachordal 
lymphangioblast string; 
lISV-PLs, migrating PL cells 
during lISV formation; 
TD, thoracic duct. Panels 
A-F are confocal images 
with accompanying 
schematic redrawing of 
the navigation routes of 
lISVs along aISVs or vISVs 
in control (A,B) and Dll4KD 
(C-F) Fli1:eGFPy1 embryos 
at 4 dpf. Permanent 
lymphatic structures 
(lISV, TD) are labeled dark 
green, and the transient 
l y m p h a n g i o g e n i c 
structures (PL) are 
consistently labeled 
light green to denote 
their participation in the process of lymphangiogenesis. A, In control embryos, lISV-PLs navigate alongside aISVs 
and establish a continuous TD (arrowhead). Note how the lISV “creeps” over the aISV, and slides down along 
this guidance template. The curved arrow indicates the point where lISV-PLs have to make a ventral turn and 
switch from tangential to radial migration along aISVs. B, lISV-PLs never navigate along vISVs in control embryos. 
Arrowhead indicates the TD. C-F, Different types of navigation defects in Dll4KD embryos. C, In a fraction of morphant 
somites, lISV-PLs lacked migration templates because fewer aISVs developed. As lISV-PLs do not normally migrate 
along vISVs, no TD was formed in these somites (asteriks). D, In other morphant somites, lISV-PLs bypassed the 
point of turning at the aISVs, and failed to switch to radial migration. Therefore, no TD could be formed (asteriks). 
E, In a small fraction of somites in Dll4KD embryos, lISV-PLs accomplished to make the turn and switched to radial 
migration, but then stalled shortly thereafter (red arrowhead denotes the arrested tip of a ventrally navigating lISV) 
or became misrouted away from their guidance aISV template (yellow arrowhead denotes lISV-PL tip cell from a 
dorsally navigating lISV, that detached from its aISV scaffold). This picture was taken from a more oblique angle to 
visualize both the ventrally and dorsally navigating lISVs. F, In most Dll4KD embryos, vISVs were not permissive to 
guide lISV-PLs, but, occasionally, lISV-PLs erroneously navigated alongside a vISV.
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Fig. 6. Expression of Dll4 / 
Notch-1b. In all panels the 
head of the embryo faces 
left. DA, dorsal aorta; ISV, 
intersomitic vessel; aISV, 
arterial ISV; lISV, lymphatic ISV; 
vISV, venous ISV; PCV, posterior 
cardinal vein; TD, thoracic duct. 
A-D, Whole-mount embryos at 
30 hpf, when lymphangiogenic 
sprouting occurs, were stained 
for Dll4 (A,B) or Notch-1b 
(C,D); expression was analyzed 
by imaging of whole-mount 
embryos (A,C) or cross-
sections of the same embryos 
(B,D). The DA is indicated by a 
red vertical bar (A,C) or white 
arrowhead (B,D), while the PCV 
is denoted by a blue vertical 
bar (A,C) or arrowhead (B,D); 
primary ISVs are indicated 
by yellow arrowheads (A,C). 
Scale bars are 50 mm. A,B, Dll4 
expression was detected in the 
DA and primary aISVs, besides 
its known expression in the 
pronephric duct (white arrow 
in A). C,D, Notch-1b is strongly expressed in the neural tube (NT), and in the DA and primary aISVs. E, Confocal 
images of the trunk vasculature in untreated Tp1bglob:eGFPxFli1:DsRed embryos, in which Fli1:DsRed marks all 
vessels (both blood and lymph vessels) in red (E) and Tp1bglob:eGFP labels cells with activated canonical Notch 
activity in green (E’). The merged image shows arterial vessels (DA; aISV) with active Notch in yellow (green-red), 
while the lISV are only red (E”). In the schematic representation (right panel), the lymphatic structures are indicated 
in green, Notch-activated vessels in yellow, and other vessels in grey (E”’). Representative images of the arterial 
activation of Notch in a 6-dpf embryo are shown (for technical reasons), but similar data were obtained at 60 hpf. 
Fig. 7. Schematic model of Notch 
in lymphatic development. 
Scheme, illustrating the different 
types of lymphatic defects in 
Dll4kd embryos (for normal 
lymphatic development in 
control embryos, see Figure S1). 
Permanent lymphatic structures 
(lISV, TD) are labeled dark green; 
transient lymphangiogenic 
structures (lymphangiogenic 
secondary sprouts; parachordal 
lymphangioblasts) are labeled 
light green. A,B, Upper panels: 
Lymphangiogenic secondary 
sprouting defects: The reduction 
of the fraction of lymphangiogenic 
secondary sprouts results in 
(continued on next page)
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Dll4 and Notch-1b were also detected in primary ISVs by in situ hybridization at 30 hpf 
(Figure 6A-C), consistent with previous findings (Leslie et al., 2007; Siekmann and Lawson, 
2007). To analyze expression in ISVs at later stages, when lISV-PLs  migrate along aISVs (from 
2.5 dpf onwards), we used the Tp1bglob:eGFPxFli1:DsRed line, in which all endothelial cells 
are red, and cells with canonicial Notch activity are green (GFP expression is driven by a 
promotor containing 12 Su(H) DNA binding sequences (Parsons et al., 2009)). Imaging of 
this line at the time when PL cells make the turn and switch from tangential to radial ventral 
migration revealed that the DA and aISVs are yellow in the merged image, indicating that 
canonical Notch signaling was active in arterial vessels, but not in lISVs or vISVs (Figure 6E). 
Discussion 
  
The cardinal finding of this study is that incomplete silencing or pharmacological inhibition 
of Notch signaling impaired lymphatic development in zebrafish. Mechanistic analysis 
indicates that Notch signaling regulates the formation of lymphangiogenic sprouts and their 
descendent PL cells, which give rise to the TD (Figure 7A,B). At a later stage, Notch signaling 
is required for guided migration of lISV-PLs along aISVs (Figure 7C-C”’). 
Role of Notch in lymphangiogenic secondary sprout formation
Given that Notch has been implicated in the morphogenesis of blood vessels (Hofmann and 
Iruela-Arispe, 2007; Li and Harris, 2009; Roca and Adams, 2007), a reasonable assumption 
was that Notch might regulate lymphatic morphogenesis as well. This hypothesis was indeed 
confirmed by our genetic and imaging experiments. Up to half of the Notch hypomorphant 
embryos failed to form a TD without later rescue, indicating that lymphatic development in the 
trunk was aborted and not simply delayed. The earliest identifiable defect in Notch-silenced 
embryos occurred at the time of secondary sprout formation, when fewer lymphangiogenic 
and more angiogenic sprouts emanated from the PCV (Figure 7A,B). That this phenotypic 
change may underlie the defective formation of the TD in morphant embryos is suggested 
by various findings. First, anatomically, lymphangiogenic secondary sprouts give rise to the 
string of PL cells, which in their turn form the LECs of the TD. Genetic studies underscore the 
participation of these lymphangiogenic secondary sprouts in lymphangiogenesis, as loss of 
Vegf-c, Ccbe1, or synectin impairs the formation of lymphangiogenic secondary sprouts and, 
in association, also of the TD ((Hogan et al., 2009a), unpublished). Second, there is a close 
Fig. 7. (continued) underdevelopment of the PL string (or even complete absence of PL cells), with accompanying 
overrepresentation of angiogenic secondary sprouts. C-C”’, Lower panels: lISV migration defects: C, As a result 
of the overrepresentation of vISVs, lISV-PLs are deprived of their normal aISV guidance template. C’-C”’, lISV 
formation is further impaired by additional navigation defects, most frequently because lISV-PLs cells bypass their 
turning point and never initiate ventral radial migration (C’), or occasionally make the turn but then stall (C’’). Still 
more rarely, navigating lISV-PLs deviate from their path (C”), or become misrouted along vISVs (C”’). The most 
frequent defects are boxed in grey. DA, dorsal aorta; DLAV, dorsal longitudinal anastomosing vessel; DLLV, dorsal 
longitudinal lymph vessel; ISV, intersomitic vessel; aISV, arterial ISV; lISV, lymphatic ISV; vISV, venous ISV; PCV, 
posterial cardinal vein; PL, parachordal lymphangioblast string; lISV-PLs: migrating PL cells during lISV formation; 
TD, thoracic duct.
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correlation between the impaired formation of the lymphangiogenic secondary sprouts, of 
the string of PL cells and of the TD. 
The secondary sprouts that emerge from the PCV and give rise to the PL string, as well as the 
PL string itself, were termed “lymphangiogenic” to denote their participation in the process 
of lymphangiogenesis. It is unknown whether ECs of these sprouts have the potential 
to become a LEC (“competence”), or are already programmed to become a LEC, albeit 
reversibly (“specification”) (Donner et al., 2006). In mammals, Prox-1 has been implicated in 
lymphatic specification (Oliver and Srinivasan, 2008); other candidates, such as Podoplanin, 
Neuropilin-2, Foxc2 and others have been implicated as markers or regulators of later 
stages of lymphatic development (Baluk and McDonald, 2008; Oliver and Srinivasan, 2008). 
Although currently available techniques are not sufficiently sensitive to define these precise 
stages of lymphatic development in zebrafish embryos (and, hence, to define the precise 
role of Notch in these processes), a number of findings suggests that these lymphangiogenic 
structures belong to the lymphatic lineage. Indeed, the lymphangiogenic sprouts and PL cells 
contribute only to lymphangiogenesis but not to angiogenesis, are not labeled in the kdr-
l:mCherryRed line which marks only arterial and venous ECs (Hogan et al., 2009a), and fail 
to form upon silencing of genes that regulate lymphangiogenesis in mice and humans, e.g., 
Ccbe1, Vegf-c, Synectin and Prox-1 ((Alders M et al.; Hogan et al., 2009a) and unpublished). 
Although our in vitro findings that activation of Notch in venous ECs upregulated LEC-
specific markers could suggest a role for Notch in the acquisition of lymphatic properties, 
other mechanisms cannot be excluded. For instance, Notch silencing might impair budding 
of lymphangiogenic cells, as occurs in VEGF-C knockout mice (Karkkainen et al., 2004). The 
latter mechanism is, however, more difficult to reconcile with the observation that the total 
number of secondary sprouts was normal in Notch hypomorphants.
Notch expression was detected at two sites along the trajectory of lymphangiogenic cells 
from the PCV to the TD. First, Notch was detectable in the DA. Since the DA and PCV lie in 
close juxtaposition to each other at the time of lymphangiogenic sprouting, Notch activation 
in arterial ECs by Dll4, expressed by the same or adjacent arterial cells, might induce 
expression of intermediate cues, that indirectly instruct venous ECs of the nearby PCV to 
acquire lymphangiogenic potential. Notch is known to elevate the expression of lymphatic 
signals such as EphrinB2 and VEGF-D (Makinen et al., 2005; O’Neill et al., 2007). A similar 
indirect model has been recently proposed to explain how BECs in the DA differentiate to 
venous BECs in the PCV (Herbert et al., 2009). Another non-exclusive model might rely on 
our observations of a weak Notch signal in ECs on the dorsal side of the PCV. In this case, 
intercellular communication between arterial Dll4 and venous Notch in trans could occur, 
whereby Notch activation in venous BECs might promote lymphatic development. Second, 
Notch activity was also detectable in aISVs at a time, when PL cells make the turn and switch 
from tangential to radial ventral migration to form the lISVs and TD. Since lISVs and aISVs lie 
very closely together, Notch signaling in the latter could indirectly signal to the former and 
thereby regulate lymphatic development. 
The lymphatic phenotype in the Notch hypomorphants is unlikely to be secondary to 
a primary change in the formation or differentiation of the PCV. Indeed, no differences in 
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the initial formation and expression of venous markers were detected in the PCV a few 
hours prior to or after secondary sprout formation in Notch hypomorphants, consistent with 
previous reports (Leslie et al., 2007; Siekmann and Lawson, 2007). Similarly, no obvious 
abnormalities were observed in the formation, differentiation and marker expression of the 
primary ISVs. Nonetheless, we cannot formally exclude the possibility that subtle alterations 
in their arterial characteristics upon silencing of Notch might have favoured or facilitated 
supernumerary connections with secondary sprouts, thereby “entrapping” sprouts that 
would otherwise have remained lymphangiogenic. Regardless of these possibilities, our 
findings document a novel role of Notch in lymphangiogenic secondary sprouting and PL 
string formation, the initial steps of lymphatic development in zebrafish.
Role of Notch in lymphatic migration from the PL
Notch signaling also regulated lymphangiogenesis by controlling the formation of lISVs, 
which arise from the PL cells and form the TD. Most frequently, the lISV was absent, but in 
other rarer cases, migrating lISV-PLs stalled or became misrouted. The available evidence 
suggests that lymphangiogenic EC migration per se (motility) was normal. Indeed, in 
embryos that formed a partial TD, cells of the lymphangiogenic secondary sprouts migrated 
dorsally without stalling and thereafter tangentially to establish the string of PL cells. Also, 
for PL cells that finished their ventral migration to the TD, Notch signaling was dispensable 
for their subsequent tangential outgrowth (not shown). Furthermore, in vitro migration 
or proliferation of LECs was also not affected by Notch signaling. Also, we did not detect 
signs of lymphatic regression or retraction (not shown). Together, this analysis suggests that 
defects in the intrinsic motoric, mitogenic or survival machinery of lymphangiogenic ECs 
unlikely explain the lISVs defects in Notch hypomorphant embryos. 
It is therefore tempting to speculate that the lISV defects in Notch-silenced embryos may 
relate to an abnormality in lymphangiogenic cell pathfinding, though future studies will be 
required to characterize this process and its molecular basis in more detail. Our imaging 
analysis shows that lISV-PLs navigated in very close association along aISV templates when 
migrating away from the horizontal myoseptum and forming the TD. This remarkable 
interaction between lISVs and aISVs raises the question whether aISVs act as guidance 
templates for lISV-PLs, reminiscent of how follower axons navigate along a pioneer axon’s 
pathway in the nervous system or how autonomic nerves use arterial tracks to reach their 
target (Bak and Fraser, 2003; Glebova and Ginty, 2005; Honma et al., 2002; Makita et al., 
2008; Mukouyama et al., 2002). Hence, it is tempting to speculate that, when fewer aISVs 
are present in Notch hypomorphants because of lymphangiogenic sprouting defects, PL cells 
are deprived of navigation templates and therefore cannot form lISVs normally (Figure 7C). 
Other observations that lISV-PLs failed to turn and switch from tangential to radial migration 
or, more rarely, stalled, explored new routes, and erroneously selected incorrect paths are 
reminiscent of classic neuronal guidance defects (Figure 7C’-C’’’). That arteries may act 
as navigation templates is evidenced by reports that autonomic nerves stall or become 
misrouted, when these arteries do not produce appropriate guidance cues (Honma et al., 
2002; Makita et al., 2008). Whether this may suggest that Notch regulates the production 
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of guidance cues for lISV-PL cells by aISVs or nearby (somitic) cells to induce turning and 
radial migration at this guidance post or to guide them along aISV templates, to name only 
a few possible explanations, remains to be further determined. Phenotypic analysis of other 
morphant zebrafish lines also suggests that lISV development requires arterial-lymphatic 
congruence (SSM et al, unpublished findings).
Conclusions
This study provides novel insight for a role of Notch in lymphatic development, in part 
by regulating the initial steps of lymphangiogenic secondary sprouting and PL formation. 
Our data are in accordance with an involvement of Notch in the acquisition of lymphatic 
potential. In addition, the navigation defects of lISV-PL cells along aISVs, in which Notch 
signaling is activated, suggest that Notch also regulates lymph vessel pathfinding along 
arteries, though the exact molecular mechanisms need to be further explored in the future. 
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Note S1: Variable penetrance of lymphatic phenotypes in Notch hypomorphants
We speculate that the variably penetrant lymphatic phenotypes and spectrum of defects in the Notch hypomorphants 
is due to a combination of reasons, including the use of a submaximal dose of morpholino (incomplete silencing), 
technical limitations of injecting an identical dose of morpholino, genetic differences of the morphant embryos 
analyzed (outbred background), uneven dispersion of morpholinos upon daughter cell division, and variable timing 
of angiogenic/lymphangiogenic secondary sprout formation along the PCV (occurring within a time window of 30 
to 50 hpf (Hogan et al., 2009)). As a result, achieving the necessary degree of silencing below the critical biological 
threshold at the distinct sprouting locations along the PCV becomes stochastic in such experimental conditions. 
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Note S2: Lymphatic reprogramming 
In the in vitro experiments, expression of VegfR3 was upregulated by activation of Notch, consistent with some, 
though not all previous reports (likely reflecting the context-dependent regulation of this receptor which has 
different roles in vascular versus lymphatic development) (Shawber et al., 2007; Tammela et al., 2008). In our 
silencing conditions, no difference in Vefgr3 expression was detectable by in situ hybrization (Figure S4), but the 
semi-quantitative and insensitive nature of this technique, may have precluded detection of such subtle differences.
Cell culture experiments
HUVEC cells (Lonza, Invitrogen, Merelbeke, Belgium) and HUVEC/COS co-cultures were grown in EGM2-MV medium 
(Lonza, Invitrogen) at 37°C. COS cells were grown in standard DMEM medium (Lonza, Invitrogen) supplemented 
with 10% FBS, 2 mM glutamin, 100 U/ml penicillin, and 0.1 mg/ml streptomycin (Lonza). 
Coculture assay: COS cells stably expressing full length human Dll4 (COSDll4) or expressing GFP (COSCTR) were 
prepared using the retroviral constructs LZRSpBMN-DLL4 and LZRSpBMN-WT, respectively (Williams et al., 2006). 
HUVECs were co-seeded with COSDll4 or COSCTR cells in 6-wells at a density of 200,000 cells each, grown for 24 hours 
and harvested for RNA analysis by quantitative RT-PCR using human gene-specific primers (Table S2). Proliferation 
assay: Primary LEC (HMVEC-DLy or HMVEC-LLy; Lonza, Invitrogen) were starved overnight in EGM2 medium (Lonza, 
Invitrogen) containing 0.1% serum and no growth factors (starvation medium). The starved cells were seeded at 
2,000 cells per well in 96-well microtiter plates, after which proliferation was induced with fully supplemented 
EGM2-MV medium with or without increasing concentrations of DAPT (20-60 mM). Proliferation was measured 
as the number of viable cells after further culturing for 48 hours, expressed in % of DMSO control. Viable cells 
were quantified using the Rapid Cell Proliferation assay (Calbiochem, San Diego, CA). Scratch wound migration 
assay: Confluent monolayers of LECs growing in 0.1% gelatin-coated wells of a 24-well plate were starved 
overnight, pretreated in starvation medium containing 30 mM DAPT or 0.3% DMSO (control), scratch wounded and 
photographed (T0). The cells were further incubated for 24 hrs and photographed again (T24). Migration distance 
(gap width at T0 minus gap width at T24; 10 measurements per wound at regular intervals along the wound) was 
determined by image analysis using KS300 morphometry software, and is expressed relative to the control (DMSO). 
Transwell migration assay in conditions of Notch inhibition: LECs were pretreated with DAPT (60m) or vehicle 
(DMSO) in starvation medium overnight, seeded at 30,000 cells per transwell on 0.1% gelatin-coated transwells 
in starvation medium with DAPT or DMSO, and cultured for 2 hours until adherence. Migration was induced by 
transferring the transwell insets into wells (bottom well) containing fully supplemented EGM2-MV medium with 
100 ng recombinant human VEGF-C (Reliatech, TecoMedical NL, Nijkerk, the Netherlands), and DAPT or DMSO. 
Background migration was determined by including transwells with starvation medium in both the top and bottom 
well (baseline). After culturing for 16 hours, the non-migrated cells on the top side of the transwell filters were 
wiped off using PBS-soaked cotton swabs, and the transwells were fixed with 1% p-formaldehyde. The transwell 
filters were cut out and mounted upside-down on micrsocope slides with DAPI containing mounting medium. The 
filters were photographed under DAPI fluorescence at 20x magnification, and the nuclei were counted as a measure 
of migrated cells. Five transwells were prepared per condition and five optical fields were counted and averaged 
per transwell filter. Transwell migration assay in conditions of Notch activation: LECs were starved overnight 
and seeded at 30,000 cells per transwell on transwell filters coated with BSA or with the extracellular domain of 
Dll4 (Dll4-ECD; R&D Systems Europe Ltd., Abingdon, UK) to activate the Notch pathway as described (Harrington 
et al., 2008). Further manipulation was as described above, using starvation medium in all top wells and fully 
supplemented medium containing VEGF-C in all bottom wells except for the baseline conditions. The filters were 
photographed under DAPI fluorescence at 10x magnification, Five transwells were prepared per condition and 1 
central optical field was counted per transwell filter.
Movie S1: Normal formation of arterial and venous ISVs in control embryos
Confocal time-lapse video-imaging analysis of a control Flt1:YFPxkdr-l:mCherryRed reporter embryo from 32 to 
72 hpf (representative movie of >100 embryos analyzed), in which venous cells are red (CherryRed+) and arterial 
cells yellow (YFP+CherryRed+). Imaging revealed normal progressive ventral-to-dorsal loss of the arterial YFP colour 
in approximately half of the ISVs, once connected by angiogenic secondary sprouts of the PCV. For instance, the 
second and third primary ISV (numbering according to the location at the start of the movie) retain their connection 
with the DA as well as their yellow arterial colour, and are thus arterial. In contrast, the fourth and fifth ISV loose 
their connection with the DA as well as their yellow arterial colour, progressively become red after establishing a 
connection with the PCV, and thus become venous ISVs. 
Note: This Flt1:YFPxkdr-l:mCherryRed reporter does not label lymph vessels. However, since lymphangiogenic 
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secondary sprouts emanate from the PCV (CherryRed+) and the CherryRed protein is only degraded after some 
time, the presence of these lymphangiogenic secondary sprouts and of the PL cells is also transiently visible. For 
instance, around 40 hpf, red lymphangiogenic secondary sprouts can be seen adjacent to the second and third 
ISV. These secondary sprouts do, however, not connect to the primary ISVs, but migrate dorsally to the horizontal 
myoseptum, where they then migrate tangentially and form the PL string. The lymphangiogenic nature of the PL 
string is illustrated by the gradual loss of its residual mCherryRed colour beyond 52 hpf; this is not due to regression 
of the PL cells, since this string disappears only around 4 dpf, i.e. after giving rise to the lISVs (not visible in this 
reporter line) that descend ventrally to the level between the DA and PCV to form the TD. DA, dorsal aorta; PCV, 
posterior cardinal vein; PL, parachordal lymphangioblast string; TD, thoracic duct.
Movie S2: Arterial-to-venous shift of ISVs in Dll4KD embryos
Confocal time-lapse video-imaging analysis of a Dll4KD Flt1:YFPxkdr-l:mCherryRed embryo from 32-72 hpf 
(representative movie of >100 embryos analyzed), in which venous cells are red (CherryRed+) and arterial cells 
yellow (YFP+CherryRed+). Imaging revealed progressive ventral-to-dorsal loss of the arterial YFP colour in all primary 
ISVs, when they became connected by an angiogenic secondary sprout and therefore adopted a venous fate. In this 
embryo, there was a shift of lymphangiogenic to angiogenic secondary sprouting in all somites imaged.  
Figure S1: Model of lymphatic 
development in zebrafish embryos
In all panels, a schematic figure is 
shown on the left, and for panel 
A,B,D a high-magnification image of 
the blood and lymphatic vasculature 
at different stages of development 
in Fli1:eGFPy1 zebrafish on the right. 
For clarity, the confocal images are 
flanked by redrawings of the vessel 
contours. DA, dorsal aorta; DLAV, 
dorsal longitudinal anastomosing 
vessel; DLLV, dorsal longitudinal 
lymph vessel; ISV, intersomitic vessel; 
aISV, arterial ISV; lISV, lymphatic 
ISV; vISV, venous ISV; PCV, posterial 
cardinal vein; PL, parachordal 
lymphangioblast string; TD, 
thoracic duct. Permanent lymphatic 
structures (lISV, TD) are labeled dark 
green; transient lymphangiogenic 
structures (lymphangiogenic 
secondary sprouts; PL cells) are 
labeled light green. A,A’, From 
around 30 hpf onwards, secondary 
sprouts arise from the PCV. About 
half of them will give rise to lymphatic 
structures and are therefore named 
lymphangiogenic secondary sprout 
(Ly sec. sprout; yellow arrows in 
A’). The other half of the secondary 
sprouts remain venous in nature 
(angiogenic secondary sprouts) 
(blue in A). B,B’, By 48 hpf, the 
lymphangiogenic sprouts (yellow 
arrows in B’) radially migrate dorsally to the level of the horizontal myoseptum, where they migrate tangentially to 
give rise to a transiently existing string of PL cells. The angiogenic sprouts connect to the aISV (red), which thereby 
(continued on next page)
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Figure S1 (continued): will acquire a venous identity. C, Around 60 hpf, PL cells turn and switch from tangential 
to radial migration closely along aISVs, thereby forming lymphatic intersomitic vessels (lISVs); note the close 
association of lISVs with aISVs. lISVs that ascend form the dorsal longitudinal lymph vessel (DLLV), while those that 
descend form the TD. ISVs that connected to the angiogenic secondary sprouts progressively loose their arterial 
identity and acquire a venous fate. D,D’, From 3 days onwards, the first TD fragments appear at distinct locations 
along the trunk and, via tangential migration, extend rostrally and caudally to merge into a complete TD. The lISV 
and TD are indicated by white arrows and arrowhead, respectively, in D’.
Figure S2: Development of embryos upon 
incomplete inhibition of Dll4
Complete silencing of Dll4/Notch signaling 
causes pronounced angiogenic defects 
(Hofmann and Iruela-Arispe, 2007; Roca and 
Adams, 2007; Phng and Gerhardt, 2009; 
Swift and Weinstein, 2009). We therefore 
performed a detailed analysis, using high-
resolution imaging, of the vasculature of 
control (A,C,E,G) and Dll4KD hypomorphant 
Fli1:eGFPy1 embryos (10 ng Dll4SPL; B,D,F,H). 
In all panels, the head of the embryo faces 
left. Scale bars are 100 mm. DA, dorsal aorta; 
PAV, parachordal vessel; PCV, posterior 
cardinal vein; TD, thoracic duct. A,B, The early 
vasculogenic stages proceeded normally in 
morphant embryos, resulting in the formation 
of properly sized and shaped axial vessels at 
timely developmental stages. Knockdown of 
Dll4 did not affect the timing or pathfinding 
of primary ISVs, or the subsequent formation 
of the DLAV (arrows) in embryos at 30 hpf. 
The DA is indicated by a red vertical bar, while 
the PCV is denoted by a blue vertical bar. C,D, 
Close-up images of the head vasculature at 30 
hpf, showing similar appearance in control and 
Dll4KD embryos. The arrow denotes the mid-
cerebral vein. E,F, The subintestinal vessels 
(arrows) in 3-dpf Dll4KD embryos displayed a 
largely comparable network morphogenesis 
with only minimal signs of hyperbranching. 
G,H, Image of a 12-dpf embryo, revealing 
that knockdown of Dll4 did not prevent the 
formation of the PAV, which develops only 
after the TD is established. Note the absence 
of the TD in the morphant embryo (asterisks 
in panel H), indicating that the TD defect 
persisted and was not rescued over time. The 
yellow arrowheads in G denote the course 
of the TD in the control embryo. The red arrowheads in H denote mild hyperbranching of the ISVs in the Dll4KD 
embryo. I-L, Whole-mount in situ stainings for Cmlc2 (I,J; 30 hpf) and MyoD (K,L; 48 hpf), showing that size and 
positioning of the heart (arrow) and somite development are normal in Dll4KD embryos. Overall, at the morpholino 
concentrations used in our analyses, no overt angiogenic malformations were detected in Dll4KD embryos prior to 
or during lymphangiogenesis. Further, imaging of the Flt1:YFP reporter line, in which only arterial ECs are labeled, 
confirmed that primary aISVs expressed the YFP transgene in Dll4KD embryos, indicating that their initial arterial 
specification occurred normally (see Movie S2). 
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Figure S3: General morphology and 
analysis of TD formation
A-D, Bright field images of 6-dpf control (A), 
Dll4KD (10 ng Dll4SPL; B), Notch-1bKD (15 ng 
Notch-1bSPL; C) and Notch-6KD (15 ng Notch-
6SPL; D) embryos, showing normal overall 
morphological development. Only morphant 
embryos with a normal trunk circulation 
and body size, without developmental 
delay, tissue malformations, general 
edema or toxic defects were included in TD 
screening assays. E, TD quantification. In all 
panels the head of the embryos faces left. 
DA, dorsal aorta; DLAV, dorsal longitudinal 
anastomosing vessels; ISV, intersomitic 
vessel; PCV, posterial cardinal vein; PL, 
parachordal lymphangioblast string; TD, 
thoracic duct. TD formation was quantified 
by measuring the length over which it 
formed in 10 consecutive somite segments 
(i.e. somites 5-15; demarcated by the green 
rectangle). Confocal images of control and 
morphant Fli:eGFPy1 embryos are depicted 
in the insets. Inset a: in the control embryo, 
a continuous TD formed over all 10 somite 
segments (100% TD formation; green 
arrowheads). Inset b: severely morphant embryo, in which the TD formed over only 10% (green arrowhead). Inset 
a’ and b’: schematic redrawing of the DA, TD and PCV in the embryo shown in inset a and b, respectively, with the 
TD or TD segment marked in green. Scale bars are 200 mm in A-D, 100 mm in E and insets of E. 
Figure S4: Normal arterial-venous differentiation after 
inhibition of Notch
A-R, Arterial-venous differentiation of the large axial 
vessels was evaluated upon incomplete silencing of the 
components of the Dll4/Notch signaling pathway that 
were shown in this study to affect lymphatic development. 
Therefore, whole-mount embryos were in situ stained for 
arterial (EphrinB2a; Tbx20 (Szeto et al., 2002; Pendeville 
et al., 2008)) and venous (Vegfr3; Dab2 (Song et al., 2004; 
Herpers et al., 2008)) markers in control embryos (A-D) 
and in Dll4KD (10 ng Dll4SPL; E-H), Notch-1bKD (15 ng Notch-
1bSPL; I-L), Notch-6 (15 ng Notch-6SPL; M,N), PS-1 (15 ng PS-
1ATG1; O,P) or DAPT-treated (25 mM; Q,R) hypomorphant 
embryos. Staining was performed at 28 hpf (few hours 
prior to secondary sprout formation) for EphrinB2a, 
Vegfr3 and Tbx20, and at 48 hpf for Dab2, when arterial 
and venous differentiation of the DA and PCV were 
completed. Overall, expression of arterial markers in the 
DA and of venous markers in the PCV was comparable in 
control and morphant embryos. Also, note that there is 
no ectopic expression of these markers. In all panels, the 
head of the embryo faces left. The DA is indicated by a red 
vertical bar, while the PCV is denoted by a blue vertical bar. 
DA, dorsal aorta; PCV, posterior cardinal vein. Scale bar, 
representative for all panels, is 100 mm. 
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Figure S5: Impaired TD formation upon silencing of Notch
Specificity of the TD defects observed upon knockdown of Dll4, Notch-1b and PS-1 
(Figure 1), was confirmed by second independent morpholinos targeting each of 
these genes.  A-C, Bar graphs, representing the percentage of embryos at 6 dpf, 
that develop a normal TD (grey), a TD over 30-90% (lilac) or over 10-30% (blue) of 
its normal length, or completely lack any TD (dark blue) in the indicated fraction of 
control embryos (N=144 in panel A; 61 in panel B; 90 in panel C) and Dll4KD (N=172; 
2.5 ng Dll4ATG; P<0.001 versus controls by Chi-Square test; panel A), Notch-1bKD 
(N=89; 20 ng Notch-1bATG; P<0.001 versus controls; panel B) and PS-1KD embryos 
(N=36; 15 ng PS-1ATG2; P<0.001 versus controls; panel C). 
Figure S6: Inhibition of 
Notch does not affect in vitro 
proliferation and migration
A, Primary LECs of dermal 
(HMVEC-DLy) and lung 
(HMVEC-LLy) origin were 
starved overnight, after which 
proliferation was induced 
with full growth medium 
with or without increasing 
concentrations of DAPT (30-
60 mM). Proliferation was 
measured as the number 
of viable cells after further 
culturing for 48 hours, 
expressed in % of control. B, 
Migration of LECs, analyzed 
using a scratch wound 
healing assay, was not 
inhibited by DAPT (30 mM). C, 
Transwell migration of LECs in 
response to culture medium 
containing 10% FBS and 100 
ng/ml VEGF-C in the lower 
compartment (“stimulated”) was not affected by DAPT (60 mM). D, Transwell migration of LECs in response to 
culture medium containing 10% FBS and 100 ng/ml VEGF-C in the lower compartment was comparable, when cells 
were seeded on transwell filters coated with BSA (control) or the extracellular domain of Dll4 (Dll4-ECD), previously 
shown to activate Notch signaling (Harrington et al., 2008). Error bars represent SEM; N=5-11.
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Figure S7: Expression of Notch-1B
Sagital section of an embryo at 30 hpf, when 
lymphangiogenic sprouting occurs, whole-mount 
stained for Notch-1b. Head of th embryo faces 
left. DA, dorsal aorta; ISV, intersomitic vessel; 
PCV, posterior cardinal vein. Scale bar is 50 mm. 
Notch-1b is strongly expressed in the DA and ISVs. 
A weak signal can be observed in the dorsal part 
of the PCV.
Figure S8: Morpholino efficacy assays
To knock down Notch family members, we injected 
one-cell stage embryos with morpholinos that 
block initiation of translation, either by targeting 
the ATG or nearby 5’UTR sequence (termed Dll4ATG, 
in the case of Dll4) or splicing (Dll4SPL); each gene 
was silenced by these complementary approaches 
for confirmation; a control morpholino was 
consistently included in each experiment. A-E, 
The silencing efficiency of the newly described 
ATG targeting morpholinos was tested in vitro. 
To demonstrate the efficacy of the morpholinos 
PS-1ATG2 (A), PS-2ATG (B), Dll4ATG (C), Notch-1aATG (D) 
and Notch-1bATG (E), we performed a luciferase 
reporter assay, as previously developed (Ny et al., 
2005). We therefore cloned 25 nucleotides of the 
5’UTR and 40 nucleotides of the coding sequence 
of the different genes (containing the ATG) 
upstream of and in frame with an open reading 
frame of the luciferase cDNA (lacking the initiator 
ATG codon) in an expression vector. Expression of 
this chimeric reporter protein in the erythrocyte 
lysate assay was monitored via luminometry (Ny 
et al., 2005). Values are represented as luciferase 
activity relative to control treatment (no addition of morpholino). Unlike the standard control morpholino (Ctr-
MO), supplementation of the gene-specific morpholinos dose-dependently blocked the expression of this chimeric 
reporter. Error bars represent SEM (N=3). *, P<0.05 versus the no morpholino treatment.
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Table S1: Morpholino oligonucleotide sequences 
MO MO sequence Target Ref
DeltaAATG 5’-CGCCGACTGATTCATTGGTGGAGAC-3’ Start site
DeltaBATG 5’- CGCCATCTCGCTCACTTTATCCTAA-3’ Start site
DeltaCATG 5’- GCACGTTAATAAAACACGAGCCATC-3’ Start site
DeltaDATG 5’- AACAGCTATCATTAGTCGTCCCATG-3’ Start site
Dll4ATG 5’-GAGAAAGGTGAGCCAAGCTGCG-3’ Start site
Dll4SPL
5’-TAGGGTTTAGTCTTACCTTGGTCAC-3’
5’-TGATCTCTGATTGCTTACGTTCTTC -3’
Exon6/intron6 
Exon4/intron4
(Leslie et al., 2007)
Jag1aATG 5’-GTCTGTCTGTGTGTCTGTCGCTGTG-3’ 5’ UTR
Jag1bATG 5’-CTGAACTCCGTCGCAGAATCATGCC-3’ Start site
Jag2ATG 5’-TCCTGATACAATTCCACATGCCGCC-3’ Start site
Notch-1aATG 5’-TTCACCAAGAAACGGTTCATAACTC-3’ Start site
Notch-1bATG 5’-ATGCATTCCTTCTTATGGATAGTCC-3’ Start site
Notch-1bSPL 5’-AATCTCAAACTGACCTCAAACCGAC-3’ intron28/exon29 
(Milan et al., 2006; Leslie 
et al., 2007)
Notch-5ATG 5’-ATATCCAAAGGCTGTAATTCCCCAT-3’ Start site
(Lorent et al., 2004; Leslie 
et al., 2007)
Notch-6SPL 5’-AGGTGAACACTTACTTCATGCCAAA-3’ exon7/intron7 
(Lorent et al., 2004; Leslie 
et al., 2007)
PS-1ATG1 5’-CCGGGATCATAGAAACAGCGGGAAC-3’ 5’ UTR
PS-1ATG2 5’-CATTCTGCACTAAATCAGCCATCGG-3’ Start site
PS-2ATG 5’-CTCTTCACTGTCTGAGGTATTCATG-3’ Start site
control MO 5’-CCTCTTACCTCAGTTACAATTTATA-3’
Standard control 
MO (Gene Tools)
90|
Table S2: qRT-PCR primer and probe sequences
Human genes
Hes1 Hs00232622_m1  (Premade Taqman Gene expression assays, Applied Biosystems)
Hey1 Hs00232618_m1  (Premade Taqman Gene expression assays, Applied Biosystems)
Hey2 Hs00232622_m1  (Premade Taqman Gene expression assays, Applied Biosystems)
Nrarp Hs01104102_s1   (Premade Taqman Gene expression assays, Applied Biosystems)
VegfR3 For
Rev
Probe
5’-TTC CTG GCT TCC CGA AAG T-3’
5’-AGG CCA AAG TCA CAG ATC TTC AC-3’
5’-FAM-ACC TGG CTG CTC GGA ACA TTC TGC-TAMRA-3’
Prox-1 For
Rev
Probe
5’-GTG CTT TGG CGA CGT CAT C-3’
5’-TCA GTG GAA CTG GCC ATC TG-3’
5’-FAM-TTC CGA ACC CCC TGG ACA CCT TTG-TAMRA-3’
Lyve-1 For
Rev
Probe
5’-CAA AGA TCC CAT ATT CAA CAC TCA A-3’
5’-GGG ATG CCA CCG AGT AGG TA-3’
5’-FAM-CTG CAA CAC AAA CAA CAG AAT TTA TTG TCA GTG ACA-TAMRA-3’
EphrinB2 Hs00970627_m1  (Premade Taqman Gene expression assays, Applied Biosystems)
Sox18 For
Rev
5’-AGA ACC CGG ACC TGC ACA-3’  (Sybr Green qRT-PCR)
5’-CAG CTC CTT CCA CGC TTT G-3’ 
Coup-TFII Hs00819630_m1  (Premade Taqman Gene expression assays, Applied Biosystems)
Neuropilin1 For
Rev
Probe
5’-TGT GAA GTG GAA GCC CCT ACA-3’
5’-GGC CTG –GTC GTC ATC ACA TT-3’
5’-FAM-CCG ACC ACT CCC AAC GGG AAC TTG-TAMRA-3’
CD31 For
Rev
5’-TCT GCA CTG CAG GTA TTG ACA A-3’ (Sybr Green qRT-PCR)
5’-CTG ATC GAT TCG CAA CGG A-3’
Ve-cadherin Hs00174344_m1  (Premade Taqman Gene expression assays, Applied Biosystems)
Endoglin  Hs00164438_m1  (Premade Taqman Gene expression assays, Applied Biosystems)
b-Actin Hs99999903_m1 (Premade Taqman Gene expression assays, Applied Biosystems)
b-Actin For
Rev
5’-TGG CAC CAC ACC TTC TAC AAT G-3’ (Sybr Green qRT-PCR)
5’-TAG CAA CGT ACA TGG CTG GG-3’
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Reprinted with permission from:
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Vegfc/Flt4 signalling is suppressed by Dll4 in 
developing zebrafish intersegmental arteries
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ABSTRACT
The development of arteries, veins and lymphatics from pre-existing vessels are intimately linked processes controlled by a number of well studied, reiteratively acting signalling pathways. To delineate the mechanisms governing vessel formation 
in vivo, we performed a forward genetic screen in zebrafish and isolated the mutant 
expando. Molecular characterization revealed a loss-of-function mutation in the highly 
conserved kinase insert region of flt4. Consistent with previous reports, flt4 mutants 
were deficient in lymphatic vascular development. Recent studies have demonstrated a 
role for Flt4 in blood vessels and showed that Dll4 limits angiogenic potential by limiting 
Flt4 function in developing blood vessels. We found that arterial angiogenesis proceeded 
normally, yet the dll4 loss-of-function arterial hyper-branching phenotype was rescued, in 
flt4 signalling mutants.  Furthermore, we found that the Flt4 ligand Vegfc drives arterial 
hyper-branching in the absence of dll4. Upon knockdown of dll4, intersegmental arteries 
were sensitised to increased vegfc levels and the overexpression of dll4 inhibited Vegfc/
Flt4 dependent angiogenesis events.  Taken together, these data demonstrate that dll4 
functions to suppress the ability of developing intersegmental arteries to respond to 
Vegfc driven Flt4 signalling in zebrafish. We propose that this mechanism contributes to 
the differential response of developing arteries and veins to a constant source of Vegfc 
present in the embryo during angiogenesis. 
INTRODUCTION
During developmental angiogenesis, arteries, veins and lymphatics arise from pre-existing 
vessels by carefully regulated processes of sprouting, migration, proliferation and patterning 
of endothelial cells, collectively termed haemangiogenesis (for arteries and veins) or 
lymphangiogenesis (for lymphatic vessels). In the zebrafish embryonic trunk, developmental 
angiogenesis takes place in two distinct stages: primary sprouts form from the dorsal aorta 
to give rise to intersegmental vessels from ~22 hours post-fertilisation (hpf), and then 
secondary sprouts form from the posterior cardinal vein (PCV) to give rise to intersegmental 
veins and lymphatic vascular precursors from ~32 hpf (Isogai et al., 2003; Yaniv et al., 2006). 
Although primary sprouts will contribute to both functional arteries and veins after the later 
remodelling of the trunk vasculature (Isogai et al., 2003), primary sprouting is considered an 
arterial angiogenic process as sprouts derive exclusively from the dorsal aorta and express 
arterial markers (Siekman and Lawson, 2007), whilst secondary sprouting from the PCV 
is a venous angiogenic process.  These processes are regulated by vascular endothelial 
growth factors and their receptors. The primary sprouting of intersegmental arteries (ISAs) 
is dependent on Vegfa, Kdr and Kdr-l (Bahary et al., 2007; Covassin et al., 2009; Covassin et 
al., 2006; Habeck et al., 2002) and the growth of ISAs has been reported to stall transiently 
upon morpholino (MO) knockdown of Flt4 or Vegfc (Covassin et al., 2006).  flt4 and vegfc 
are essential for lymphangiogenesis in the zebrafish trunk (Kuchler et al., 2006; Yaniv et al., 
2006) and vegfc is required at the level of venous angiogenic sprouting (Hogan et al., 2009). 
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Mouse mutants or transgenic mice deficient for the ligand Vegfc, or for signalling by its 
receptor Flt4, lack lymphatic vessels and consequently display lymphedema (Karkkainen et 
al., 2004; Makinen et al., 2001; Veikkola et al., 2001). Vegfc deficient mice lack lymphatic 
vessels, due to a block in lymphangiogenesis  that occurs at the level of budding of 
lymphangioblasts from venous endothelium, the earliest event in lymphatic vascular 
differentiation (Karkkainen et al., 2004).  Consistent with the established functions of these 
factors during development, Vegfc and Flt4 drive tumour lymphangiogenesis (Karpanen et 
al., 2001), their antagonists  inhibit tumour metastasis (He et al., 2002) and FLT4 mutations 
lead to primary (inherited) lymphedema in humans (Karkkainen et al., 2000).
A recent study has demonstrated a role for Flt4 in haemangiogenesis (Tammela et al., 
2008).  The inhibition of Flt4 reduced angiogenic sprouting of blood vessels during retinal 
or tumour associated angiogenesis  (Tammela et al., 2008).  Consistent with this role, Flt4 
is expressed in intersegmental vessels in the trunk of the developing mouse embryo and in 
the vasculature of the retina during angiogenesis, with enhanced expression in sprouting tip 
cells (Tammela et al., 2008).  Notch signalling generally acts to robustly repress angiogenic 
potential of endothelial cells during development and disease (Hellstrom et al., 2007; 
Noguera-Troise et al., 2006; Siekmann and Lawson, 2007; Suchting et al., 2007). Consistent 
with this model, Dll4 inhibition leads to dramatically increased angiogenesis that produces 
morphologically abnormal and non-functional blood vessels (Leslie et al., 2007; Noguera-
Troise et al., 2006; Siekmann and Lawson, 2007). During retinal angiogenesis, Dll4 induced 
signalling suppresses Flt4 expression in endothelial tip cells but when Dll4 or Notch signalling 
is inhibited, up-regulated Flt4 activity drives ectopic sprouting and increased angiogenesis 
(Tammela et al., 2008).  
During arterial angiogenesis in zebrafish, increased vessel sprouting induced by the loss 
of the Notch target transcription factor Rbpsuh (Rbpja – Zebrafish Information Network) can 
be suppressed, at least in part, by the depletion of Flt4 using MOs, indicating that there is 
likely to be a conserved relationship between Notch signalling and Flt4 function in zebrafish 
arteries (Siekmann and Lawson, 2007).  During both arterial and venous angiogenesis, there 
is a constant source of vegfc in the zebrafish trunk, expressed first in the hypochord and 
then in the dorsal aorta (Covassin et al., 2006). Zebrafish flt4 expression is found at high 
levels in venous endothelial cells during both arterial and venous angiogenesis but has also 
recently been identified in arterial cells (Covassin et al., 2009; Siekmann and Lawson, 2007). 
The presence of a constant source of ligand in the developing embryo, as well as receptor 
expression in sprouting endothelial cells during both arterial and venous angiogenesis, 
raises the question of how developing arteries and veins are programmed to differentially 
respond to Vegfc/Flt4 signalling and what role Notch signalling may play.  
Here we report the identification of a Flt4 signalling deficient zebrafish mutant and 
investigate the relationship between Dll4 function in arteries and Vegfc/Flt4 signalling in the 
developing vasculature. As with vegfc, flt4 is required for all venous derived angiogenesis 
in the zebrafish trunk, both in lymphangiogenesis and for the formation of intersegmental 
venous sprouts.  Surprisingly, arterial angiogenesis is normal in zebrafish flt4 signalling 
deficient mutants and we show that dll4 suppresses Vegfc/Flt4 signalling in zebrafish 
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arteries in order to allow for normal ISA development.  Analysis of the expression of vegfc 
and flt4 in dll4 deficient arteries indicates that this suppression is not due to any observable 
changes in ligand or receptor transcription. We propose that this role of dll4 contributes to 
the differential response of arteries and veins to a constant source of Vegfc in the trunk of 
the embryo during developmental angiogenesis.  
MATERIALS AND METHODS
Zebrafish
All zebrafish strains were maintained in the Hubrecht Institute using standard husbandry conditions. Animal 
experiments were performed in accordance with the rules of the Animal Experimentation Committee of the Royal 
Netherlands Academy of Arts and Sciences (DEC). The published transgenic lines used were TG(fli1a:gfp)y1(Lawson 
and Weinstein, 2002), TG(flt1:YFP)hu4624 (Hogan et al., 2009) and TG(kdr-l:Cherry)s916 (Hogan et al., 2009).  Embryos 
genotyped in Fig. 4 were of the TG(fli1a:gfp)y1 strain.
ENU mutagenesis was performed as previously described (Wienholds et al., 2002). The F1 progeny of mutagenised 
males were crossed to the TG(fli1a:gfp) strain to produce transgenic F2 families.  Subsequent in-crossing of F2 
progeny generated F3 embryos that were screened for the presence or absence of the thoracic duct. 
Positional cloning of expando 
The flt4hu4602 mutation was mapped using standard meiotic mapping with simple sequence length polymorphisms 
(SSLPs). The primers used for SSLP markers depicted in Fig. 2 were: z43267 – 5’-CAAAGGGTGCAAAGTGCATT-3’ and 
5’-AGCAAAAGTGCTGGTGATCA-3’; z26376 – 5’-CCTGCTAACCTGCGTTCTTC-3’ and 5’-CGTTAGCATATGCGCACTCT-3’; 
and z11725 – 5’-GCTTCCAGAAGTGGAGCAAC-3’ and 5’-TGATTTTGATTGGGGACCAT-3’.  Subsequent genotyping 
and SNP analyses were performed by sequencing using the primer pair:  5’-AGCTCTTGATTTGGCTTTAG-3’ and 
5’-GGAAAGTATCCTTGCTCTGC-3’. Bioinformatic construction of the genomic region was performed using the 
Ensembl database http://www.ensembl.org, release 44, April 2007. 
FLT4 kinase assay
Full-length human wild-type FLT4 and I1034S mutant FLT4 constructs were cloned into the pMXs vector (generous 
gift from Dr Toshio Kitamura, University of Tokyo, Japan) and transfected to HEK 293T cells (American Type 
Culture Collection) grown in DMEM supplemented with 10% foetal bovine serum (FBS) (PromoCell), glutamine 
and antibiotics. For immunoprecipitation and immunoblotting analysis, confluent plates of the cells were serum-
starved for 2 hours, stimulated with VEGF-C (100ng/ml) and lysed in lysis buffer (50 mM HEPES, pH 7.5, 1 % Triton 
X-100, 5 % glycerol, 1 mM EGTA, 150 mM NaCl, 1.5 mM MgCl
2
, 100 mM NaF, 1 mM each Na
3
VO
4
, PMSF, Aprotinin 
and leupeptin) (Saharinen et al., 1997). Equal amounts of protein in the lysates were used for immunoprecipitation 
using mouse monoclonal anti-human FLT4 antibodies (9D9) (Petrova et al., 2008). The immunocomplexes were 
captured using protein-G sepharose (GE Healthcare Bio-Sciences, Uppsala, Sweden), separated by 7.5% SDS-PAGE, 
transferred to a nitrocellulose membrane and detected using monoclonal mouse anti-phosphotyrosine (4G10; 
Upstate Biotechnology, Lake Placid, NY) or rabbit anti-human FLT4 antibodies, biotinylated secondary antibodies 
(Dako Denmark A/S, Glostrup, Denmark) and streptavidin-biotinylated horseradish peroxidase complex (GE 
Healthcare, Little Chalfont, UK) followed by enhanced chemiluminescence detection with the SuperSignal West 
Femto Maximum Sensitivity Substrate (Pierce, Rockford, IL). For re-probing, the membranes were stripped for 15 
min at room temperature using Re-Blot Plus Strong Solution (Chemicon).
mRNA and morpholino injections
MOs targeting the vegfc and flt4 start codons were as follows: flt4 ATG MO – 5’-CTCTTCATTTCCAGGTTTCAAGTCC-3’ 
(Open Biosystems) and vegfc ATG MO 5’-GAAAATCCAAATAAGTGCATTTTAG-3’ (Genetools LLC), both 
injected at a concentration of 5 ng/embryo. The dll4 MO targeted the exon 4/intron 4 splice donor site 
(5’-TGATCTCTGATTGCTTACGTTCTTC-3’) and was injected at concentrations of 3ng or 6ng/embryo as indicated.
The sFLT4, vegfc and vegfd cDNA clones used have been previously described (Hogan et al., 2009; Ober 
et al., 2004). The full length dll4 cDNA was sub-cloned into the pCS2+ vector by first amplifying from a 
full length template cDNA clone (accession number BC117624; Open Biosystems) using the PCR primers: 
5’-GCGCGGATCCACCATGGCAGCTTGGCTCACCTTTC-3’ and 5’-GCGCTCTAGATTATACCTCAGTTGCTATGAC-3’ followed 
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by sub-cloning with BamHI and XbaI. mRNA was transcribed from a KpnI-linearised template using the SP6 RNA 
polymerase and the mMessage mMachine kit (Ambion) and injected at a concentration of 200 pg/embryo. The full-
length human wild-type FLT4 and I1034S mutant  constructs were cloned into the pCS2+ vector using the primers 
5’-GCGCGGATCCACCATGCAGCGGGGCGCCGCGCT-3’ and  5’-GCGCTCTAGACTACCTGAAGCCGCTTTCTT-3’ to amplify 
the cDNA from the templates described above and the restriction enzymes BamHI and XbaI digestion for cloning. 
mRNA for the wildtype and mutant forms of human FLT4, sFLT4  and zebrafish vegfc and vegfd was transcribed from 
NotI digested template using the SP6 RNA polymerase and the mMessage mMachine kit (Ambion) and injected at 
the concentrations indicated.   
Transgenesis
The stable, germline transmitted TG(flt4:YFP)hu4881 transgenic line was generated by recombining 
a citrine-neomycin cassette using Red/ET Recombination Technology (Gene Bridges) into the BAC 
(bacterial artificial chromosome) clone DKEY-58G10 using the homology arm tagged PCR primers: 
aacgcgcaggtttgctagaatatctaaaaccccggaggactggaaacctgACCATGGTGAGCAAGGGCGAGGAG-3’ and 5’- 
aagaagggaatcccaatccaaatccgacagaaaaacgtaaaatctctcttTCAGAAGAACTCGTCAAGAAGGCG-3’ (homology arms 
are shown in lowercase). We found that BAC transgenesis produced germline founders but that embryos 
expressing YFP were highly dismorphic and died at stages prior to 24 hpf (data not shown). Hence,  6.6kb of the 
5’UTR of flt4 as well as the YFP coding sequence was PCR amplified using Phusion high fidelity PCR (Finnzymes) 
followed by cloning into the miniTol2 transgenesis vector (Kawakami, 2005).  Amplification primers were: 
5’-GCGCGAATTCTAAGCAAAGTCAGACCTTACTGTCC-3’ and 5’- CACGTACGGTGTGGTAACG-3’.  One cell-stage embryos 
were co-injected with construct DNA (25ng/µL) and transposase mRNA (25ng/µL) and the progeny was screened 
for germline transmission. Low level-expressing germline stable lines were generated but expression was found 
to wane after 48 hpf suggesting that the construct may not contain all necessary regulatory elements for late 
expression.  
Imaging and expression analysis
In situ hybridisation was performed as previously described (Bussmann et al., 2007).  The tie2 (Lyons et al., 1998), 
flt4 (Thompson et al., 1998), vegfc (Hogan et al., 2009), vegfd (Hogan et al., 2009), dll4 (Herpers et al., 2008) and 
hey2 (Zhong et al., 2000) probes were prepared as previously described.  Embryos were mounted in 1% low melting 
point agarose in a culture dish with a cover slip replacing the bottom. Imaging was performed with Leica SPE or 
SP5 confocal microscopes (Leica Microsystems) using a 10x or 40x objective with digital zoom. Angiography was 
performed as previously described (Kuchler et al., 2006).
RESULTS
expando is a flt4 signalling deficient mutant
In a screen for developmental mutants that fail to form lymphatic vessels, we identified the 
mutant expandohu4602 that lacked the thoracic duct at 5 days post fertilisation (dpf) whilst 
retaining blood circulation (Fig. 1A-D).  To determine the stage at which lymphangiogenesis 
was first impaired in expando mutants, we examined the phenotype in double transgenic 
TG(fli1:GFP, kdr-l:Cherry) embryos in which trunk blood vessels express both GFP and 
Cherry but lymphatic vessels express only GFP (Hogan et al., 2009).  We found that all 
trunk lymphatic vessels, including the intersegmental lymphatic vessels (islv) and dorsal 
longitudinal lymphatic vessel (dllv) vessels, were absent in expando mutants at 5 dpf and 
that parachordal lymphangioblasts (PLs) had failed to bud from the PCV and were absent at 
54 (hpf) (Fig. 1E-H).  We examined tie2 expression at 48 hpf as a marker for venous derived 
intersegmental vessels and found that venous sprouts were absent in expando mutants (Fig. 
1I,J), a phenotype identical to that of vegfc MO-injected embryos which lack all venous 
angiogenic sprouting (Hogan et al., 2009). 
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To identify the causative mutation for the expando phenotype, we used a traditional 
positional cloning approach and found the expando locus to be linked to a region of 
chromosome 14 containing the flt4 gene (Fig. 2A). Sequencing of flt4 revealed a point 
mutation predicted to change a conserved isoleucine residue into a serine at position 1042 in 
the split kinase domain (Fig. 2 B,C).  To examine the functional consequence of this mutation 
we introduced the equivalent mutation (I1034S) into human FLT4 and compared the ability 
Fig. 1. Zebrafish expando mutants lack lymphatic vessels and venous sprouting. (A,B) Lateral views of TG(fli1:GFP) 
expression in wild-type (wt; A) and expando mutant (B) larvae at 5 dpf demonstrate that overall vascular patterning 
is not perturbed in expando mutants. (C,D) Overlay image of angiogram (red) and TG(fli1:GFP) (white) indicating 
the presence of blood flow in wildtype (C) and mutant (D) embryos. The thoracic duct (arrows) is present in 
wildtype but absent (asterisks) in mutant larvae. (E,F) Lateral views of wildtype (E) and expando mutants (F) in a 
double transgenic TG(fli1:GFP), TG(kdr-l:Cherry) background. All lymphatic vessels are absent in mutants at 5dpf. 
Arrows indicate the thoracic duct (td), intersegmental lymphatic vessels (islv) and dorsal longitudinal lymphatic 
vessels (dllv) in wildtype embryos.  Asterisks indicate their absence in expando mutants. (G,H) Parachordal 
lymphangioblasts (PLs) are absent from the horizontal myoseptum in expando mutants (asterisk in H) compared 
with wildtype siblings (arrow in G indicates PL) in the double transgenic TG(fli1:GFP), TG(kdr-l:Cherry) background 
at 54 hpf. (I,J). tie2 expression in venous sprouts (arrows in I) is absent in expando mutants (J) (n=6/29 embryos 
scored and confirmed by genotyping).
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of VEGFC to stimulate kinase domain activity of the wildtype and mutant forms of the 
receptor. We found that the I1034S mutation led to a loss of kinase domain function in this 
in vitro assay (Fig. 2D). Consistent with a flt4 mutation leading to the expando phenotype, 
we found that the injection of either a flt4 targeting morpholino oligomer (MO) or an mRNA 
encoding the soluble Ig domain of human FLT4 (sFLT4) that acts as a dominant inhibitor of 
Flt4 signalling in zebrafish (Ober et al., 2004), phenocopied the loss of lymphatic vessels (Fig. 
3G; data not shown) as previously described (Kuchler et al., 2006; Yaniv et al., 2006). We 
hereafter refer to the expando (Flt4 I1042S) mutant as flt4hu4602.
Angiogenesis defects of the Primordial Hind-Brain Channel are observed in flt4 
morphants, vegfc morphants and sFLT4 mRNA injected embryos but not in flt4hu4602 
mutants
Previous studies have described angiogenesis defects after inhibition of flt4 translation by 
MO injection (Covassin et al., 2006; Siekmann and Lawson, 2007).  We injected sFLT4 mRNA 
and also MOs targeting the start codons of flt4 and vegfc. We found that these injections 
consistently induced angiogenesis defects during the formation of the Primordial Hind-
Brain Channel (PHBC) (Fig. 3 C-E) in 20-40% of injected embryos. When all injected embryos 
from the same clutch were grown to 5 dpf they completely lacked lymphatic vessels, 
phenocopying the flt4hu4602 phenotype with 100% penetrance (Fig. 3 F,G).  The dependency of 
PHBC formation upon Vegfc and Flt4 in zebrafish has been previously reported (Covassin et 
al., 2006). Surprisingly, in contrast to the injected embryo phenotypes, detailed examination 
of flt4hu4602 mutant embryos failed to reveal PHBC defects (Fig. 3B). 
Taken together, these observations suggest two distinct possibilities: (1) that different 
thresholds of Flt4 signalling are required for distinct angiogenesis events in the zebrafish 
embryo such that normal signalling is necessary for lymphangiogenesis and venous 
angiogenesis, whereas very low level, residual signalling in the presence of the I1042S 
mutation is sufficient for PHBC development;  or (2) that a non-signalling function of Flt4 
regulates PHBC angiogenesis whereas signalling is indispensable for PCV sprouting and 
lymphangiogenesis.         
To evaluate the possibility of performing experiments to rescue the morphant PHBC 
defect with mutant or truncated forms of Flt4, we injected full length mRNA encoding the 
human wildtype and I1034S mutant forms of FLT4 (300pg/embryo). We found that upon 
forced expression, both of these mRNAs were capable of inhibiting thoracic duct formation 
(wildtype FLT4 mRNA 47% thoracic duct deficient, n=42; I1034S FLT4 mRNA 26% thoracic 
duct deficient, n=31 (data not shown)) indicating that FLT4 has mild dominant negative 
activity upon overexpression by mRNA injection in zebrafish , therefore precluding an 
attempt to rescue PHBC defects.      
Fig. 3 (continued): vegfc MO (5ng/embryo) inhibits PHBC development in 22% of injected embryos (n=41) and 
TD development in 97% of embryos in the same injection (n=37) and sFLT4 mRNA (200pg/embryo) inhibits PHBC 
development in 42% of injected embryos and TD development in 100% of embryos in the same injection (n=120). 
Uninjected control embryos showed normal PHBC and thoracic duct (TD) development in 100% of cases (n=20) at 
28 hpf and 4 dpf (F and G). 
Dll4 suppresses Vegfc/Flt4 signalling
Ch
ap
te
r 
6
|101
Fig. 2.  A mutation in the flt4 kinase 
domain is responsible for the expando 
phenotype. (A)   Meiotic mapping 
links the expando locus to a region 
of chromosome 14 containing flt4. 
Analysis of 131 zebrafish embryos (262 
meioses) identifies 2 recombination 
events at the marker z43267 and 3 
independent recombinants at the 
marker z26376, thereby localising the 
mutation to a region containing flt4. 
(B,C) Sequencing of the coding exons 
of flt4 reveals a T>G mutation (see 
chromatogram in B) changing a highly 
conserved isoleucine to a serine at 
position 1042 of the predicted zebrafish 
Flt4 protein sequence. Flt4 receptor 
structure is depicted with Ig domain 
(I-VII), transmembrane domain (TM) and split tyrosine kinase domain (TK1 and TK2).  An alignment of conserved 
sequences (C) demonstrates that I1042 is a conserved residue, with grey shading indicating non-conserved 
residues. (D) Tyrosine phosphorylation (pY; upper panel, phosphotyrosine blot) was seen upon in vitro stimulation 
with VEGFC of wildtype human FLT4, but not of I1034S mutant FLT4. Lower panel (Flt4 protein blot) indicates the 
presence of the FLT4 protein post transfection in the assayed samples. 
Fig. 3: Zebrafish flt4hu4602 mutants lack PHBC defects observed upon flt4 morpholino, vegfc morpholino or sFLT4 
mRNA injection. (A-E) Angiogenesis of the primordial hind-brain channel (PHBC) fails to occur in flt4 MO injected 
(5ng) (C), sFLT4 mRNA injected (200pg/embryo) (D) and vegfc MO injected (E) embryos (yellow asterisk) compared 
with wildtype controls (A), but is unaffected (yellow arrow) in individually genotyped flt4hu4602 mutants (B) at 28 
hpf. (F,G) Angiogenesis of the PHBC and lymphangiogenesis respond differently to injection of flt4 MO, vegfc MO 
and sFLT4 mRNA.  Injection of flt4 MO (5ng/embryo) inhibits PHBC development in 29% of injected embryos at 28 
hpf but inhibits lymphangiogenesis (thoracic duct (TD) scored as readout) with 100% efficiency at 4dpf in the same 
injection (n=55 embryos scored). (continued on previous page) 
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Excessive arterial angiogenesis caused by the depletion of Dll4 is rescued in flt4hu4602 
mutants
We next examined arterial development in flt4hu4602 mutants by taking advantage of the 
TG(flt1:YFP)hu4624 transgenic line, in which the arteries of the embryonic trunk are labelled by 
YFP (Hogan et al., 2009). We examined the presence of the venous derived ISV components: 
these sprouts form during secondary sprouting from the vein, connect to ISAs in order to 
establish intersegmental venous vessels (Isogai et al., 2003) and are identifiable by the 
absence of flt1 expression in the ventral component of functional intersegmental vessels 
at 3 dpf (Hogan et al., 2009). We found that like vegfc MO injected embryos (Hogan et al., 
2009), flt4hu4602 mutants failed to form intersegmental venous derived vessels and in the 
absence of these venous sprouts, an increased number of ISA connections to the dorsal 
aorta were formed (Fig. 4A,B).  Apart from the increased ISA connections to the dorsal aorta, 
the ISAs appeared otherwise normal in flt4hu4602 mutants.
Given the known relationship between Dll4 and Flt4 in angiogenesis (Siekmann and 
Lawson, 2007; Tammela et al., 2008), we injected a dll4 MO that recapitulated the previously 
described dll4 loss-of-function arterial hyper-branching phenotype (Leslie et al., 2007) into 
embryos derived from flt4hu4602 heterozygous crosses (flt4hu4602 +/- x flt4hu4602 +/-). We found the 
hyper-branching phenotype to be variable and sorted embryos displaying severe arterial 
hyper-branching (e.g. Fig. 4C) from those not displaying hyper-branching phenotypes (e.g. 
Fig. 4D) into separate groups for genotyping.  We found that the mutant genotype was 
almost completely absent from the severe phenotypic category (present in 1/29 genotyped 
hyper-branching embryos) and was enriched in the non hyper-branching category (present 
in 21/55 genotyped embryos) indicating a rescue of the arterial hyper-branching phenotype 
associated with the mutant allele (Fig. 4E). 
Excessive arterial angiogenesis caused by the depletion of Dll4 is dependent on Vegfc 
To test whether the flt4 dependent dll4 hyperbranching phenotype is driven by Vegfc, we 
injected embryos with dll4 MO alone, dll4 MO with vegfc MO or dll4 MO with sFLT4 mRNA. 
For all treatments, the dll4 MO induced arterial hyper-branching phenotype was scored 
as either severe, mild or wildtype (no hyper-branching) (for examples, see Fig. S1 in the 
supplementary material). We found that the injection of either vegfc MO or sFLT4 mRNA 
rescued the dll4 excessive angiogenesis phenotype at 72 hpf (Fig. 4F).   We observed no ISA 
defects upon injection of either vegfc MO or sFLT4 mRNA at concentrations that completely 
inhibited lymphangiogenesis and also rescued the dll4 phenotype.  
flt4 and vegfc are expressed in arterial endothelial cells during angiogenesis and 
their expression is unaltered upon loss of dll4
To determine if the phenotype could be explained by changes in gene expression during 
arterial angiogenesis, we analysed the expression of flt4, vegfc, vegfd (figf – Zebrafish 
Information Network) and hey2 in dll4 morphants at 24 hpf.  We found flt4 expression to be 
present in all ISAs and in the dorsal aorta at 24 hpf, but rapidly down-regulated thereafter, 
with expression vastly reduced in arteries as compared with the PCV by 26 hpf (Fig. 5A,C). 
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We carefully staged dll4 MO injected and uninjected control embryos at 24 hpf (based on 
head angle and tail extension) and detected no appreciable change in flt4 expression in 
the ISAs at 24 hpf (Fig. 5 A,B) or later during down-regulation of flt4 expression (25, 27, 
29 and 31 hpf; see Fig. S2 in the supplementary material) although we cannot exclude the 
possibility of mild changes for which in situ hybridisation is insufficiently sensitive to detect. 
We next generated a flt4 promoter driven transgenic line utilising a 6.6 kb fragment of the 
flt4 5’UTR. We found that this promoter fragment drove expression of YFP in ISAs, the dorsal 
aorta and the PCV in both wildtype and dll4 MO injected embryos with no apparent change 
in expression levels in stage matched embryos (Fig. 5 D,E). In dll4 morphants at 24hpf, vegfc 
expression in the dorsal aorta (Fig. 5F,G) and vegfd expression in the tailbud (Fig. 5 H,I) were 
unchanged.  In addition, we observed no change in the expression of hey2, indicating that 
developmental gene expression programs in arterial endothelial cells were largely normal in 
dll4 MO injected embryos (Fig. 5 J,K).   
 
dll4 morphant arteries are sensitised to increased Vegfc during primary sprouting 
of intersegmental arteries
The arterial phenotype induced by the loss of dll4 is not be observed before 28-32 hpf, 
after which time the ISAs progressively display excessive angiogenesis and hyperbranching 
defects.  Given that this phenotype is dependent on Vegfc/Flt4 signalling we hypothesised 
that the introduction of excessive vegfc may increase the severity or alter the onset of the 
phenotype.  We introduced mRNA encoding full length zebrafish vegfc into wildtype and 
dll4 MO injected embryos in the TG(flt1:YFP) hu4624  transgenic background and examined 
the ISAs at 28 hpf, a timepoint preceding secondary sprouting of vessels from the PCV and 
the arterial phenotype induced by the knockdown of dll4.  We found that vegfc mRNA 
injection in combination with dll4 MO synergistically induced aberrant sprouting of ISAs, 
which turned bilaterally at approximately the level of the base of the neural tube in a 
distinctive manner (Fig. 5 L-N,P). This phenotype was robustly reproducible, was not present 
in embryos injected with dll4 MO only, and occurred only rarely upon injection of vegfc 
mRNA only (Fig. 5M,N,R). Interestingly, we also observed this phenotype upon injection of 
full length zebrafish vegfd mRNA, but found no difference when vegfd mRNA was injected 
in combination with dll4 MO (Fig. 5O,Q,R).    Taken together, these data indicate that in the 
absence of dll4, arterial cells are more responsive to exogenously introduced vegfc at stages 
prior to venous sprouting, confirming an early capability, as well as an ongoing, suppressive 
role for dll4 during Vegfc/Flt4 signalling in arterial angiogenesis.  
Overexpression of dll4 reduces sprouting from venous endothelium
Taken together, the above data suggest that dll4, which is restricted in expression to the 
early arteries in developing embryos (Leslie et al., 2007; Siekmann and Lawson, 2007), 
functions to suppress the response of arteries to Vegfc mediated Flt4 signalling.  This would 
predict that ectopic dll4 in embryonic veins may inhibit or reduce Vegfc/Flt4 driven venous 
sprouting.  To test whether this was the case, we injected mRNA encoding full-length dll4 
into TG(flt1:YFP) hu4624  embryos and examined the formation of venous sprouts at 52 hpf. 
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Fig. 4. The dll4 morphant hyper-branching phenotype is rescued in flt4hu4602 mutants, vegfc morphants and 
sFLT4 mRNA injected embryos. (A-D) Lateral views of uninjected control (A) and flt4hu4602 mutant (B) compared 
with wildtype (C) and flt4hu4602 mutant zebrafish embryos (D) injected with dll4 morpholino. Images taken in the 
TG(flt1:YFP)hu4624 background labelling trunk arteries to reveal the failure to form intersegmental venous sprouts in 
expando mutants (B), indicated by the yellow arrows.  The dll4 morphant arterial hyper-branching phenotype (C) is 
rescued in  flt4hu4602 mutants (D). Venous sprouts were identified by the absence of flt1:YFP expression in ISVs as 
indicated by the brackets. Embryos at 72 hpf. (E) Arterial hyper-branching phenotypes were scored post-injection 
of dll4 MO and subsequently genotyped.  The mutant genotype was almost completely absent from the severe 
category (e.g. C) (1/29 embryos, * p<0.01 by Chi Square test) and was enriched in the category not displaying 
hyper-branching (e.g. D) (21/55 embryos, # p<0.01 by Chi Square test). (F) In transgenic TG(flt1:YFP) hu4624  embryos, 
co-injection with dll4 MO together with vegfc MO (green bars, n=57 embryos), or of dll4 MO together with 
sFLT4 mRNA (200pg/embryo) (red bars, n=67 embryos) led to a rescue of the arterial hyperbranching phenotype 
observed upon injection of dll4 MO alone (blue bars, n=81 embryos). Arterial hyper-branching phenotypes were 
categorized as no hyperbranching (none), mild or severe (see Fig. S1 in the Supplementary material) 
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We identified venous sprouts by scoring the ventral segments of intersegmental vessels 
that did not express TG(flt1:YFP) hu4624  at 52 hpf. We found that dll4 overexpression led to 
cardiac defects and loss of circulation when injected at high doses but did not lead to the 
ectopic venous expression of flt1 (data not shown).   We selected embryos with normal 
blood circulation and omitted embryos severely affected by dll4 overexpression.  When the 
number of venous sprouts present across the first 12 intersegmental vessels anterior to 
the cloaca was scored, there was a significant reduction in the number of venous sprouts 
present in injected embryos compared with uninjected controls (Fig. 6).  
 
Discussion
Flt4 signalling is required for zebrafish lymphangiogenesis and venous sprouting
Here we describe a new zebrafish flt4 mutant phenotype that is caused by an amino acid 
substitution in the conserved split kinase domain of Flt4 (I1042S). Using this in vivo model, 
we have shown a strict requirement for normal Flt4 signalling for venous angiogenesis. We 
find that primary angiogenesis of ISAs can occur independently of normal Flt4 signalling in 
zebrafish. This finding is consistent with previous studies suggesting that ISA sprouting is 
chiefly regulated by Vegfa, Kdr and Kdr-l (Bahary et al., 2007; Covassin et al., 2006; Habeck 
et al., 2002; Lawson et al., 2003) but would suggest that previously described ISA morphant 
phenotypes for Vegfc and Flt4 do not reflect a requirement for wildtype kinase domain 
activity of the Flt4 receptor (Covassin et al., 2006). The defects in secondary sprouting from 
the veins observed in flt4hu4602 mutants are apparently identical to the previously described 
phenotypes of full of fluid (ccbe1) mutants and vegfc morphants (Hogan et al., 2009).
flt4 MO, vegfc MO or sFLT4 mRNA injections led to the failure of PHBC development but 
the defects observed were far less penetrant than lymphangiogenesis failure seen within 
the same injection experiments and were not observed in flt4hu4602 mutants. These data 
suggest (1) that there is a differential dosage sensitivity for Flt4 signalling during different 
Fig. 5. Sprouting intersegmental arteries express flt4 and are sensitised to exogenously introduced Vegfc in the 
absence of dll4. (A-E) At 24 hpf (A and B) the expression of flt4 is present in all arterial cells (A) and is unaltered 
upon loss of dll4 (B) (n=40 uninjected control and n=40 dll4 MO injected embryos scored). By26 hpf (C), flt4 is 
down-regulated in the dorsal aorta (n=20 embryos analysed). Analysis of a flt4 promoter-driven transgenic line 
identifies YFP expression in all arterial cells at 24hpf (D). The expression of YFP is unaltered in dll4 MO injected 
embryos (E). (F,G) At 24hpf the expression of vegfc is present in the dorsal aorta (F) and is unaltered in  dll4 MO 
injected embryos (G) (n=20 uninjected and n=20 MO injected embryos analysed). (H,I)  The expression of vegfd 
in the tailbud is unaltered in dll4 MO injected embryos (I) compared with uninjected control (H) embryos (n=20 
uninjected and n=20 MO injected embryos analysed). (J,K)  The expression of the arterial marker gene hey2  is 
unaltered in dll4 MO injected embryos (K) compared with uninjected control (J) embryos (n=20 uninjected and 
n=20 MO injected embryos analysed). (L-R) dll4 morphants are sensitised to exogenously introduced vegfc mRNA 
during arterial angiogenesis. Forced expression by the injection of mRNA encoding full length zebrafish vegfc into 
dll4 MO injected embryos (n=133) (P) led to aberrant ectopic bilateral turning of ISAs by 28 hpf (yellow arrows) 
which was never observed in either wildtype (L) or in those injected with dll4 MO only (n=90) (M). ISAs rarely turn 
bilaterally upon injection of vegfc mRNA only (n=106) (N), whereas injection of full length zebrafish vegfd mRNA did 
robustly show this phenotype without (O) (n=211) or with dll4 MO (Q) (n=227). For each of the conditions tested, 
the percentage of embryos showing wildtype, mild (aberrant ISAs spanning two somites) or severe (aberrant ISAs 
spanning more than two somites) ISA phenotypes is shown in (R).
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angiogenesis events and/or (2) that some degree of flt4 regulated angiogenesis may occur 
independently of kinase domain function. The scenario described here closely resembles 
that observed in the mouse, where mutants for Vegfc, double mutants for Vegfd and Vegfc 
together, or a hypomorphic Flt4 allele all produce lymphatic vascular specific defects, 
whereas the complete loss of Flt4 leads to defects in haemangiogenesis and early lethality 
(Dumont et al., 1998; Haiko et al., 2008).  
Dll4 function provides a mechanism by which arteries, but not veins, suppress the 
response to Vegfc driven Flt4 signalling during development 
Despite the lack of a marked arterial phenotype in flt4hu4602 mutants, we find that flt4 is 
actively transcribed in the ISAs and the dorsal aorta concurrent with sprouting arterial 
angiogenesis at 24 hpf. Furthermore, a source of Vegfc is present in the trunk derived from 
the dorsal aorta during this period.  We find that the severe hyper-branching phenotypes 
observed in the absence of dll4 are dependent on Vegfc and on Flt4 kinase domain activity, 
indicating that one function of dll4 is to suppress the arterial response to Vegfc/Flt4 signalling 
in developing arteries of the trunk.  Consistent with this, Dll4 depleted arteries are sensitised 
to increased Vegfc levels supplied exogenously by mRNA injection and the overexpression 
of dll4 reduces venous sprouting, which is dependent on Vegfc/Flt4 signalling.  Hence, the 
severe, progressive arterial hyperbranching phenotype that has been previously described 
upon loss of dll4 in zebrafish is predominantly a consequence of failing to suppress the ability 
of developing arteries to respond to endogenous Vegfc/Flt4 signalling.  A working model 
summarising the contribution of Dll4 in the context of arterial and venous angiogenesis and 
Vegfc/Flt4 signalling is outlined in Fig. 7. 
Changes in vegfc or flt4 expression do not explain the suppression of the arterial 
response to Vegfc/Flt4 signalling  
We find that flt4 transcript levels are progressively down-regulated in developing arteries 
after 24 hpf, an event likely to contribute to lowering the responsiveness of arteries to 
endogenous Vegfc. However, the increased responsiveness of dll4 morphants to Vegfc/Flt4 
signalling does not coincide with changes in vegfc or flt4 transcription. In particular, there is no 
change in vegfc or flt4 expression   in dll4 morphants during the formation of primary arterial 
sprouts (24-31 hpf) despite the fact that these sprouts are sensitised to increased levels of 
vegfc at early stages, prior to 28 hpf (Fig. 5). This indicates that dll4 can regulate Vegfc/Flt4 
signalling at a level independent of vegfc or flt4 gene transcription.  In zebrafish, it has been 
previously demonstrated that notch1b knockdown or chemical treatment with a γ-secretase 
inhibitor (DAPT) that blocks the cleavage of the Notch intracellular domain (Geling et al., 
2002) leads to the same increased exploratory behaviour of arterial endothelial cells that is 
observed upon dll4 loss-of-function (Leslie et al., 2007). This correlation is suggestive of dll4 
acting through intracellular Notch signalling and would indicate that altered transcription 
should precede an altered response to VegfC/Flt4 signalling.  In this context, the unchanged 
expression of the key molecular players (flt4, vegfc, vegfd) in dll4 morphants implies that 
other, yet to be identified, molecular regulators are involved.      
Dll4 suppresses Vegfc/Flt4 signalling
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Fig. 6. Overexpression of 
dll4  reduces sprouting 
from the PCV. (A,B) 
Injection of mRNA 
encoding full-length dll4 
into TG(flt1:YFP) hu4624 
zebrafish embryos leads 
to a reduction in the 
number of venous sprouts 
in injected embryos (B), compared with uninjected control embryos (A) at 52hpf.  ISAs that connect directly to the 
dorsal aorta (red bar) are indicated by yellow arrows.  Venous spouts (yellow brackets) can be readily identified by 
the absence of TG(flt1:YFP) hu4624 expression in the ventral component of an intersegmental vessel. Venous sprouts 
connect directly to the posterior cardinal vein (blue bar) from which they derive during secondary sprouting. (C) 
Quantification of the number of venous sprouts (Y-axis) on one side of the embryo across 12 segments anterior 
to the cloaca (n=23 embryos scored for both dll4 MO injected and uninjected controls). dll4 MO injected embryos 
showed a significant decrease in the number of intersegmental venous sprouts  (P <0.001, Mann-Whitney Rank 
Sum Test).
Fig. 7. Dll4 inhibits arterial Vegfc/Flt4 signalling in the developing zebrafish trunk (A-C) Expression analysis 
at 24hpf for dll4 (A), flt4 (B) and vegfc (C) indicates the arterial restricted expression of dll4, expression of flt4 
in all venous and arterial cells and expression of vegfc restricted to the dorsal aorta. (D) Schematic overview of 
the developing vasculature in the zebrafish trunk. DA indicates dorsal aorta; PCV, posterior cardinal vein; ISA, 
intersegmental artery; ISV, intersegmental vein; PL, parachordal lymphangioblast. (E) Working model of the 
interplay between Dll4 and Vegfc/Flt4 signalling. Previous studies  have shown that vegfa (vegfaa and vegfab 
duplicates in zebrafish) is necessary for ISA development [a (Bahary et al., 2007; Nasevicius et al., 2000)], that vegfc 
influences ISA development [b (Covassin et al., 2006)], and that the receptors kdr and kdr-l mediate intracellular 
signalling to control ISA development [c (Bahary et al., 2007; Covassin et al., 2009; Covassin et al., 2006; Habeck et 
al., 2002; Lawson et al., 2003; Meng et al., 2008)].  We have previously shown that vegfd is unlikely to play a role 
in ISA development due to its restricted expression [d (Hogan et al., 2009)].  Here we demonstrate that signalling 
through the Flt4 kinase domain (KD) does not contribute to ISA development as it is suppressed by Dll4 (dotted 
lines indicate that the mechanism of suppression is unknown).  In the absence of Dll4, endogenous Vegfc drives a 
Flt4 (KD) dependent ISA hyperbranching phenotype.  In the vein (which does not express dll4), Vegfc/Flt4 signalling 
is indispensable for normal venous angiogenesis and lymphangiogenesis.
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Interestingly, we find that vegfd mRNA injection alone can lead to the early ectopic 
turning of developing ISAs, but these defects were not enhanced upon knockdown of 
dll4.   Vegfd has varying capabilities in mammals: for example it is a Flt4 specific ligand in 
mouse but, like VEGFC, can bind to both VEGFR2 (KDR) and FLT4 in humans (Baldwin et 
al., 2001). The capability of Vegfd to stimulate aberrant angiogenesis of ISAs likely explains 
why the embryonic expression of vegfd is highly restricted to the tailbud during zebrafish 
development (Fig. 5) (Hogan et al., 2009). This restriction of vegfd expression would be 
required for normal arterial angiogenesis to occur in the absence of Flt4 activation.
Comparison of expression patterns and phenotypes for different Notch signalling 
components suggests combinatorial and context dependent roles during 
angiogenesis 
In the developing mammalian retina, both dll4 and flt4 display restricted expression in tip 
cells during angiogenesis (Hellstrom et al., 2007; Tammela et al., 2008).  In zebrafish, we did 
not see any restricted expression of flt4 in tip cells at 24 hpf during ISA angiogenesis and dll4 
expression is found in all arterial cells at this stage (as discussed in (Leslie et al., 2007)). In the 
developing mouse trunk, Flt4 expression is also seen in all arterial cells of the intersegmental 
vasculature although it is enriched in tip-cells when assayed by immunohistochemistry 
(Tammela et al., 2008). These data suggest context dependent differences in the expression 
patterns of Flt4 and Dll4. 
Previous studies in zebrafish have shown that mindbomb mutants (which cause a block in 
intracellular Notch signalling) have up-regulated flt4 expression throughout the developing 
arterial system (Lawson et al., 2001) and rbpsuh morphants have up-regulated expression 
specifically in the tip cells of arterial sprouts (Siekmann and Lawson, 2007).  However, we 
found no marked increase in flt4 expression by in situ hybridisation in dll4 morphants, 
suggesting significant differences between loss-of-function phenotypes for different Notch 
pathway components during angiogenesis.  Furthermore, the phenotype seen upon 
MO knock-down of rbpsuh is observed earlier than that of dll4 morphants or mutants. 
Dramatically increased arterial angiogenesis is seen in rbpsuh morphants during the initial 
stages of primary sprouting (Siekmann and Lawson, 2007) whilst dll4 morphants or mutants 
(Leslie et al., 2007) do not display defects until hours later.  Given that multiple Notch ligands 
are expressed and capable of acting during  angiogenesis in vertebrates (Benedito et al., 
2009; Lawson et al., 2001; Smithers et al., 2000), it is likely that the combinatorial use of 
ligands contributes to these differences in loss-of-function phenotypes. It seems plausible 
that differences in Notch ligand or receptor gene expression patterns and activities could 
be very widely utilised to allow for unique, context dependent and restricted Vegf signalling 
outputs in order to generate diverse spatial and temporal responses during angiogenesis in 
the embryo or the adult.   
Taken together, the above findings indicate that one function of arterial Dll4 is to inhibit 
the responsiveness of arteries to Vegfc, whilst the development of the venous and lymphatic 
lineages (which do not express dll4) are completely dependent on Vegfc/Flt4 signalling in 
the developing zebrafish trunk.  This mechanism contributes to the differential response 
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of arteries and veins to a constant source of Vegfc in the embryonic trunk and further 
characterises a specific role of the Notch ligand Dll4 in regulating the Vegfc/Flt4 signalling 
axis. 
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Supplemental Material
Supplementary information, including 2 figures can be found in the data supplement or 
online, at http://dev.biologists.org/cgi/content/full/136/23/4001/DC1.    
Supplementary Figure 1: Categories of hyperbranching scored in Figure 4. (A-C) Examples of embryos categorised 
as having no sprouting defects (wildtype) (A), Mild sprouting defects (B) or severe sprouting defects (C) at 72 hpf 
taken from experiment summarised in Figure 4F.  Arrows in B and bracket in C indicate regions of hyperbranching.
Supplementary Figure 2: 
No appreciable change in 
arterial flt4 expression in 
dll4 morphants between 
25 and 31 hpf. (A-H)
Expression of flt4 in trunk 
arteries and veins in 
stage matched wildtype 
uninjected control and 
dll4 MO injected (6ng/
embryo) embryos.  No 
difference was observed 
at 25 hpf (A and B) 
between control (n=15 
embryos) compared 
with morphant (n=28) 
embryos. At 27 hpf (C and 
D), no difference was seen between carefully stage matched control (n=18) and morphant (n=29) embryos. Some 
morphants that were clearly developmentally delayed (n=11) showed higher levels of flt4 expression than controls, 
consistent with the dynamic down regulation of ISA flt4 expression between 25 and 29 hpf, and demonstrating 
the need to stage match rather than age match embryos during this analysis. At 29 hpf, (E and F, n=16 control and 
n=34 morphant embryos analysed) and at 31 hpf (G and H, n=16 control and n=33 morphant embryos analysed), 
no difference was observed in the ISA expression of flt4 between control and morphant embryos. Embryos from 
the same morpholino injection sessions were grown to 3dpf and the robust dll4 MO induced hyperbranching 
phenotype observed, demonstrating that the embryos anaylsed were morphants
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The subject of this thesis is the molecular and genetic regulation of the differentiation of angioblasts into a functional network of blood and lymphatic vessels, with a focus on the early stages of development of the vascular tree. The complex vertebrate body 
requires an effective means of transportation of liquids, gases, nutrients and circulating 
cells to tissues and organs for its normal functioning. This requirement is met by the blood 
and lymphatic vessels. Over the past few decades, it has become increasingly apparent 
that the malformation or malfunctioning of blood and lymphatic vessels contributes to 
an important part of the pathogenesis of diseases like cancer, atherosclerosis, myocardial 
infarction and others (Cueni and Detmar, 2006; Alitalo et al., 2005; Adams and Alitalo, 2007). 
It has been hypothesized that controlling the angiogenic growth potential of the vascular 
tree could be an effective strategy for preventing tumor growth and tumor metastasis 
(Folkman, 1992; Ferrara, 2004). Alternatively, controlled stimulation of angiogenic growth 
could be of great value in alleviating ischemic conditions by reconstituting local tissue 
perfusion. Recent research has greatly improved our understanding of the origin and 
growth of the vascular system concurrent with the identification of several genetic factors 
essential during this process. However, some fundamental questions, like what are the 
genetic factors required for the migration or differentiation of the angioblasts, remain 
unanswered. To contribute to the growing knowledge on endothelial cell biology we have 
designed a screening strategy to identify novel players in the genetic control of vessel 
development and growth. The findings of this study are briefly summarized here.
In chapter 2 we elaborate on the setup of the screen which was the starting point for 
this work. For this screen we made use of the respective strengths of two model organisms; 
mouse (Mus musculus), which is widely used within endothelial cell biology, and zebrafish 
(Danio rerio), a relatively new but increasingly widely used model organism.  To determine 
the genetic pathways of angioblast emergence and subsequent angiogenesis we performed 
a global expression analysis of endothelial cells during early vascular development in mouse 
embryos by using a combination of FACS sorting and microarray gene-profiling. The genetic 
fingerprint conveyed by these analyses was further characterized by a whole mount in situ 
hybridization screen in zebrafish. The positive identification of a given candidate gene was 
followed by an assessment of its function using a morpholino based (Nasevicius and Ekker, 
2000) gene knock-down strategy. Functional data for candidate genes that could be linked to 
the process of vascular development provided the basis for the in depth analyses described 
in chapters 3 to 6. Taken together, we analyzed nearly 400 transcripts of individual gene 
products in our in situ hybridization screen and found 61 genes with an expression pattern 
closely linked to the endothelial lineage.  Eleven of these vascular restricted genes were not 
or only poorly characterized and thus included in our functional analyses (see chapter 3 to 
6). In summary, we have developed a robust, high-throughput means of screening for and 
characterizing of novel genes involved in vascular development by the use of the combined 
strengths of both mice and zebrafish as model organisms.
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sox7 and sox18 are redundantly required for arteriovenous differentiation 
In chapter 3 we describe a novel role for sox7 and sox18 in the process of arteriovenous 
differentiation in zebrafish embryos. Both genes are part of the Sox-F family of transcription 
factors, are expressed in early angioblasts and continue to be expressed in the vascular bed 
at later stages of development of the zebrafish embryo (Herpers et al., 2008; Cermenati 
et al., 2008; Pendeville et al., 2008). Single knock-down of either sox7 or sox18 did not 
yield any obvious vascular malformations, whereas combinatorial repression of both gene 
functions led to arteriovenous shunting and fusion. Next to the arteriovenous fusions we 
observed based on immuno-histochemistry, we detected a marked change in both arterial 
and venous marker gene expression: the dorsal aorta (DA) showed a loss or reduction of 
several arterial markers and concurrent ectopic expression of venous markers. Similar 
examples of redundancy within the Sox-F family of transcription factors can be found in 
mice or tadpoles, where for example Sox17 and Sox18 or sox7 and sox18 respectively play 
redundant roles in cardiovascular development (Sakamoto et al., 2007; Zhang et al., 2005). 
Unsurprisingly, a similar role for members of the Sox-F family of transcription factors in 
arteriovenous differentiation can be observed in other species. In humans, mutations in 
SOX18 cause vascular, lymphatic and hair follicle defects in subjects with dominant and 
recessive forms of hypotrichosis-lymphedema-telangiectasia (HLT) syndrome (Irrthum et 
al., 2003). Vascular dysfunction in HLT is characterized by cutaneous telangiectasias and 
other abnormal dilations of the superficial vasculature. HLT has been attributed to recessive 
missense mutations within the SOX18 HMG-type DNA binding region and, in one case, to a 
dominant nonsense mutation that interrupts the trans-activation domain and removes the 
native C-terminus of the SOX18 protein. Sox18 mutations also underlie the ragged series 
of spontaneous mouse mutants, which all show phenotypes reminiscent of the syndromes 
typical for human HLT patients. The four alleles of ragged (ragged (Ra), ragged-Jackson 
(RaJ), ragged-like (Ragl) and ragged-opossum (RaOp)) carry single base deletions in Sox18 
associated with the trans-activation domain-encoding region, reflecting the dominant 
mutation observed in HLT. In contrast to the dominant-negative loss of function of SOX18 
as a result of these mutations (Downes and Koopman, 2001), SOX18-null mice did not 
reveal any vascular dysfunction (Pennisi et al., 2000). It has been hypothesized that the 
point mutations found in the ragged series of mouse mutants generate a SOX18 protein 
that acts in a dominant-negative fashion to hamper wildtype SOX18 function and of related 
proteins that underlie the phenotypes observed upon disruption. In SOX18-null mice this 
dominant-negative character is diminished by the compensatory action of other redundant 
SOX factors (James et al., 2003; Downes and Koopman, 2001), which is indeed reflected by 
our studies in zebrafish. As the interplay of the various SOX factors in the process of vascular 
development appears largely conserved across species, the zebrafish could be an attractive 
model organism to use to elucidate the downstream targets of these transcription factors. 
In a recent study, Sox18 was shown to be directly upstream of Prox-1, placing itself at a 
central point of lymphatic development (Francois et al., 2008). Other putative downstream 
targets of the SOX transcription targets could be rapidly verified in the zebrafish using either 
in situ hybridization or a gene knock-down strategy.  
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agtrl1b is required during angiogenesis
The G protein-coupled receptors Angiotensin receptor like 1b (Agtrl1b) and Agtrl1a, which 
have been duplicated in the zebrafish genome, are expressed in the developing vasculature 
where they serve as a receptor for the Apelin (Apln) peptide (Tucker et al., 2006; Scott et al., 
2007; Zeng et al., 2007). This small, diffusible ligand is locally produced at the dorsal side of 
the embryo during primary angiogenesis and diffuses in a gradient across the dorsoventral 
axis. The Apln gradient is sensed by the intersegmental sprouts emerging from the DA, 
which facilitates the normal growth of the ISVs toward the dorsal side of the trunk and the 
subsequent formation of the dorsal longitudinal anastomitic vessels (DLAVs). We showed 
that the ISVs show abnormal migratory behavior upon loss of agtrl1b and a concurrent 
failure of formation of the DLAV. No differences were found in the number of endothelial 
cells within a single ISV in agtrl1b mutants compared to wildtype siblings, arguing against 
the possibility that Agtrl1b-Apln signaling exerts a mitogenic function on the endothelial 
cells of an ISV during angiogenesis. Analysis of the extending filopodia of the ISVs during 
angiogenic migration showed a clear reduction in both number and length of these filopodia 
in agtrl1b mutants compared to wildtype siblings. The function of the extending filopodia 
formed at the tip of migrating ISVs is to probe the environment for directional cues (Gerhardt 
et al., 2003). Thus, loss or reduction of the number of filopodia could very well explain the 
reduced migratory behavior of the ISVs in agtrl1b mutants. Previous studies showed that 
upon stimulation with Apln, Agtrl1b can activate Cdc42 through the activation of the PI3K/
Akt pathway (Masri et al., 2005; Kojima and Quertermous, 2008), which in turn induces 
cytoskeletal rearrangements and the formation of filopodia (Shiojima and Walsh, 2002; 
Sasaki and Firtel, 2006). This would suggest that Apln not only sets out the directional cue 
for chemotactic migration, but also amplifies the response of migrating endothelial cells by 
inducing the formation of filopodia upon binding to its receptor. Both apln receptors (agtrl1a 
and agtrl1b) are expressed in the endothelial compartment, with agtrl1b being expressed in 
all endothelial cells and agtrl1a being restricted to the venous compartment. This differential 
expression pattern for both gene duplicates might prove insightful in unveiling the potential 
function of agtrl1a during angiogenesis. The recent acquirement of a zebrafish agtrl1a 
mutant will be instrumental in studying the role of agtrl1a during secondary sprouting from 
the PCV. If agtrl1a-apln signaling in secondary sprouts from the PCV has a similar function 
to that of agtrl1b-apln signaling in primary sprouts from the DA, it is to be expected that 
the secondary sprouts from the PCV would fail to migrate in a wildtype fashion in agtrl1a 
mutants. As a result of this, potentially fewer venous intersegmental vessels or PLs would be 
formed, resulting in defective lymphangiogenesis in these animals. 
The role of dll4 during lymphangiogenesis
In chapter 5 we put forward a novel role for Dll4-Notch signaling during lymphangiogenesis. 
Lymphangiogenesis is initiated by Sox18-induced localized expression of Prox-1 in the 
cardinal vein (Francois et al., 2008). Prox-1 positive endothelial cells within the cardinal vein 
will transdifferentiate to lymphatic endothelial cells and bud off from the cardinal vein to 
contribute to lymphangiogenesis (Wigle et al., 2002). In zebrafish, lymphatic precursor cells 
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(termed parachordal lymphangiogenic cells (PLs)) arise during secondary sprouting from 
the posterior cardinal vein (PCV). Approximately one half of the sprouts that emerge from 
the PCV during secondary sprouting have angiogenic potential and remodel the primary 
arterial sprouts to venous connections, whereas the other half of secondary sprouts have 
lymphangiogenic potential and ultimately contribute to lymphatic development (Hogan 
et al., 2009; Chapter 5 of this thesis). In our study we find that in zebrafish embryos with 
compromised Dll4-Notch signaling, the proportion of venous intersegmental vessels (vISVs) 
is increased as a result of a larger proportion of the secondary sprouts from the PCV that 
connect to and remodel the primary sprouts. As a consequence, fewer or no PLs as well 
as fewer arterial intersegmental vessels (aISVs) are present in zebrafish embryos with 
compromised Dll4-Notch signaling. During these studies we also found a close association 
of the PLs with the aISVs, which appeared to serve as guidance templates for PL migration 
during lymphangiogenesis. The few residual PLs that still formed upon loss of Dll4-Notch 
signaling would thus be deprived of these migratory templates, contributing to the failure 
of formation of lymphatic vasculature in zebrafish embryos with compromised Dll4-Notch 
signaling. The close association of lymphatic cells with intersegmental arteries and the 
localized expression of dll4 in zebrafish arteries are suggestive of a potential role of the 
arteries contributing to the development of lymphatic vessels. The analogy with other model 
organisms would dictate that particular cells in the dorsal roof of the PCV become specified 
to differentiate to lymphatic endothelial cells in response to Sox18-Prox1 signals, eventually 
contributing to lymphangiogenesis. To date however, no specification marker of lymphatic 
commitment in zebrafish embryos has been identified. Although the DA and PCV develop in 
close association with each other, and even make physical contact during early development, 
it is an open question as to how dll4 exerts its function on the endothelial cells of the PCV. 
Notch1b, a receptor for dll4, is highly expressed in the DA, but can also be detected at 
low levels at discrete locations of the dorsal roof of the PCV. In a scenario where there is 
physical contact between dll4 expressing arterial endothelial cells and notch1b expressing 
venous endothelial cells, an instructive signal to lymphangiogenesis could be conveyed. 
Alternatively, the secondary sprouts that arise from the PCV could fulfill a rather passive 
role during lymphangiogenesis, whereas the already formed primary sprouts from the DA 
would then dictate the final specification (angiogenic vs. lymphangiogenic) of the secondary 
sprouts from the PCV. In this model, the reconnection of a secondary sprout from the PCV 
with a primary sprout from the DA (thus fulfilling an angiogenic role) is defined by dll4-notch 
signaling within the primary (DA-derived) sprout. Secondary sprouts from the PCV that are 
not recruited by the primary sprouts from the DA to remodel the intersegmental vessel to an 
intersegmental vein continue their dorsal migration and contribute to the lymphatic lineage. 
In this scenario the molecular nature of lymphatic commitment can arise either as a default 
state by the downregulation of vascular markers, as is seen by the downregulation of kdr-
l:mCherry in the PLs (Chapter 5 of this thesis), or by another, as of yet unknown, mechanism. 
Either way, lineage differentiation of venous endothelial cells towards lymphatic endothelial 
cells would be controlled by the activity of Dll4-Notch signaling in the arterial derived 
intersegmental vessels. The reported role for dll4 in limiting angiogenesis and the increased 
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number of angiogenic sprouts and connections being formed upon loss of dll4 (Siekmann 
and Lawson, 2007, Leslie et al., 2007), provide a logical explanation for the supernumerary 
fraction of venous intersegmental vessels. During angiogenesis, the leading cells of the ISV 
sprouts (tip cells) and the cells that follow behind them (stalk cells) show intense filopodial 
activity and express similar levels of dll4 (Leslie et al., 2007). When filopodial activity ceases 
upon formation of the DLAV, it ceases throughout the entire population of intersegmental 
endothelial cells. It has been suggested that the contact between the tip cells of the sprouts 
that meet triggers this event through the mutual activation of Notch, (Leslie et al., 2007). 
Timelapse confocal imaging of the primary sprouts showed an increased filopodic behavior 
of the endothelial cells at the ventral base of a primary sprout (Chapter 5 of this thesis), 
which suggests prolonged angiogenic potential of these cells even after formation of the 
DLAV. From this observation, it would follow that a greater number of secondary sprouts 
would be reconnected to the vascular system and few sprouts from the PCV would undergo 
lymphatic commitment. Future studies that utilize mutants defective in primary sprouting 
from the DA, but not secondary sprouting from the PCV, should yield insights into the exact 
role of the intersegmental arteries during lymphangiogenesis. According to this model, 
an increase in the number of PLs would be expected, since fewer primary arterial sprouts 
are present to remodel the secondary sprouts. Other studies, including transplantation of 
wildtype arterial endothelial cells into dll4 morphant hosts or ablation of whole arteries 
should contribute to answering the question whether lymphangiogenic development in 
zebrafish embryos is primarily controlled by cellular and molecular processes in the PCV or 
intersegmental arteries. 
dll4 restricts vegfc-flt4 signaling in arteries
In chapter 6 we elaborate on the role of Dll4 in restricting the response of developing 
zebrafish intersegmental arteries to Vegfc-Flt4 signaling. This work was initiated upon the 
isolation of the mutant expando from a forward genetic screen aimed at finding novel 
players in lymphatic development. Molecular characterization of expando mutants revealed 
a loss-of-function mutation in the highly conserved kinase insert region of flt4. Secondary 
sprouting, including both venous and lymphangiogenic sprouting, from the PCV in flt4 
signaling mutants was completely abolished, in agreement with previous reports on the loss 
of vegfc (Küchler et al., 2006; Hogan et al., 2009). Although flt4 is consistently expressed in 
the PCV, but also DA and ISVs, primary, arterial angiogenesis proceeded normally in expando 
mutants. Previous studies have shown that Flt4 signaling is required for hemangiogenesis and 
that Dll4 limits angiogenic potential by limiting Flt4 function in developing vessels (Tammela 
et al., 2008). Strikingly, dll4 loss-of-function induced an arterial hyper-branching phenotype 
(Siekmann and Lawson, 2007, Leslie et al., 2007), which was rescued when dll4 morpholinos 
were injected in flt4 signalling mutants.  Furthermore, we found that ectopic expression 
of the Flt4 ligand Vegfc is capable of driving arterial hyper-branching in the absence of 
dll4. Upon knockdown of dll4, intersegmental arteries were sensitised to increased vegfc 
levels, while ectopic expression of dll4 reduced Vegfc/Flt4 dependent sprouting from the 
PCV.  In summary, these data demonstrate that dll4 suppresses the ability of primary ISVs to 
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respond to Vegfc driven Flt4 signalling in zebrafish. This sophisticated mechanism of control 
contributes to the differential response of developing arteries and veins to a constant source 
of Vegfc present in the embryo during angiogenesis. 
Clinical implications 
In the westernized world, the two major causes of lethality are cardiovascular diseases and 
cancer, both of which are linked to vascular dysfunction. Increasing evidence of hereditary 
genetic aberrations as a risk factor in vascular malformations has underlined the importance 
of research in the field of the genetic regulation of endothelial cell biology. Some of the genetic 
factors identified in this screen have already been linked to a human pathological condition, 
such as HHT and HLT for Sox18 (Irrthum et al., 2008). Given the role of the Sox-F factors 
in cardio-vascular and lymphatic development, these transcription factors have become 
attractive targets for therapies designed to control angiogenesis or lymphangiogenesis 
(Francois et al., 2009). It has already been shown that a dramatic reduction of tumor growth 
through the reduction of angiogenesis occurs in mice lacking Sox18 function (Young et al., 
2006). With the utilization of zebrafish as a novel model organism for the function of Sox18, 
previously impossible studies on the molecular nature of HHT and HLT become feasible. 
The evolutionarily conserved nature of the genetic control of vascular development 
also enables us to study the process of tumor growth and tumor metastasis. The ability of 
endothelial cells to grow and proliferate in response to secreted growth factors is hijacked 
by tumors to allow tumor vascularization and growth (Holash et al., 1999). Similarly, tumor 
metastasis chiefly occurs through the spread of tumor cells via the lymphatic system. Thus, 
both growth and spread of tumors is facilitated by the endothelial lineage, which would 
be a highly attractive target during cancer treatment. Some exciting clinical progress has 
been made in limiting tumor growth by the use of monoclonal antibodies targeted at VEGF 
(Ferrara, 2004; Hurwitz et al., 2004; Laskin and Sandler, 2005). Nonetheless, these strategies 
have also been shown to induce tumor hypoxia and resulting tumor resistance by a systemic 
feedback loop of VEGF production. Similarly, withdrawal of the anti-VEGF treatment leads to 
rapid re-growth of endothelial sprouts into empty sleeves of vascular basement membranes 
that function as a scaffold for revascularization. As not all tumors are sensitive to anti-VEGF 
therapies, and as initialy susceptible tumors might become resistant, additional targets will 
be required to exploit the full advantages of anti-angiogenesis therapies. Currently, the 
inhibition of Dll4 function is being developed as a method to induce aberrant growth of tumor 
associated vasculature, leading to non-functional vasculature and reduced tumor growth 
(Noguera-Troise et al., 2006). Unlike VEGF, compromised Dll4 function leads to excessive, 
but non-productive, angiogenesis, which leads to decreased tumor growth (Thurston et 
al., 2007, Li Harris 2009). The vessels that form in the absence of Dll4 are highly branched 
and often lack a vessel lumen or are too disorganized to support perfusion of the tumor. 
Combinatorial blockage of both the DLL4-Notch and VEGF pathways inhibits tumor growth 
in preclinical models and may lead to exciting new therapies for clinical application. In this 
context, it is noteworthy that our studies on the role of Dll4 in suppressing Flt4/VEGFC-
dependent angiogenesis suggest that Dll4 inhibitors might exhibit a higher therapeutic effect 
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in tumors expressing high levels of VEGFC by increasing non-productive tumor angiogenesis. 
Besides increased non-productive tumor angiogenesis upon Dll4 inhibition, a concurrent 
block in tumor lymphatic growth upon Dll4 blockage might also be induced as our studies 
show a specific requirement for Dll4 during lymphangiogenesis. 
General Discussion & Future Directions
The emergence of the heamangioblast is an essential step towards vascular development 
(Choi et al., 1998; Vogeli et al., 2006). These pluripotent cells form the precursors to the very 
first steps in both hematopoietic development and vascular development. The question of 
heamangioblast emergence and subsequent differentiation towards endothelial cell fate 
has been a central question in vascular and stem cell biology for a long time.  The reverse 
genetic screen described within this thesis addressed the molecular mechanisms that 
underlie early vascular development. This resulted in the identification of several (novel) 
factors contributing to angiogenesis and lymphangiogenesis, as described within this thesis. 
In recent years a number of other studies have addressed a largely similar question, using 
a slightly different approach (Weber et al., 2005; Sumanas et al., 2005; Eckfeldt et al., 2005; 
Covassin et al., 2006, Wong et al., 2009). A quantitative comparison of the various screens 
conducted using zebrafish to identify novel regulators of vascular development showed that 
well known key players in vascular development were nearly all identified with a relatively 
large overlap between our and other studies. In all studies, the number of newly identified 
genes associated with vascular development represented only a fraction of the total 
number of genes involved in vascular development, suggestive of a degree of saturation 
of such screens. Nonetheless, new genes involved in more specialized requirements of 
vascular development are still being discovered, whereas only few key regulators of early 
vasculogenic events have been identified over the last few years (e.g. Sumanas and Lin, 
2006). Although no direct comparison between the different screens can be made, a 
qualitative comparison of the various screens favored our screen over others in that it used 
a cross-species approach that combined functional analyses with expression data, rather 
than relying on expression data alone. Conserved gene expression across different species 
positively correlates with conserved gene function, i.e. a gene with vascular expression in 
both mouse and zebrafish is highly likely of fulfilling a similar role in the process of vascular 
development in both species. These implications, together with other advantages of cross-
species screening, including relative ease and speed of screening could greatly benefit future 
studies aimed at the identification of regulators of tissue specific development. Moreover, 
with the recent availability of transgenic zebrafish that express fluorescent proteins in only a 
subset of the endothelial cell lineage, previously unattainable experiments become feasible. 
For instance, a purified population of either arterial, venous or lymphatic endothelial cells 
can be obtained by FACS sorting of the right combination of transgenic fish. Expression 
analysis of such populations has the potential of answering some of the fundamental 
questions outstanding.   
The initial goal of identifying novel regulators of vascular development was met by the 
discovery and characterization of several genes, but to what extent can these discoveries 
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lead to a better understanding of vascular development? The de novo formation of the 
vasculature is defined by three distinct stages; during vasculogenesis, mesodermally 
derived angioblasts coalesce and give rise to the major axial vessels, followed by 
subsequent angiogenesis in which capillaries sprout from pre-existing vessels (Risau et al., 
1995; Carmeliet, 2000).  Finally, a transdifferentiation of a subset of venous endothelial 
cells will allow for lymphangiogenesis during which the lymphatic vasculature is formed 
(Adams and Alitalo, 2007). Although this screen was designed to uncover regulators of 
early vascular development, all three abovementioned stages are covered by the genetic 
factors identified in this work. The demarcation between these stages is clear; however it 
has become increasingly obvious during this study that no such demarcation is reflected 
in the genetic control of the three stages of vascular formation. For example, sox7 and 
sox18 control arteriovenous differentiation, which takes place during vasculogenesis. Later, 
during lymphangiogenesis, Sox18 fulfils a second, different role in controlling the induction 
of Prox-1 expression in lymphangioblasts (Francois et al., 2008). Similarly, dll4 limits the 
angiogenic potential of sprouting blood vessels (Siekmann and Lawson, 2007, Leslie et al., 
2007), and at later stages contributes to lymphatic development (Chapter 5 of this thesis). 
Other examples such as the intimate relationship between the development of arteries 
and that of veins (Lawson and Weinstein, 2002; Herbert et al., 2009), as well as the close 
association of developing lymphatic vessels with arterial intersegmental vessels (Chapter 5 
of this thesis) suggests that the three stages of vascular development mentioned are highly 
linked processes that share many common molecular and genetic regulators. Rather than 
having differing genetic factors for differing vascular developmental processes, precise 
temporal and spatial control of action of re-used genetic factors controls the development 
of the vertebrate embryo. Therefore, the study of individual genetic factors during vascular 
development should not be limited to only a single aspect of the endothelial lineage, but 
rather take into account the vasculature as a whole. 
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Hart- en vaatziekten vormen naast kanker de belangrijkste doodsoorzaak in de westerse 
wereld. Om deze ziektes beter te kunnen bestrijden is het van belang om beter te begrijpen 
hoe zulke ziektes ontstaan. Hiertoe wordt veel onderzoek gedaan naar de normale functie 
van hart- en bloedvaten, maar ook naar wat er mis kan gaan, zoals tijdens aderverkalking. 
Binnen dit onderzoek hebben we de vraag hoe bloedvaten ontstaan centraal gesteld. 
Meer specifiek hebben we gekeken welk deel van het erfelijk materiaal betrokken is bij de 
aanmaak van nieuwe bloedvaten, en wat de functie van specifieke delen van dit erfelijk 
materiaal binnen dit proces is.
Elk levend organisme bestaat uit cellen, die erfelijke informatie bevatten, opgeslagen in 
het DNA. Het DNA is het genetisch materiaal wat nodig is voor de aanmaak van eiwitten. 
Elk eiwit wordt afgeleid van een specifiek deel van aaneengesloten DNA, ook wel een gen 
genoemd. Naar schatting bevat het menselijke DNA zo’n 25.000 genen. Niet al deze genen 
zijn tegelijkertijd actief binnen één cel. Zo wordt het onderscheid tussen bijvoorbeeld een 
zenuwcel, een bloedcel en een huidcel bepaald door welke combinatie van genen actief 
is binnen deze cellen. Voor heel veel eiwitten, en dus ook genen, kan een gelijkwaardige 
kopie worden gevonden wanneer de mens met soortgelijke organismen wordt vergeleken. 
Zo delen zebravissen ongeveer 75% van het erfelijk materiaal met mensen, terwijl onze 
gemeenschappelijke voorouders alweer zo’n 300 miljoen jaar geleden leefden. Dit 
komt omdat essentiële levensprocessen, zoals de aanleg van het hart- en bloedvaten 
systeem, zo belangrijk zijn dat de genen betrokken bij dit proces bewaard zijn gebleven 
gedurende de evolutie. Gezien de grote genetische overeenkomsten tussen verschillende 
organismen kunnen sommige soorten worden ingezet als modelorganisme voor de mens in 
wetenschappelijk onderzoek, zoals ook de zebravis. Een volwassen zebravis wordt ongeveer 
3 à 4 cm groot en wordt gekenmerkt door het typische strepenpatroon dat over zijn lijf 
loopt. Gezien de geringe grootte van de zebravis is het mogelijk om tegen relatief lage 
kosten grote aantallen te houden. Zebravissen worden geslachtsrijp na 2 à 3 maanden en 
een volwassen zebravis vrouwtje kan tot soms wel 1000 eitjes per legsel produceren. Het 
feit dat deze eitjes zich buiten de moeder ontwikkelen, tezamen met de transparantie van 
de zebravisembryo maakt het tot een ideaal systeem voor de visualisatie van verschillende 
ontwikkelingsprocessen. Daarnaast ontwikkelt een zebravisembryo zich razendsnel; al een 
dag na bevruchting van de eicel heeft het embryo een kloppend hart en circuleert er bloed 
door de bloedvaten. Dankzij deze redenen is sinds drie decennia de zebravis in zwang als 
klein modelorganisme voor wetenschappelijk onderzoek. Binnen dit onderzoek zetten wij 
de zebravis in voor de bestudering van de genetische regulatie van de ontwikkeling van 
bloedvaten. 
In hoofdstuk 2 beschrijven we een nieuwe methode voor het ontdekken en beschrijven 
van onbekende genen die een rol spelen in de ontwikkeling van het bloedvatenstelsel. Hiertoe 
hebben we cellen uit de bloedvatwand van muizenembryo’s geïsoleerd, om vervolgens te 
analyseren welke genen actief zijn (tot expressie komen) in deze cellen. Voor deze genen 
hebben we bekeken of ze ook actief zijn in de vaatwand van de zebravis. Zodra we vonden 
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dat dit het geval was, gingen we over tot de functionele karakterisatie van het betreffende 
gen. Dit hebben we gedaan door deze genen één voor één uit te schakelen. De defecten die 
ontstaan in de vorming van het bloedvatstelsel nadat een gen wordt uitgeschakeld geven 
een aanwijzing over de functie van dit gen in de natuurlijke situatie. 
In hoofdstuk 3 wordt de functie van de genen sox7 en sox18 bestudeerd. Deze twee 
genen behoren tot dezelfde klasse van genen en zijn beide actief op eenzelfde locatie 
binnen het bloedvatenstelsel. Simultane uitschakeling van deze genen in zebravisembryo’s 
heeft tot gevolg dat er haast geen circulatie van bloed meer tot stand komt. Dit ondanks 
het feit dat er normale hoeveelheden bloed worden gevormd en dat het hart normale 
contractiliteit vertoont. Tegelijkertijd hebben we kunnen aantonen dat deze embryo’s fusies 
van de aders en slagaders vertonen (zogenaamde shunts), wat verklaart waarom het bloed 
vroegtijdig richting het hart terugvloeit of zelfs helemaal niet in circulatie komt. Analyse van 
een aantal genen dat betrokken is bij de segregatie van aders en slagaders (zogenaamde 
arterioveneuze differentiatie) toonde aan dat de expressie van arteriële genen binnen 
de aorta na uitschakeling van sox7 en sox18 sterk gereduceerd was. Anderzijds bleek de 
expressie van veneuze genen nu ook aanwezig te zijn binnen de aorta. Hiermee hebben 
we kunnen aantonen dat sox7 en sox18 een essentiële rol vervullen in het aansturen van 
de expressie van genen die de arterioveneuze differentiatie van bloedvaten controleren. 
In zowel muizen als mensen leiden defecten in Sox18 functie tot vergelijkbare vasculaire 
afwijkingen. Zo heeft men elders aangetoond dat hypotrichosis-lymphedema-telangiectasia 
(HLT), een ziektebeeld gekenmerkt door haarverlies, lymfe- en bloedvatdefecten, wordt 
veroorzaakt door defecten in SOX18. Onze bevindingen tonen aan dat een defect in de 
arterioveneuze differentiatie van de bloedvaten een mogelijke oorzaak vormt voor de 
vorming van de telangiectasias in patiënten met HLT. 
In hoofdstuk 4 gaan we in op de uitgroei van de vertakkingen van het bloedvaten 
stelsel en welke rol het gen agtrl1b hierin speelt. In onze studie hebben we gevonden dat 
de vertakkende vaten die normaliter uit de hoofdslagader worden gevormd onvoldoende 
uitgroeien wanneer agtrl1b wordt uitgeschakeld. Eerder heeft men al aangetoond dat 
agtrl1b wordt aangetrokken door apelin als een kompas naald die naar het noorden wordt 
aangetrokken. Dit apelin wordt geproduceerd op de locatie waar de vertakkende vaten 
naartoe groeien. Wat wij hebben kunnen aantonen is dat de hoeveelheid cellen in deze 
vertakkende vaten hetzelfde is in vissen waarin agtrl1b is uitgeschakeld in vergelijking 
met normale vissen. Het werkelijke defect van deze cellen zit hem in de mate waarin deze 
zich voortbewegen; zij bewegen veel minder en vertonen ook minder karakteristieken die 
typerend zijn voor migrerende cellen.
In hoofdstuk 5 bestuderen we de rol van het gen dll4 in de aanmaak van lymfevaten. 
Wat we hebben kunnen aantonen is dat wanneer dll4 wordt uitgeschakeld, er geen enkel 
lymfevat wordt aangemaakt. Van lymfevaten is bekend dat ze oorspronkelijk ontstaan vanuit 
de hoofdader. Wij hebben kunnen aantonen dat de cellen die uit deze hoofdader ontstaan 
zich niet meer gedragen als lymf cellen, maar juist als bloedvat cellen wanneer dll4 wordt 
uitgeschakeld. Als een consequentie van het veranderde karakter van deze oorspronkelijke 
lymf cellen worden er middels een complex proces van herverbindingen van bloedvaten 
méér veneuze vaten gevormd ten kosten van het aantal arteriële vaten. Dat lijkt in eerste 
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instantie een onschuldig iets, maar aangezien we ook voor het eerst hebben aangetoond dat 
lymfevaten zich consequent langs een arterieel vat vormen, heeft dit desastreuze gevolgen. 
De geijkte paden waarlangs deze lymfevaten zich normaal zouden vormen zijn dus niet, of 
in lagere aantallen, aanwezig, waardoor eventuele cellen die zich wel als lymf cel gedragen 
geen normaal lymfevat meer kunnen vormen. Lymfevaten vormen een belangrijke route 
waarlangs tumoren zich verspreiden (zogenaamde metastaseringen). Een manier om de 
spreiding van tumoren tegen te gaan is dan ook door de groei van lymfevaten te blokkeren. 
Dll4 functie wordt al in soortgelijke behandelingen geblokkeerd om de bloedvatgroei 
naar tumoren te remmen. Onze bevindingen suggereren dat Dll4 ook een aantrekkelijke 
kandidaat vormt om lymfvat groei naar tumoren te blokkeren. 
Tenslotte beschrijven we in hoofdstuk 6 hoe het gen dll4 een rol speelt bij de regulering 
van flt4/vegfc signalering in arteriën. Het feit dat één en hetzelfde gen (dll4 in dit geval) 
meerdere functies kan vervullen vormt een mooie illustratie van hoe de natuur effectief met 
haar middelen omspringt. Flt4 is een gen dat specifiek een rol speelt in de bloedvaatwand. 
Flt4 kan echter pas normaal functioneren nadat het geactiveerd is, door in dit geval vegfc, dat 
specifiek bindt aan flt4. Wanneer bepaalde cellen vegfc uitscheiden, zullen de bloedvaten 
hierop reageren via flt4 (ook wel flt4/vegfc signalering genoemd). Wat we hebben kunnen 
aantonen is dat de wildgroei van bloedvaten die plaatsvindt wanneer dll4 is uitgeschakeld 
wordt opgeheven zodra ook flt4/vegfc signalering wordt onderdrukt. Wanneer we vegfc 
voortijdig introduceren terwijl dll4 is uitgeschakeld vinden we dat de arteriële bloedvaten 
hierop reageren door extra materiaal te produceren. De arteriële bloedvaten zijn dus als 
ware gevoelig geworden voor vegfc wanneer dll4 afwezig is. Hieruit hebben we kunnen 
concluderen dat een van de functies van dll4 is om flt4/vegfc signalering in arteriën te 
onderdrukken. Deze bevinding biedt interessante perspectieven voor de bestrijding van 
tumoren. Zo scheiden tumoren stoffen uit (o.a. Vegfc) die de groei van bloed- en lymfevaten 
naar de tumor bevorderen, wat de groei en spreiding van de tumor weer bevordert. Sinds 
enige jaren probeert men de groei van tumoren te remmen door de groei van bloedvaten 
naar de tumor te verhinderen. Dll4 is een geschikte kandidaat gebleken om de bloedvatgroei 
te remmen. Onze bevindingen suggereren dat tumoren die Vegfc uitscheiden een verhoogde 
gevoeligheid zullen vertonen wanneer een tumor wordt behandeld met Dll4 remmers. 
Dit onderzoek heeft een sterk fundamenteel karakter, dat er aanvankelijk op uit is de 
kennis en begripsvorming rondom de aanleg van het cardiovasculaire stelsel te vergroten. 
Zulk soort fundamenteel onderzoek vormt soms een directe basis voor verder geneeskundig 
onderzoek. Zo is bijvoorbeeld het erfelijkheidsonderzoek erop gericht om te bepalen of 
iemand een erfelijke aanleg heeft voor een ziekte en of die aanleg ook bij andere familieleden 
voorkomt. Genetisch onderzoek zoals dat beschreven is in dit proefschrift kan leiden tot de 
ontdekking van nieuwe genen die, wanneer er fouten in optreden, de oorzaak vormen voor 
het ontstaan van erfelijke cardiovasculaire ziektes. Tevens biedt dergelijk onderzoek een basis 
voor de bestrijding van bepaalde tumoren, door hun groei en verspreiding tegen te gaan. 
Anderzijds kan de kennis over de groei van bloedvaten worden ingezet om bloedvatvorming 
te stimuleren. Zo zouden mensen erbij gebaat zijn als na hartfalen de doorbloeding van de 
hartspier gestimuleerd zou worden, zodat de hartspierfunctie weer genormaliseerd wordt. 
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